Skip to content
Pharma Observatory a Scientist.com platform
  • Supplier site
  • Group of sites (click to zoom)

Scientist.com supplier network (site locations)

Research supplier

Vector Laboratories

Vector Laboratories is listed as a mid sized business research supplier in the Scientist.com network, with 4 sites in 2 countries and 2 service areas.

View Vector Laboratories on Scientist.com

Sign in to Scientist.com to open this supplier in your organization's marketplace.

Email me this page as a PDF

Search companies, drugs, suppliers and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Sites 4
Countries 2

Services

What this research supplier says it provides, as listed in the Scientist.com network.

Type of company: Mid sized business

Agricultural Sciences Compliance and Quality Control Measures

  • Ecological Toxicity testing for terrestrial and aquatic animals and plants.
  • Endocrine Screening Screening to determine risk due to disruption of the endocrine system.
  • Environmental Impact Tests designed to determine environmental impact of product.
  • Exposure Tests which assess human health impact upon exposure of product.
  • Fusarium Plate Test Determine the abundance of a specific fusarium species in seed or foliar samples to inform treatment regimen.
  • GMO Seed Testing Evaluate whether or not a seed has been genetically altered from its native state.
Show all 38 in Agricultural Sciences Compliance and Quality Control Measures 32 more
  • Grain Quality Testing Use various tests to assess intrinsic and extrinsic factors for grain quality characterization.
  • Herbicide Volatility Field Trial Evaluate factors influencing pesticide vaporization and risk for vapor drift to direct steps for volatility reduction.
  • Juvenile Growth Test Examine the adverse effects of recurrent and long-term toxin exposure on juvenile fish development.
  • Master Seed Testing Test your Master Seed Bank or Master Virus Seed Stock (MVSS) to insure that the Working Virus Bank or Working Virus Seed Stock (WVSS) remains the same genotype and phenotype as the initial Master Seed Bank.
  • Microbial Pesticides Testing requirements for registration of microbial pesticide products.
  • National Pollutant Discharge Elimination System Analyze tests according to permits issued by the National Pollutant Discharge Elimination System permitting authority.
  • Non-GMO Certification Ensure compliance with non-GMO standards and obtain formal recognition.
  • OECD 104: GLP Vapour Pressure Measure the vapor pressure of a test substance.
  • OECD 106: Adsorption Study Estimate the adsorption/desorption behavior of a chemical on different soil types.
  • OECD 213: Honey Bee Acute Oral Toxicity Test Expose adult bees to a test chemical by feeding over 2 days for short-term toxicity assessment.
  • OECD 214: Honey Bee Acute Contact Toxicity Test Expose adult bees to a test chemical by topical application over 2 days for short-term toxicity assessment.
  • Pesticide Product Testing Use laboratory assays to evaluate the efficacy, safety and selectivity of a pesticide under GLP standards.
  • Plastic Biodegradability Testing Biodegradation testing helps to determine the lifespan and behaviour of plastic materials in the environment, which is crucial for waste management.
  • Product Performance Antimicrobial efficacy and invertebrate control agent testing.
  • Product Properties Determination of physical and chemical properties of product
  • Production and Preservation Assistance with the transfer of primary products to end consumer.
  • Residue Chemistry Pesticide residue and tolerance testing.
  • Resource Conservation and Recovery Act Perform tests in accordance to the Resource Conservation and Recovery Act for disposal of pesticides
  • Sediment-Water Toxicity Test Isolate the water of a sediment-based habitat to analyze the properties for toxicity evaluation.
  • Seed Cleaning Remove foreign material from seeds in compliance with the Plant Variety Protection Act (PVPA).
  • Seed Genetic Purity Test (Non-Hybrid) Utilize sensitive and robust methods to evaluate the genetic purity of non-hybrid seed lots.
  • Seed Germination Test Assess the potential of live seeds to develop into normal seedlings under conducive conditions.
  • Seed Health Test Meet safety standards by using different tests to verify the absence of seed disease and defects.
  • Seed Identification Test Use protein extracts from an unknown seed sample to determine the identity.
  • Seed Moisture Test Measure the water content of seed sample and assess related physiological properites.
  • Seed Physical Purity Test Separate the parts of a seed sample to determine the percentage by weight of each component.
  • Seed Technology Process, test, and conserve food and agricultural seeds to improve quality of seeds
  • Seed Vigor Test Use a range of tests to monitor seed capacity for plant growth under sub-optimal conditions.
  • Seed Weight Test Measure the weight of a seed sample to calculate the corresponding weight of commercial quantities.
  • Soybean Performance Testing Evaluate key agronomic traits of soybean varieties to inform farming practice for optimal harvest.
  • Spray Drift Testing requirements for the movement of product through air.
  • Whole Effluent Toxicity Methods Perform Whole Effluent Toxicity tests to determine toxicity of wastewater effluent.

Agricultural Sciences Research & Development

  • Agro-product Storage Stability Testing Monitor agro-product changes over time to optimize packaging, storage conditions and product longevity.
  • Agrochemical Analytical Method Development Engineer sensitive and selective methods that meet GLP validation requirements to assess different agrochemical properties.
  • Agrochemical Identification Product identification and composition of pesticides; which includes fungicides, insecticide, herbicides and nematicides analysis.
  • Agrochemical Physio-Chemical Testing Conduct extensive property characterization of agrochemicals for geo-specific product approval and registration.
  • Animal Feed Supplements Test for mineral nutrients and medicinal compounds for the prevention or control of disease.
  • Bacteriology PCR and MS-Based Bacterial Identification
Show all 26 in Agricultural Sciences Research & Development 20 more
  • Biofortification Efficacy and effectiveness studies in the enhancement of nutrients in plants
  • Chemical and Physical Determination of chemical and physical properties of pesticide product.
  • Chronic Whole Effluent Toxicity(WET) Test Identify the effluent dilution that impairs growth, development or reproduction in aquatic organisms in 7 or more days of exposure.
  • Crop and Seed Genetic Engineering Genetics screens using microarrays, transcriptomics, or gene sequencing to find the best genes to be selected for improved crop varieties.
  • Crop Sustainability (site specific) Research physical environmental (weather, soil, minerals, etc) affects crop for sustainability
  • Diagnostic Reagents Creation of custom reagents and certified standards when commercial source is not available or meeting diagnostic needs.
  • DNA/Protein analysis Analyze DNA and proteins for allergens, pathogens and species identification.
  • Gene Isolation and cloning Development of methods for isolation of gene(s) of interest.
  • General Agrochemical Compound Library Find potential compound candidates for agrochemical or agro-product research and development.
  • GMO and GE Viability Measure the viability and germination rate of genetically engineered organisms
  • Hormone & Soil Conditioning Agents Detection of emerging chemicals of concern.
  • Method Development & Validation Engineer sensitive and selective methods that meet GLP validation requirements to access different agrochemical properties
  • Micropropagation Growing entire plants from small pieces of plant tissue in a cultured medium
  • Molecular Markers Use of molecular diagnostics to analyze biological markers in the genome and proteome.
  • Pesticide Conduct field trials to determine environmental risk assessment and associated studies pertaining to residue, efficacy, soil dissipation and the like.
  • Plant Preservation Storage of genetic information (germ-plasm) for future use
  • Qo Inhibitors (Quinone Outside Inhibitors) Determine anti-fungal activity against a wide range of fungal diseases.
  • Soil Science Test for microbial inoculants that promote plant health
  • Synthetic Fertilizers Determination of heavy metals and other toxic compounds in addition to composition.
  • Vaccines Testing transgenic plants as promising systems for vaccine production.
Show all 2,355 services 2,343 more

Animal Science and Welfare Audits

  • Vendor Audits/Qualifications vendor audits for non-GLP and GLP nonclinical CROs throughout the US and Canada.
  • Veterinary Support Lab technician and veterinarian services providing support for model organisms and animal husbandry.
  • Vivarium Support Source procurement, housing, husbandry, and care of laboratory animals as well as designing, building and managing vivarium facilities.

Antibodies

  • Affinity Maturation Use mutagenesis to optimize a complementary determining region and increase antibody affinity.
  • AlphaLISA Quantification of analytes with high sensitivity, wider dynamic range and no wash steps involved.
  • Antibody based Assay Development Create specific and sensitive assays for the immunodetection of disease-specific target antigens.
  • Antibody Conjugation Conjugate an enzyme, biotin, or fluorophore to an antibody.
  • Antibody Detection Quantitate, localize and visualize proteins and other antigens.
  • Antibody Discovery Identifying and developing antibodies that specifically bind to target antigens for therapeutic or diagnostic use.
Show all 40 in Antibodies 34 more
  • Antibody Expression with GenScript Antibody production per 96 well plate at 1-2mg scale including expression, yield quantification with HP-SEC for aggregate analysis
  • Antibody Humanization Increase an antibody's similarity to a variant produced naturally in humans.
  • Antibody Isotype Switching Modify antibody isotypes from any species to any human IgG isotype.
  • Antibody Products Purchase antibody, antibody pair kit or ELISA kit.
  • Antibody Protein De Novo Sequencing Sequence antibody proteins using multiple enzyme digestion and high-resolution LC-MS/MS.
  • Antibody Purification Purify multiple antibody types including IgG, IgM, IgA and IgY.
  • Antibody Reagents Request information or a price quote for Antibody Reagents services
  • Antibody Reformatting Re-configure antigen binding regions into soluble antibody fragments or full-length monoclonal antibodies.
  • Antibody Sequencing Sequence cDNA encoding variable heavy (VH) and variable light (VL) domains of a hybridoma cell line.
  • Antibody Therapy Efficacy In vivo assessment of monoclonal/bispecific antibody efficacy in a humanized mouse
  • Antibody-Dependent Cell-Mediated Cytotoxicity Request services related to cell-mediated immune defense.
  • Antibody-Drug Conjugation Improve therapeutic properties of an antibody or drug by joining them together.
  • Antigen Binding Fragment (Fab) Create antigen-binding antibody fragments that lack the heavy-chain constant region.
  • Antigen Specific T-cells T cell lines that recognize specific peptide antigens to enable analysis of T cell immunity.
  • Biotin-Antibody Conjugation Biotinylate an antibody for improved detection.
  • Custom Antibodies Design and produce polyclonal and monoclonal antibodies.
  • Direct Antibody Labeling Conjugate a primary antibody to a label for direct antigen detection.
  • Epitope Mapping Map the antibody-antigen binding region to define protein-protein interaction sites.
  • Hybridoma Sequencing/Antibody Sequencing Determine the sequences of monoclonal antibodies.
  • Immunodetection Use antibodies to identify a protein or antigen.
  • In Silico Humanization Predict epitope binding specificity, increase in vivo half-life and allow rapid modeling and humanization of antibodies.
  • In Vitro Monoclonal Antibody Production Generate monoclonal antibodies in vitro using cultured antibody-secreting hybridoma cell lines.
  • Integrated Antibody Development Package-US Process an entire Antibody Development Pipeline Project including: Antigen Synthesis, Antibody Generation, Antibody Characterization, Antibody Modification, Antibody Purification, Antibody Products from our bundle...
  • Membrane Proteome Array (MPA) Services Use a high-throughput, cell-based platform for profiling antibody specificity that targets human membrane proteins.
  • Monoclonal/Polyclonal Antibody Development Develop a monoclonal and/or polyclonal antibody.
  • OmniRat Transgenic Animal Platform Produce humanized antibodies using a transgenic rat platform.
  • Pepscan Analysis Screen overlapping peptide sequences to identify linear epitopes.
  • Phosphospecific Antibodies Create antibodies to detect phosphorylated protein targets.
  • Polyclonal Antibody Production Generate polyclonal antibodies in vivo using evolutionary distant animal species.
  • Polyclonal/Monoclonal Antibody Production Generate polyclonal or monoclonal antibodies in a range of animal species, over-express antibodies in cultured cells.
  • Rabbit Monoclonal Antibody Development Develop monoclonal antibodies using rabbit as the host animal.
  • Recombinant Antibody Production Request services related to antibody production services.
  • Single Chain Variable Fragment (scFv) Create an antigen-specific antibody derivative using a linker to join a heavy and a light variable chain.
  • Yeast Display Discover or optimize eukaryotic proteins and antibodies that contain post translational modifications

Bioimaging

  • 3D Bioprinting 3D bioprinting uses 3D printing techniques to fabricate living tissues and organs by layering cells, growth factors, and biomaterials layer by layer
  • Ab-Targeted Positron Emission Tomography Visualize sites of HIV replication that are difficult to access by tissue biopsies.
  • Bioimaging Visualize biological process non-invasively in real time.
  • Confocal/Optical Microscopy Use optical imaging technique to increase optical resolution and contrast of a micrograph.
  • Cryo Electron Microscopy Examine the 3D structure of biological complexes and organelles.
  • Cryo-electron Tomography This advanced imaging technique is used to visualize the detailed structures of biological samples at near-atomic resolution in their native state.
Show all 34 in Bioimaging 28 more
  • Cryo-EM Study the structure the stucture of macromolecular at near atomic resolution.
  • DEXA Body Composition Scan DEXA (Dual-Energy X-ray Absorptiometry) body composition scans are used in medical imaging to measure body composition (including fat and lean body mass and bone mineral density).
  • Electron Microscopy Examine the fine structures of molecules, cells and tissues with sub-nanometer resolution.
  • Fluorescence-Lifetime Imaging Microscopy (FLIM) Use FLIM to produce an image based on the differences in the excited state decay rate from a fluorescent sample.
  • Functional Ultrasound Functional ultrasound (fUS) is an advanced imaging technique used to study brain activity and other physiological processes in real time.
  • In Vivo Imaging In-vivo imaging using PET, MRI, CT etc.
  • In Vivo Positron Emission Tomography (PET) Imaging Image tumor progression or conduct biodistribution investigations in experimental animals injected with a radiolabeled molecular probe.
  • In Vivo Whole Tissue and Animal Imaging Visualize, analyze and track light producing reporters in whole animals.
  • In Vivo Whole Tissue and Animal Imaging Analysis Analysis of images from in vivo studies produced using PET, MRI, CT, etc. in a variety of species.
  • In-vivo Fluorescence In-vivo fluorescence enables visualisation and the study of biological processes in live organisms by using fluorescent markers.
  • Luminescence Imaging Monitor biological processes and pathologies using reporter proteins such as firefly and Renilla luciferase.
  • Magnetic 3D Bioprinting Fabricate spheroids representative of native cellular environments and easy to handle.
  • Magnetic Resonance Imaging Use MRI to obtain chemical and physical information about molecules and map the internal structure of an object.
  • Magnetoencephalography (MEG) Magnetoencephalography (MEG) is a non-invasive neuroimaging technique that measures the magnetic fields produced by neuronal activity in the brain to map brain function.
  • Mass Spectrometry Imaging Visualize the spatial distribution of molecules, as biomarkers, metabolites, peptides or proteins by their molecular masses
  • Medical Imaging Visualize and analyze internal structures in animal models or patients.
  • Micro Electron Diffraction (MicroED) Use electron diffraction to determine the structure of biological materials.
  • Microscopy Use microscopy to analyze surfaces of biological materials and to develop 3D images of biological structures.
  • Photoactivated Localization Microscopy (PALM) Visualize and localize individual endogenous fluorophores.
  • Positron Emission Tomography (PET) Imaging Use PET imaging with radioactive agent to visualize and measure metabolic processes in the body.
  • Scanning Electron Microscopy Examine the fine structures of molecules, cells and tissues with sub-nanometer resolution.
  • Second-Harmonic Generation Imaging Microscopy (SHIM) Visualize biomolecular arrays in cells, tissues, and organisms.
  • Single Molecule Localization Microscopy Enable structural resolution of biological samples at the nanometer range using light in the visible spectrum.
  • SPECT-CT and PET-CT Imaging Get images that combine the spatial context of metabolic or biochemical activity with an anatomic image.
  • Super Resolution Microscopy Utilize fluorescence microscopy and super-resolution techniques including STED, SIM, SMLM, and/or STORM to directly observe living subcellular structures and activities.
  • Thermal and Acoustic Imaging Measure the dielectric and optical properties of biological tissues corresponding to pathological states.
  • Ultrasonography diagnostic imaging technique, or therapeutic application of ultrasound.
  • X-Ray Powder Diffraction Structural analysis of crystalline powders via X-rays to detect and quantify polymorphs

Biomarkers

  • Adipogenesis Assay Detect and quantify intracellular triglyceride accumulation in adipocytes.
  • Anatomic Pathology Do macroscopic, microscopic, biochemical, immunologic and molecular examination of organs and tissues.
  • Antimicrobial Effectiveness Testing Measure the efficacy of anti-microbial preservatives added to a product.
  • Antioxidant Assays Use biochemical, cell-based or in vivo assays to measure total antioxidant capacity.
  • Autoantibody Testing Screen for the presence of an autoimmune disorder.
  • Basic Metabolic Profiling Set up assays that monitor drug metabolite formation after administration of drug to an animal model or patient.
Show all 91 in Biomarkers 85 more
  • Biomarker Analytical Validation Assess and optimize the characteristics of a candidate biomarker to ensure reproducibility and consistency.
  • Biomarker Clinical Utility Evaluate the potential clinical applications of a candidate biomarker.
  • Biomarker Clinical Validation Evaluate the predictive ability of a candidate biomarker for a disorder.
  • Biomarker Discovery Identify a biomarker associated with disease progression of disease, effectiveness of therapy or diagnosis of disease or condition.
  • Biomarker Services Evaluating normal/abnormal biological conditions and characteristics within the body
  • Bone Resorption Assay Functionally analyze osteoclast activity in vitro.
  • Cell Membrane Lipidomics Study the pathways and networks of membrane lipids.
  • Cell Migration Assays Measure chemotaxis, haptotaxis, transmigration and wound-healing.
  • Cell Viability Measure changes in cell number, cell division, DNA content or a cell metabolism marker such as ATP levels.
  • Cerebrospinal Fluid Analysis Use CSF to detect or monitor a variety of nervous system diseases or conditions.
  • Chemotaxis Assays Investigate the in vivo or in vitro movement of cells towards or away from a chemotactic agent.
  • Clinical Chemistry Measure analytes in serum, plasma, cells, tissue lysates or other biological materials.
  • Colony Forming Cell Assay Examine ability of hematopoietic stem cells to form colonies in vitro.
  • Complete Blood Count Set of medical laboratory tests that provide information about the cells in blood.
  • Complete Metabolic Panel Testing Detect electrolyte or glucose imbalance to identify or monitor related disorders.
  • Creatine Kinase (CK) Testing Detect and monitor pathologies associated with muscle inflammation or damage.
  • Customized Primary Cell Isolation Plan and execute the isolation of primary cells from a specific biosample.
  • Cytogenetics Examine the structure and function of the cell, especially chromosomes.
  • Cytokine Release Assay Use in vivo or in vitro assays to detect unregulated or excessive release of pro-inflammatory cytokines.
  • Diagnostic Biomarkers Discovery Identify candidate biomarkers indicative of the presence of a disorder.
  • Digital Biomarkers Objective, quantifiable physiological and behavioral data that are collected and measured by means of digital devices such as portables, wearables, implantables, or digestibles.
  • Digital Pathology Acquire, manage and interpret pathology information generated from a digital image of a slide preparation of cells or tissue.
  • Endocrine Assays Use biochemical, cell based or in vivo assays to measure the concentration of hormones.
  • Epigenetics Epigenetics sits at the cutting edge of drug discovery. The ability to modify genomes without changing any sequences with methylation.
  • Extended Banding Enhance chromosome structures to enable improved screening for abnormalties.
  • Flow Cytometry Identify fluorescently-labeled cells or physically separate cells from a larger population using biomarkers.
  • Fluorescent In Situ Hybridization Use FISH to identify abnormal chromosome structures and to quantify specific DNA sequences.
  • Focus Forming Assay Use colorimetric or immunofluorescence-based readouts to quantify virions prior to any plaque formation.
  • Genomics Genomic services including applications to DNA (*sanger sequencing, whole genome amplification, library screening, cloning, sub-cloning, and DNA isolation*) and RNA (*microRNA analysis, RNA isolation, qRT-PCR, mRNA...
  • HCS Assay Development Requesting services related to HCS assay development.
  • Hematology CBC Run automated and manual complete blood cell counts (CBCs) as well as microscopic evaluations of cell types.
  • Hematoxylin & Eosin (H&E) Staining Visualize microscopic structures in cells or tissues.
  • Histamine Release Assay Use in vivo or in vitro assays to measure the release of histamine in response to an allergen stimulation.
  • Histopathology Evaluate slide preparation of cells or tissues for abnormal features.
  • Human Primary Cell Isolation Isolate primary cells from various human tissues.
  • Immunoassays Create antibody-based assays for the identification and quantification of specific antigens.
  • Immunohistochemistry Examine the toxic effects of pre-clinical compounds in small animal and patient histological samples.
  • Immunophenotyping Separate cell types based on their expression of biomarkers or based on their individual and unique expression patterns.
  • Immunostaining Use labeled antibodies to detect proteins or other antigens in cells or tissues.
  • In Vivo Apoptosis Detection Visualize and quantify apoptosis in real time.
  • Insulin Autoantibodies (IAA) Testing Detect the risk or presence of type 1 diabetes in early childhood.
  • Interferon Gamma Release Assay Use in vivo or in vitro assays to measure the cell-mediated immune response to an infectious agent.
  • Islet Cell Autoantibodies (ICA) Testing Detect Type 1 diabetes-related autoantibodies.
  • Large Molecule Bioanalysis Detect and analyze the pharmacokinetic profile of small molecules.
  • Lipid Kinase Assays Use biochemical, cell-based or in vivo assays to measure lipid kinase activity.
  • Lipid Peroxidation Assay Use in vitro or in vivo assays to evaluate the effects of oxidative stress on lipid structure and function.
  • Lipid Profiling Use quantitative analysis of blood lipid components to assess cardiac risk.
  • Lipoprotein Associated Phospholipase A2 Testing Assess vascular inflammation and determine the risk for atherosclerosis or arterial plaque rupturing.
  • Metabolomics Biomarker Discovery Identify and quantitate metabolite biomarkers in blood, urine, CSF and bodily fluids.
  • Microalbumin/Creatinine Ratio (MACR) Screen for kidney disease or monitor the extent of kidney damage from disease complication.
  • Microbiome Services Examine the community of commensal, symbiotic, and pathogenic microorganisms that make up the microbiome.
  • Microfluidics-Based Biomarker Isolation and Detection Isolate and detect rare biomarkers in blood samples, such as CTCs, cfDNA, and exosomes.
  • Multi-Omics Study Use an integrated multi-omics study to understand a disease mechanism.
  • MultiOmyx Molecular Pathology Tumor Analysis Assess multiple proteins from a single tissue section at a single-cell level.
  • Multiplex Circulating miRNA Assay Profile miRNAs directly from just 10 μl of crude biofluid or 0.1 ng of purified RNA.
  • Myeloperoxidase Testing Detect inflammatory markers and determine the risk for atherosclerosis or arterial plaque rupturing.
  • NBE Biomarkers Request information or a price quote for NBE Biomarkers services
  • Osteoclasts Measure osteoclast activity and bone resorption in human, mouse or rat assays.
  • Oxidized Low Density Lipoproteins (LDL) Testing Identify the risk for metabolic syndrome and the development of associated diseases.
  • Paraffin-based Histology Perform sectioning and histological analysis of wax-embedded samples.
  • Peptide Bioanalysis Analyze the structure of Peptides.
  • Peritoneal Fluid Analysis Determine the cause of fluid accumulation in the peritoneal space.
  • Pharmacodynamic Biomarkers Discovery Identify candidate biomarkers indicative of the therapeutic outcome of a drug-target interaction.
  • Plaque Assays Determine infectious viral titer using plaque-forming units or purify viral stocks.
  • Platelet Function Testing Evaluate complete platelet function in vivo or in vitro.
  • Predictive Biomarkers Discovery Identify candidate biomarkers suggestive of a response to a treatment.
  • Prognostic Biomarkers Discovery Identify candidate biomarkers representative of disease progression without treatment.
  • Propidium Iodide FACS Analysis Use DNA staining and flow cytometry to analyze the cell cycle and detect apoptosis or cell proliferation.
  • Protein Bioanalysis Quantitative measurement of xenobiotics (drugs and their metabolites, and biological molecules in unnatural locations or concentrations) and Proteins in biological systems
  • Protein Glycosylation Mapping Technique Map glycosylation sites in proteins using liquid chromatography and mass spectrometry.
  • Protein Tomography Visualize individual proteins or complexes in three dimensions using COMET (Constrained Maximum Entropy Tomography) software.
  • Proteocarta™ HCP Detect Services Identify and track host cell proteins (HCP) with mass spectrometry for higher sensitivity and coverage.
  • Single Cell Isolation Isolate single cells for subsequent single-cell analysis.
  • Single Cell quantitative Real Time-PCR Assess gene expression levels and patterns in a single cell.
  • Single Cell Transcriptome Sequencing Detect distinct, rare or abnomal cell types in a heterogenous population.
  • Small Molecule Bioanalysis Detect and analyze the pharmacokinetic profile of small molecules.
  • Solid Tumor CDx Design and validate companion diagnostics for solid tumors that help select the most appropriate patients, identify patients at increased risk, or monitor treatment effectiveness.
  • SomaScan Proteomic Assay Measure 11,000 protein measurements from a 55-µL sample.
  • Spatial Metabolomics The study of the spatial distribution and localization of metabolites within biological tissues using advanced imaging and analytical techniques.
  • Special Stainings Use a variety of techniques for the selective visualization of specific tissue or cell types.
  • Stem Cell Analysis Assess hematopoietic, neural and mesenchymal cell progenitor proliferation and differentiation.
  • T Cell Epitope Characterization Evaluate the potency and immunodominance of T-cell epitopes within a molecule.
  • TUNEL Assay Detect in situ DNA fragmentation.
  • Whole Transcriptome Amplification Amplify total RNA from a single cell.
  • Wound Healing Assay Use cell-based assays to investigate cell proliferation, cell migration and wound closure.

Biometrics

  • Specialty/Niche Labs Find providers covering a broad range of services that go beyond routine testing and analyses to support clinical trials.

Brand Communications

  • Patient-HCP Communication Aids Design and development of tools (visuals, guides, devices) that facilitate clear, accurate, and empathetic two-way dialogue between patients and their healthcare providers.

Cell Culture and Characterization

  • 3D Cell Culture Use a scaffold-based or scaffold-free format to grow three dimensional cell and tissue structures.
  • Adherent Cell Culture Grow monolayers of anchorage-dependent cells.
  • alvetex® 3D Cell Culture Technology Use alvetex® technology, a highly porous interconnected scaffold, for routine 3D cell culture.
  • Bacterial Cell Culture Culture and Grow bacterial cells.
  • Cell and Tissue Histology Prepare and stain frozen, fixed and embedded (FFPE) tissue samples.
  • Cell Culture Culture primary or immortalized cell lines.
Show all 50 in Cell Culture and Characterization 44 more
  • Cell Line Authentication Verify the identity and purity of an experimental cell line or industrial culture.
  • Cell Line Characterization Track source history and characterize cell lines to establish identity, purity and stability.
  • Cell Line Construction Create new recombinant cell lines to exact specifications.
  • Cell Lines Purchase culture reagents, cell lines and cellular material of any species. Cell Lines typically refer to legacy immortalised cells, that can be cultured and passaged “indefinitely” Primary Cells are cells that have...
  • Cell Sorting The purpose of cell separation is to isolate a cell population from other cells in a biological sample.
  • Cell Transfection Produce, package and optimize transfection of your siRNA or DNA construct.
  • cGMP Cell Banking Request information or a price quote for cGMP Cell Banking services
  • Chromosomal Characterization Establish karyotype/chromosome profile by cytogenetic analysis of cell preparation.
  • Cryo-based Histology Perform sectioning and histological analysis of frozen non-fixed samples.
  • Custom 3D Microtissue Development Convert cell lines into highly functional 3D microtissues using scaffold-free self-assembly.
  • Endotoxin Characterization Identify specific molecular structure (e.g., Lipid A profiling), determine bacterial source/strain, and assess biological potency of endotoxins
  • Explant Culture Culture cells obtained from a part or parts of an in vivo structure.
  • Gene-Edited iPSCs Disease Models Use gene-edited iPSCs to model human diseases.
  • H & E Services For requesting services related to H&E Services
  • Histology Examine by microscopy the anatomy of cells and tissues of clinical patients and animal models.
  • In Vitro Hydrogel-Based Culture of PDXs Enable the extended laboratory culture of cancer PDXs and other primary cells in 3D.
  • Induced Pluripotent Stem (iPS) Cell Reprogramming Generate induced pluripotent stem cells from adult somatic cells.
  • Insect Tissue Culture Grow insect cells.
  • Isogenic Knockout iPSC Lines Mimic loss of function of genes associated with various diseases and disorders.
  • Karyotyping Evaluate the number and appearance of chromosomes in the nucleus of a eukaryotic cell.
  • Lab On The Skin - The Sweat Analysis Platform Use a skin-like microfluidic wearable device to measure sweat production in response to exercise.
  • Lipofection Transfection of DNA/RNA using lipofection reagents to create lipoplexes.
  • Microphysiological system (MPS)/organoid analytics microTMA produced from fixed microtissues (MPS)
  • Microphysiological Systems/organoid transcriptomics Microphysiological Systems/organoid transcriptomics
  • Microsatellite Instability Analysis Compare allelic profiles and detect genomic instability.
  • Mycobacterium Screening Detect and distinguish between mycobacterium strains and species.
  • Neurosphere Generation Neurosphere generation is a laboratory technique for culturing and studying neural stem cells by growing them in suspension to form free-floating clusters (neurospheres).
  • Organotypic Culture Co-culture different cells to enable in vitro growth of an in vivo tissue or organ equivalent.
  • Recombinant Technology Manipulate genotypes to introduce or modify the expression of specific cell products or physical traits.
  • Resin-based Histology Perform sectioning and histological analysis of epoxy/acrylic/polycarbonate-embedded samples.
  • RNA-Based Transfection Deliver RNA to cells by microinjection, electroporation or lipid-mediated transfection.
  • Signaling Pathways Find proteins, assays and custom reagents for the analysis of cell signaling pathways.
  • Single Cell DNA Sequencing Examine genetic variations in a single cell.
  • Single Cell Services Request services to perform genomics, transcriptomics, proteomics, metabolomics and cell–cell interactions at the single cell level
  • Spectral Karyotyping Identify chromosomal abnormalties often not detected by traditional methods.
  • Spent Media Analysis Measure chemical alterations, such as variations in amino acids, glucose, contaminants, and metabolites, in a cell culture medium throughout the culturing process.
  • Stem Cell Differentiation Acquire specialized cells from differentiated stem cells.
  • Stem Cell Methodologies Study Stem Cell characteristics.
  • STR Profiling - Microsatellite Short Tandem Repeat Confirm cell line identity and detect cross-contamination.
  • STR profiling of human and mouse cell lines STR profiling of human and mouse cell lines
  • Trichrome Staining Use a variety of techniques for the selective visualization of muscle, collagen fibers, fibrin and erythrocytes.
  • Viral Mediated Gene Delivery Use viral carriers to introduce new genetic material into a cell.
  • Virus Products Purchase virus strains
  • Yeast Cell Culture Grow yeast strains or species.

Chemical and Compound Analysis

  • Accelerator Mass Spectrometry Detect trace levels of naturally-occurring radionuclides and stable nuclides.
  • Adsorption/Desorption Studies Obtain data on groundwater risk assessment.
  • Affinity Selection Mass Spectrometry (AS-MS) A high-throughput drug discovery technique that identifies small-molecule ligands by binding them to a target biomolecule, removing unbound compounds, and detecting the binders using mass spectrometry
  • Amino Acid Analysis (AAA) Determine protein quantities, relative compositions and amino acid content profiles.
  • Analytical Separations and Purification Analytical Separation and Purification of compound/molecule.
  • API Physical Characteristics Characterize physical and chemical properties of new drug molecules to develop safe, effective, and stable dosage forms.
Show all 97 in Chemical and Compound Analysis 91 more
  • Atomic Absorption Analysis Measure the elemental composition of a diverse array of samples.
  • Atomic Force Microscopy Use atomic force microscopy to reveal information about the atomic topography and mechanical properties of a sample.
  • Bioanalysis Bioanalysis involves the determination of the concentration of test compounds in biological samples including plasma, urine, an...
  • Centrifugal Precipitation Chromatography Separate analytes based on their solubility in ammonium sulfate solution.
  • Chemical Stability Measure the stability of small molecules in solution.
  • Chiral Separation Purify therapeutically active isomers of drug candidates.
  • Circular Dichroism Examine the secondary structure and folding properties of proteins in solution.
  • Compound Integrity Analyze the identity and purity of small molecule drug candidates.
  • Compound Purification Purify compounds using preparative HPLC, exchange resins, filtration and crystallization.
  • Computed Tomography Visualize the internal features of solid objects.
  • Denaturing High Performance Liquid Chromatography Separate mixtures of denatured and reannealed oligos to identify single nucleotide substitutions, deletions and insertions.
  • Differential Scanning Calorimetry Elucidate the thermodynamics associated with conformational transitions.
  • Diffuse Wave Spectroscopy Evaluate the micro-rheological properties of particles in opaque and concentrated media.
  • Dissolution Profiling Measure release of API from formulation (tablet or capsules) under GMP guidelines.
  • Dynamic Light Scattering Determine the size of particles and extent of molecular aggregation in a suspension.
  • Dynamic Mechanical Analysis Measure mechanical properties of solids and polymer melts as a function of time, temperature and frequency.
  • Electron Diffraction Measurement (microED) Use electron diffraction patterns to characterize the crystallographic properties of a sample.
  • Electrophoresis Separate nucleic acids or proteins based on physical properties such as charge or mass.
  • Elemental Impurity Analysis Identify and evaluate the presence of heavy metals in pharmaceuticals.
  • Endotoxin Testing Use standard assays like LAL (Limulus Amebocyte Lysate), rFC (Recombinant Factor C), or MAT (Monocyte Activation Test) to detect and quantify the level of endotoxins in a sample
  • Energy Dispersive X-ray Spectroscopy Identify and estimate the elemental composition of a sample based on x-ray emission patterns.
  • Excipient Compatibility Test excipients for drug formulation, effects of temperature, time, humidity, pH and light exposure as well as excipient release.
  • Field Desorption Mass Spectrometry Use high potential fields to detect intact molecular ions of an analyte.
  • Filler Content Analysis Evaluate filler material to optimize product performance and process conditions.
  • Fluorescence Mediated Tomography Visualize the spatial distribution of fluorescencently labeled probes and substances.
  • Focused Ion Beam Apply a highly focused beam of gallium ions to remove material at high spatial resolution.
  • Gas Chromatography Gas chromatography is an analytical technique that separates, identifies, and quantifies compounds in a mixture
  • GLP Large Molecule Bioanalysis Detect and analyze the pharmacokinetic profile of large biomolecules.
  • GLP Small Molecule Bioanalysis Detect and analyze the pharmacokinetic profile of small molecules.
  • Headspace Gas Chromatography Analyze volatile organic compounds (VOCs) partitioned above the liquid/solid phase of a sample.
  • Heavy Metals Analysis Ensure trace levels of heavy metals are below the maximum allowable limits for consumer safety.
  • High Resolution MS Elucidate the sequence and structure of peptides, proteins, biomarkers and organic compounds.
  • Hot Stage Microscopy (HSM) Visualize and characterize temperature-dependent phase transitions in pharmaceutical solids, polymers, and amorphous dispersions using polarized light microscopy coupled with a controlled thermal stage.
  • Immunoaffinity Chromatography Use antibody-antigen interactions to isolate and concentrate analytes.
  • Impurities in API Risk assessment Create a risk-based control strategy to determine any impurities in Active Pharmaceutical Ingredients (API).
  • Inductively Coupled Plasma (ICP) Analysis Characterize ultra-small levels of multiple solid analytes simultaneously.
  • Inductively Coupled Plasma-Mass Spectrometry (ICP-MS) Analysis Detect metals and several non-metals at concentrations as low as one part in 1015 (part per quadrillion, ppq) on non-interfered low-background isotopes.
  • Ion Exchange Chromatography Separate and detect analytes.
  • Isothermal Titration Calorimetry An ITC assay will be established and optimised for the affinity measurement of test substance to target molecule.
  • Light Sheet Fluorescence Microscopy Use a planar sheet of light to section transparent tissues and generate a 3D image.
  • Lipid Nanoparticle (LNP) Characterization Lipid nanoparticle (LNP) characterization is the process of comprehensively analyzing the physical and chemical properties of LNPs and their components to understand their structure, quality, and functionality
  • Liquid Chromatography Separate substances using a mobile and stationary phase.
  • Low Energy X-ray Emission Spectrometry (LEXES) Use a low energy electron beam to selectively analyze elements at or near a sample surface.
  • MALDI-TOF Analysis Use mass spectrometry technique to analyze compound, biomolecules and large organic molecules.
  • Melting Point Use melting point analysis to characterize compounds based on calorimetry and thermodynamic data.
  • Microchip Capillary Electrophoresis Conduct rapid high-efficiency separation on a microchip.
  • Nano-High Performance Liquid Chromatography Separate and detect low levels of analytes.
  • Natural Product Libraries Find microbial, botanical and marine sources of natural products.
  • NBE RIB 2/5 BA Request information or a price quote for GLP Large Molecule Bioanalysis services and products
  • NMR Methods Use nuclear magnetic resonance spectroscopy to identify drug intermediates.
  • NMR Structure Determine molecular structure, identify chemical impurities and validate sample integrity.
  • Non GLP Large Molecule Bioanalysis Detect and analyze the pharmacokinetic profile of large biomolecules.
  • Non GLP Small Molecule Bioanalysis Detect and analyze the pharmacokinetic profile of small molecules.
  • Optical Rotation Distinguish between optical isomers as well as between natural versus man-made compounds.
  • Optical Tomographic Imaging Use multiply-scattered light to reconstruct images of illuminated objects.
  • Particle Size Analysis Measure particle size distribution and characterize particle size, porosity and composition.
  • Partition Coefficient Determine lipophilicity (hydrophobicity) of compounds by measuring log P.
  • Phase Contrast X-Ray Imaging Visualize dense and intricate samples with high spatial three-dimensional resolution.
  • Photostability Measure drug degradation rates after exposure to various light sources.
  • Phototoxicity & Photosensitization Test Test the potential for a product to elicit a reaction under UV exposure.
  • Physicochemical Analysis Physicochemical Analysis of material or preparation evaluating (e.g.) particle size, composition, or compound structure.
  • Process Residual Impurities Detection Measure trace levels of impurities.
  • Protein Binding HPLC Uses high pressure liquid chromatography to separate protein-drug complexes.
  • Protein Crystallization Create high quality protein-ligand crystals for x-ray diffraction studies.
  • Protein Melting Point Analysis Assess protein stability by Differential Scanning Calorimetry (DSC) or Fluorimetry (Thermofluor) methods.
  • Protein Separation and Detection Separate proteins based on properties such as solubility, adsorption or size differences.
  • Protein Structure Determine the three dimensional structure of a protein by NMR or x-ray crystallography.
  • Raman Spectroscopy Use spectroscopic technique to observe vibrational, rotational and other low-frequency modes in a system.
  • Sample Bioanalysis Determination of concentration of an analyte in biological sample.
  • Scanning and Transmission Electron Microscopy Examine the fine structures of molecules, cells and tissues with sub-nanometer resolution.
  • Secondary Ion Mass Spectrometry Detect trace level impurities and obtain elemental or molecular chemical data for solid sample surfaces.
  • Size Exclusion Chromatography Separate and identify analytes based on their molecular size.
  • Small Angle X-Ray Scattering Obtain low-resolution structures of biopolymers in solution using an x-ray beam.
  • Solid State Nuclear Magnetic Resonance Identify molecular structure or impurities and assess product integrity of solid samples.
  • Solubility Studies Analyze substances for kinetics of solubility using nephelometry and UV-Vis spectrometry.
  • Solution Nuclear Magnetic Resonance Identify molecular structure or impurities and assess product integrity of solution samples.
  • Spray Drying Convert a liquid into a powder by rapidly drying the mixture and removing the moisture component.
  • Static Light Scattering Use scattered light intensity to determine the average molecular weight of biopolymers.
  • Stochastic Optical Reconstruction Microscopy (STORM) Visualize and localize individual fluorescent molecules.
  • Structural Chemistry Examine the relationship between protein structure and function.
  • Structural Elucidation Determine chemical structure of a compound. Characterization techniques include mass spectrometry, infrared spectroscopy and X-ray crystallography.
  • Structural Spectroscopy Assess conformational transitions that proteins undergo in response to changes in their environment.
  • Structure Determination Determine the three-dimensional structure of proteins in the presence or absence of ligands.
  • Total Internal Reflection Fluorescence Microscopy Visualize single molecule fluorescence at a surface to produce high quality images with low background.
  • Total Reflections X-Ray Fluorescence Analyze liquid or smooth solid surfaces to detect ultra-trace levels of particles, residues and impurities.
  • Ultrasound Tomography Use the transmission and acquisition of ultrasound waves to create a non-invasive technique for imaging.
  • UV-Spectroscopy Conduct sample analysis based on light absorption and transmission.
  • Viscosity Testing Evaluate the fluid flow properties of liquids for product evaluation and quality control.
  • X-Ray Fluorescence (XRF) Identify and quantify the elemental composition of solid and liquid samples.
  • X-ray Microscopy and Nanotomography (Nano-CT) Create two- and three-dimensional imaging of objects in real time.
  • X-ray Photoelectron Spectroscopy (XPS) Analyze the surface composition and chemistry of ultra-thin layers of a sample.

Chemical and Compound Testing

  • Agricultural Sciences Research & Development Develop and/or implement new and existing technologies to improve crop yields, livestock health, soil fertility, water conservation, as well as other aspects of agricultural productio
  • Bacterial Water Analysis Analyzing water samples to identify the bacteria present.
  • Batch Release Request information or a price quote for Batch Release services
  • Clinical Pathology Diagnose disease based on the laboratory analysis of bodily fluids, such as blood, urine and tissues.
  • Clinical Urinalysis Analyze protein loss and kidney dysfunction and run urine chemistry panels.
  • Impact Testing Measure the ability of a material to resist high-rate loading for product safety and longevity.
Show all 15 in Chemical and Compound Testing 9 more
  • Limulus Amebocyte Lysate (LAL) Test Detect bacterial endotoxins in raw materials used for the production of cosmetics products.
  • Nutritional Testing Analyze food safety, vendor specifications, foreign substance identification processes and nutritional labeling.
  • Occupational Exposure Limits (OEL) Reports Develop and determine the Occupational Exposure Limit of a substance or compound. The OEL is the value which indicates the level of exposure to be safe in the workplace.
  • Occupational Exposure Risk Analysis/Assessment Conduct risk assessment and analysis of any potential Occupational Exposure Risks that may occur during the manufacturing of compounds.
  • Product Testing Ensure product quality standards are met.
  • Puncture Strength Testing Use compressive tests to determine the rupture properties of a material.
  • USP <2021> Microbial Enumeration Tests Estimate the total aerobic microbial count, total combined yeast and mold counts, and the presence of bile-tolerant gram-negative bacteria present in nutritional supplements.
  • USP <2022> Microbiological Procedures for Absence of Specified Microorganisms Determine the absence of objectionable organisms in nutritional supplements.
  • USP <85> Bacterial Endotoxin Test Test to detect or quantify bacterial endotoxins that may be present in or on a sample.

Chemistry, Manufacturing and Controls (CMC)

  • Abrasive Acquisition (Calcium Carbonate, Fumed Silica, Pumice) Acquire abrasives, such as calcium carbonate, fumed silica, and pumice, to use as ingredients in consumer healthcare products.
  • Advanced intermediates Sourcing advanced intermediates
  • Analgesic Active Ingredients Acquire analgesic active ingredients for making over-the-counter medicines.
  • Analytical Development and Validation Request services related to Analytical Development and Validation
  • Anorectal Active Ingredients Acquire anorectal active ingredients for making over-the-counter medicines.
  • Anthelmintic Active Ingredients Acquire anthelmintic active ingredients for making over-the-counter medicines.
Show all 86 in Chemistry, Manufacturing and Controls (CMC) 80 more
  • Anticaries Active Ingredients Acquire anticaries active ingredients for making oral health care products.
  • Antidiarrheal Active Ingredients Acquire antidiarrheal active ingredients for making over-the-counter medicines.
  • Antiemetic Active Ingredients Acquire antiemetic active ingredients for making over-the-counter medicines.
  • Antimalarial Active Ingredients Acquire antimalarial active ingredients for making over-the-counter medicines.
  • API and Drug Product Stability Testing API and Drug Product Stability Testing.
  • API and Drug Product Storage and Distribution API and Drug Product Storage and Distribution.
  • API and drug product storage and release API and drug product storage and release
  • API manufacturing process development, tech transfer and validation API manufacturing process development, tech transfer and validation
  • API Stress Testing Studies Develop analytical methods to predict stability problems and identify degradation products/pathways under forced degradation conditions.
  • API/ Excipients Compatibility Studies Delineate real and possible interactions between potential formulation excipients and the API as an important risk reduction exercise early in formulation development.
  • API/DP specific test methods API/DP specific test methods (e.g., stability indicating HPLC assay and purity)
  • Bi-specific Antibodies Create a protein made of fragments of two monoclonal antibodies that bind to different antigens.
  • Biocidals Acquire biocidals, such as glycerine carbonate and propylene carbonate, to use as ingredients in consumer healthcare products.
  • Bulk Manufacturing Find facilities for large-scale mass production.
  • Bulk Raw Materials Acquire raw materials in large volumes at wholesale pricing.
  • Chemistry Manufacturing Controls Access contract manufacturing and regulatory guidance in setting specifications and drug dosage formulations.
  • Chemistry, Manufacturing and Controls (CMC) Request Chemistry, Manufacturing and Controls services
  • Cholecystokinetic Ingredients Acquire cholecystokinetic active ingredients for making over-the-counter medicines.
  • Clinical supply management Clinical supply management
  • Coating Analysis Evaluate the coat properties of pharmaceuticals, polymers and other finished materials.
  • Compendial test methods Run Compendial test methods (e.g., KF)
  • Cough/Cold Active Ingredients Acquire cough/cold relief active ingredients for making over-the-counter medicines.
  • Crystallization studies Crystallization studies
  • Digestive Aid Active Ingredients Acquire digestive aid active ingredients for making over-the-counter medicines.
  • Drug Formulation Combine substances including the active drug into a final product with the desired metabolic and therapeutic properties.
  • Drug product packaging and labeling Drug product packaging and labelling
  • Drug Product Stability Use accelerated stress conditions to determine degradation pathways and identify manufacturing issues.
  • Drug Repurposing Discovering new therapeutic uses for existing drugs that are outside the scope of the original medical indication.
  • Drug Substance and Drug Product Characterization and Manufacturing Drug Substance and Drug Product Characterization and Manufacturing.
  • Emulsifiers & Solubilizers Acquire emulsifiers and solubilizers to use as ingredients in consumer healthcare products.
  • Excipients Acquire synthetic or natural inert components to formulate therapeutic agents.
  • Fill and Finish Processing Confirm final product sterility, formulation and packaging in the biopharmaceutical process.
  • Flow Agents Acquire flow agents, such as aluminum stearate, calcium stearate, and zinc stearate, to use as ingredients in consumer healthcare products.
  • Forced Degradation Run light, heat, humidity, acid hydrolysis and oxidation tests to evaluate substance degradation.
  • Formulation Development Optimize bioavailability, stability, salt forms, plasma stability and excipient release in vivo.
  • Formulation Services Assistance when determining the look, texture, fragrance of a product with compatibility with product packaging, knowledge of competitive performance traits and product shelf life.
  • Fragment Screening Screen fragment libraries for activity against a protein or cellular target.
  • Gingivitis/Plaque Active Ingredients Acquire gingivitis/plaque active ingredients for making oral healthcare products.
  • GMP Synthesis Synthesize APIs including small molecules, formulations and protein-based drugs under GMP compliance.
  • Hangover Reliever Active Ingredients Acquire active ingredients, such as acetaminophen, aluminum hydroxide, and bismuth subsalicylate, for making OTC hangover relief products.
  • HTP-BCP Platform Screen chemical libraries to identify novel antibiotics.
  • Hydrogen Deuterium Exchange Mass Spectrometry HDX-MS is a mass spectrometry technique that measures how hydrogen atoms in a protein exchange with deuterium, revealing information about protein structure, dynamics, and interactions. It’s widely used to map binding...
  • ICH-compliant stability testing Perform ICH-compliant stability testing
  • Impurities in Drugs Risk Assessment Create a risk-based control strategy to determine any toxic elemental impurities that may be present in human medicines.
  • IND Enabling Package Request a package of Investigational New Drug (IND) Enabling Studies from our group of trusted suppliers that have enrolled in our IND-Enabling Package Program.
  • Integrated Antibody Development Package Process an entire Antibody Development Pipeline Project including: Antigen Synthesis, Antibody Generation, Antibody Characterization, Antibody Modification, Antibody Purification, Antibody Products from our bundle...
  • Integrated Antibody Development Package-Europe Process an entire Antibody Development Pipeline Project including: Antigen Synthesis, Antibody Generation, Antibody Characterization, Antibody Modification, Antibody Purification, Antibody Products from our bundle...
  • Integrated Antibody Development Package-UK Process an entire Antibody Development Pipeline Project including: Antigen Synthesis, Antibody Generation, Antibody Characterization, Antibody Modification, Antibody Purification, Antibody Products from our bundle...
  • Integrated Small Molecule Package Process an entire Small Molecule/Compounds Pipeline Project including: Compound Synthesis or Purchase, Compound Analysis/Testing, In Vitro Assays, and Formulation/Reformulation from our bundle of suppliers
  • Internal Analgesic Ingredients Acquire internal analgesic active ingredients for making over-the-counter medicines.
  • ISO Testing Services for Quality Assessments Testing Services follow standards developed by the International Organization for Standardization (ISO), ensuring consistency, accuracy, and international comparability in various industries including manufacturing...
  • Ketone Derivatives Acquire chemicals that are ketone derivatives.
  • Key Starting Materials Sourcing key starting materials (KSM)
  • Laxative Active Ingredients Acquire laxative active ingredients for making over-the-counter medicines.
  • Lipoparticle Technology Capture conformationally intact membrane proteins directly from the cell surface using lipoparticle technology.
  • Lyophilization Lyophilization, also known as freeze-drying, is a dehydration process typically used to preserve perishable materials
  • Medical Device Manufacturing Prototyping and Short run production
  • Menstrual/Diuretic Active Ingredients Acquire menstrual/diuretic active ingredients for making over-the-counter medicines.
  • Milling, grinding, spray-drying Milling, grinding, spray-drying
  • Monosaccharide Derivatives Acquire chemicals that are monosaccharide derivatives.
  • NAMSA Class VI Testing NAMSA Class VI Testing
  • Otic Active Ingredients Acquire otic active ingredients for making over-the-counter medicines.
  • Oxidizers/Bleaches Acquire oxidizers/bleaches, such as hydrogen peroxide and sodium hypochlorite, to use as ingredients in consumer healthcare products.
  • Pearlizing Agents Acquire pearlizing agents, such as glycol distearate and glycol stearate, to use as ingredients in consumer healthcare products.
  • Phosphates Acquire phosphates to use as ingredients in consumer healthcare products.
  • Plant Extracts Acquire plant extracts, such as lutein, lycopene, and quinine, to use as ingredients in consumer healthcare products.
  • Poison Treatment Ingredients Acquire active ingredients, such as ipecac fluidextract, ipecac syrup, and ipecac tincture, for making over-the-counter poison treatment products.
  • Polymorph Screening Screen for unwanted API forms resulting from the drug formulation process.
  • Powder Blending Use automatic or semi-automatic powder blending machinery to produce consistent mixes.
  • Powder Filling Use manual, automatic or semi-automatic machinery to package a variety of powder and granules.
  • Product Insert Packaging Use product insert or leaflets to inform patients, satisfy regulatory requirements or extend a coupon offer.
  • Raw Materials & Ingredients Purchase raw materials, ingredients, or chemicals for personal care, cosmetic, consumer health, and beauty products and substances.
  • Regulatory Starting Materials Sourcing regulatory starting materials (RSM)
  • Salt Form Selection Use high-throughput automated arrays to combine APIs with multiple salts and ions to optimize formulation.
  • Selenium Derivatives Acquire chemicals that are selenium derivatives.
  • Subcellular Fraction Test System Obtain human, minipig, mouse, or rat dermal microsomes as in-stock standard test systems for the development of safer topical and transdermal products.
  • Tablet Manufacturing Use automatic or semi-automatic machinery to create various standard and non-standard tablets.
  • Targeted Locus Amplification (TLA) Technology This technology enables targeted complete sequencing of any locus of interest.
  • Thermal Analysis Characterize compounds based on calorimetry and thermodynamic data.
  • Thermo Scientific iCAP Q ICP-MS Expand your analytical capabilities with this complete trace elemental analysis solution for your high-throughput lab.

Clinical Consulting

  • Bioanalysis Consulting Expert advice to properly and effectively discover, evaluate, and measure chemical or biological materials.
  • Biomarker Services Consulting Expert advice to conduct solutions for evaluating normal/abnormal biological conditions and characteristics within the body.
  • Biometrics Consulting Apply statistics and mathematics to drug discovery, clinical trials, and data analysis.
  • Biostatistics Consulting Apply statistical theory and mathematical principals to research
  • Cell Services Consulting Whether you are an experienced drug hunter working in the pharmaceutical industry or an academic researcher looking to submit g...
  • Clinical Consulting Provide high quality data, on time and within budget, while maintaining the flexibility in delivering personalized services.
Show all 24 in Clinical Consulting 18 more
  • Clinical Data Management Collect, analyze and interpret data on clinical data/specimens for review by regulatory agencies.
  • Clinical Development Planning Complex document that entails the entire clinical research strategy of a drug, describing the clinical studies that will be carried out for a pharmaceutical entity.
  • Clinical Protocol Design & Development Creation of clinical protocol document which details how a clinical trial is designed,&nbsp;relating to to the methodology, hypothesis, and operation of clinical trial to ensure the safety of the patients is...
  • Clinical Study Reporting (CSR) Report results of clinical trials to regulatory agencies. This includes participant flow, baseline characteristics, outcome measures, statistical analyses, and adverse events.
  • Clinical Trial Consulting Consulting services for Clinical trials.
  • Clinical Trial Feasibility Request services related to Clinical Trial Design and feasibility.
  • Clinical Trial Recruitment Recruitment, enrollment and retention of patients for clinical trials.
  • Data & Risk Management Determine the extent of the risk and the reliability of the data used to access the aforementioned risk.
  • IND Writing Consulting Consulting for an Investigational New Drug Application
  • Medical Science Liason (MSL) The primary purpose of the MSL role is to establish and maintain peer-peer relationships with leading physicians, referred to as Key Opinion Leaders (KOL’s), at major academic institutions and clinics.
  • Orphan Disease Consulting FDA requires that an Investigational Review Board (IRB) must review all the documents related to the inclusion of participants within clinical trials. IRB is expected to review all the research documents...
  • Patient Advocacy Help patients communicate with their healthcare providers so they get the information they need to make decisions about their health care.
  • Process Analytical Technology (PAT) A system for designing, analyzing and controlling pharmaceutical manufacturing processes through measurements of critical quality and performance attributes of raw and processed materials to ensure final product quality.
  • Product Testing Consulting Expert advice to evaluate the effectiveness, quality, and legitimacy of a given item or good.
  • Regulatory Compliance & Documentation Regulatory compliance describes the goal that organizations aspire to achieve in their efforts to ensure that they are aware of and take steps to comply with relevant laws, policies, and regulations.
  • Regulatory Consulting Ensure that each product or device complies with all FDA rules and regulations.
  • Study Budgeting Consulting Request for Consulting Services
  • Support Staff Recruitment Recruit nurses, clinical staff, certified clinical research coordinators and research support staff.

Clinical Trials

  • Analgesia Clinical Trials Conduct clinical trials to test the efficacy and safety of over-the-counter analgesia drugs.
  • Antacids Clinical Trials Conduct clinical trials to test the efficacy and safety of over-the-counter antacid drugs.
  • Bayesian Adaptive Trial Design Bayesian adaptive trial design allows real-time adjustments to clinical trials based on ongoing data analysis, enhancing flexibility and efficiency.
  • Bioequivalence Studies Assess the expected biological equivalence of two proprietary preparations of a drug.
  • Case Report Monitoring & Auditing Ensure the adequate collection and traceability of clinical data in preparation for review by the FDA.
  • Central Institutional Review Board Services Ensure the safety and protection of human subjects participating in a study.
Show all 67 in Clinical Trials 61 more
  • Central Laboratory Services A centralized facility that handles the processing and analysis of samples collected from multiple sites in a study.
  • Clinical Biostatistical Services Analyze and interpret data throughout all phases of clinical trial development.
  • Clinical Lab Services Comprehensive testing, analysis, and research support for a medical study.
  • Clinical Research Services Determine the safety and effectiveness of medications and medical devices.
  • Clinical Trial Design Develop study-related protocols, case report forms (CRFs) and database tools for records management.
  • Clinical Trial Risk Management Plan that maintains treatment quality throughout lifecycle and improve decision making.
  • Clinical Trial Simulation and Forecasting Using of computational models to predict the outcomes, optimize designs, and evaluate the feasibility of clinical trials before they are conducted.
  • Comparator Drug Sourcing Streamline new drug development and clinical trials by comparing the efficacy of an experimental drug to a comparator drug.
  • Consumer Healthcare Product Trials Conduct clinical research to ensure the safety and efficacy of consumer healthcare products used for oral care, skin care, nutrition, and hair care.
  • DCT Platform A digital environment designed to support and streamline decentralized clinical trials.
  • Digital Recruitment Strategy Design Digital recruitment strategy design involves creating a comprehensive plan that leverages online platforms and technologies to attract, engage, and hire the best talent efficiently.
  • Direct-To-Patient Logistics and Drug Delivery Direct-to-patient logistics and drug delivery is a service model that involves delivering medication or healthcare products directly to patients' homes, bypassing traditional healthcare facilities, to enhance...
  • Diversity and Inclusion Consulting For Trials Diversity and inclusion consulting for trials involves providing expert guidance to ensure that clinical trials are designed and conducted in ways that include diverse populations and address barriers...
  • eCOA - Electronic Clinical Outcomes Assessments Use smartphones, computers and tablets to allow patients to directly report health outcomes.
  • eConsent - Electronic Informed Consent Monitor clinical trials through electronic informed consent given by patients.
  • EHR to EDC Transfer data from an Electronic Health Record (EHR) system to an Electronic Data Capture (EDC) system, which is commonly used in clinical trials
  • ePRO - Electronic Patient-reported Outcome Patient reported outcome collected by electronic methods.
  • eSource and Wearable Integration Platforms eSource and wearable integration platforms are digital systems that streamline the collection, integration, and analysis of electronic health data from wearable devices and other digital sources for clinical research...
  • Healthy Normal Studies Design and perform studies on healthy normal individuals to act as controls to&nbsp; compare healthy volunteers with people who have a specific disease or condition. Research with healthy volunteers is designed...
  • Human Challenge Trials (CHIM) Human Challenge Trials (CHIM) are research studies where volunteers are deliberately exposed to a pathogen under controlled conditions to study the effects and potential treatments or vaccines.
  • Investigator Meeting Planning & Execution Investigator planning and meetings ensure that there is proper communication and reliability during a clinical trial. Allows for efficient work flow.
  • Investigator Recruitment Enlist clinical research experts to assist in investigator selection, recruitment monitoring and database evaluation.
  • IP Import/ Export Licensing Receive assistance with intellectual property import and export licensing.
  • IP Labeling Proper IP labeling guidelines are produced by the Food and Drug Association. Based on the compound or product in need of proper labelling there are guidelines that can be followed.
  • IP Packaging Proper packaging of pharmaceutical products and goods is crucial to ensure the validity and quality of the product being supplied.&nbsp;Proper investigational product packaging is aided by the use of quality...
  • IP Returns & Destruction Return the used and unused IP to the clinical trial sponsor for destruction, as well as send the used and unused IP for destruction in accordance with institution policy, or the standard operational procedure. Theses...
  • IP Shipments & Resupply IP shipments and resupply aid in the management of shipping of clinical trial material from warehouses to clinical sites, or vice versa. Shipping and resupply aids in restocking, drug orders, shipment tracking...
  • IP Storage IP storage protocols are specifically defined by the&nbsp;U.S. Pharmacopeia, Japanese Pharmacopeia,&nbsp;and the European Pharmacopeia that specifically define the proper storage and transportation conditions...
  • IRT Customization for Non-Standard Dosing IRT customization for non-standard dosing involves modifying interactive response technology systems to accommodate dosing regimens that deviate from standard protocols, ensuring accurate tracking and management...
  • IRT Services IVRS and Drug supply services allow research conducting clinical trials to&nbsp;receive real time subject updates,&nbsp;drug supply and shipment tracking, and&nbsp;randomization for the clinical trial.&nbsp;These...
  • Mass Balance Studies Design a study to determine the mass balance of drug-related material occurring administration of dose, the ratio of parent drug metabolite(s) in circulation, and the primary route of excretion of drug-related material.
  • Nutraceuticals Clinical Research Trials Conduct clinical trials to test the efficacy and safety of nutraceuticals.
  • Nutritional Trials and Studies Conduct clinical trials to test the efficacy and safety of food and dietary products.
  • Patient Concierge Services Find a liaison between patients and healthcare providers, ensuring a smoother and more comfortable experience throughout the patient's journey.
  • Patient Recruitment Recruit and retain patients for clinical trials.
  • Patient Reimbursement and Travel Process individuals participating in clinical trials or receiving medical care are compensated for expenses related to travel, such as transportation, lodging, and meals
  • Pharmacokinetic Studies Design a study that observes the time course of drug absorption, distribution, metabolism, and excretion, as means to test the safety and effective therapeutic management of drugs in an individual patient.
  • Phase 1-3 Studies Design phase 1-3 studies that seek to identify&nbsp;if a drug is safe, effective, and more efficient than other available treatments on the market.
  • Post-Marketing (Phase 4) Studies Conduct phase 4 studies for confirming unrecognized safety issues, investigating possible hazards or establishing the expected safety profile of a veterinary medicinal product under market conditions.
  • Prospective Explorative Studies Conduct a prospective exploratory study to assess the safety and efficacy of a test drug during clinical trials.
  • Protocol Optimization via AI/ML Using of artificial intelligence and machine learning techniques to enhance and streamline experimental protocols or operational procedures for improved efficiency, accuracy, and outcomes.
  • Psoriasis Clinical Research Trials Conduct clinical trials to test the efficacy and safety of over-the-counter psoriasis drugs.
  • Recruiting Healthy Volunteers Recruit volunteers who have no known significant health problems, and is willing and consenting to participate in research to test a new drug, device, or intervention.
  • Recruiting Special Populations Recruitment of volunteers who are categorized as part of a special population, or a protected part of the population such as the elderly, women, and children.
  • Regulatory Affairs Consulting Receive assistance ensuring compliance with regulatory requirements.
  • Regulatory Operations Ensure that all specific regulatory documents are published and properly organized before submission.&nbsp;
  • Remote Patient Monitoring Devices and Services Remote Patient Monitoring Devices and Services refer to technology and healthcare solutions that allow healthcare providers to monitor patients' health data and vital signs remotely, enabling real-time tracking...
  • Sample Management Find providers who offer process of handling, organizing, and tracking samples in a lab
  • Site Feasibility and Enrollment Modeling tools Site feasibility and enrollment modeling tools are analytical resources used to assess the viability of clinical trial sites and predict participant recruitment rates to optimize study design and execution.
  • Site Monitoring Maintain oversight over participant's health during a clinical trial.
  • Site Selection Select clinical trial sites with clinicians who recruit, enroll, treat and evaluate trial patients.
  • Site/Patient Payments Allow for different suppliers to organize the proper patient and site payments for a clinical trial. Provides real-time payments, reduce workloads for site staff and minimize the amount of time participants spend...
  • Statistical Analysis Planning Technical and detailed elaboration of the principal features of the analysis described in the protocol, and includes detailed procedures for executing the statistical analysis of the primary and secondary variables...
  • Study/Site Feasibility Study Explore and test study practicality.
  • Synthetic Control Arm Creation Using RWD Using patient data from sources like electronic health records or claims databases to construct a comparator group for clinical trials, instead of enrolling a separate group of control patients.
  • TeleHealth Delivery of healthcare services and information using electronic communication and information technologies, allowing for long-distance patient and clinician interactions
  • Telehealth Integration for Study Visits Telehealth integration for study visits involves using digital communication technologies to conduct clinical research visits remotely, allowing participants to engage with researchers from their own locations. This...
  • Temperature Excursion Management Tools Systems or software designed to monitor, record, and manage temperature deviations from specified ranges, ensuring the integrity and quality of temperature-sensitive products.
  • Trial Insights: Clinical Trials Intelligence Dashboard Trial Insights is the industry’s first digital research reporting dashboard made specifically to track ongoing clinical trials, observational, diagnostic and medical device studies. The solution aggregates and curates...
  • Virtual Clinical Trial Monitoring Platform This digital research platform allows researchers to monitor their clinical trials remotely.
  • Wearables / Remote Patient Monitoring Source medical-grade or consumer-grade devices that track patients' vital signs and other health data remotely and wirelessly transmit this information to healthcare providers

Commercial

  • Electrohydrodynamic Atomization Technology (EHDA) Apply an electrical force to drive atomization of liquids to micro and nano structures.

Commercial Consulting

  • New Consultant Signup Please provide consultant contact details below. Note: to ensure efficient on-boarding and track progress, you will be added in our initial communication with the consultant.
  • Portfolio Management Manage a portfolio of projects in early-stage drug discovery and provide factors that determine the success of the proposed portfolio.
  • Production Process Consulting Use expert advice to identify sustainable improvements for manufacturing process operations.

Companion Diagnostics

  • Cervical Cancer CDx Design and validate companion diagnostics for cervical cancer that help select the most appropriate patients, identify patients at increased risk, or monitor treatment effectiveness.
  • Osteoarthritis CDx Design and validate companion diagnostics for osteoarthritis that help select the most appropriate patients, identify patients at increased risk, or monitor treatment effectiveness.
  • Pancreatic Cancer CDx Design and validate companion diagnostics for pancreatic cancer that help select the most appropriate patients, identify patients at increased risk, or monitor treatment effectiveness.
  • Rheumatoid Arthritis (RA) CDx Design and validate companion diagnostics for RA that help select the most appropriate patients, identify patients at increased risk, or monitor treatment effectiveness.
  • Systemic Sclerosis (SSc) CDx Design and validate companion diagnostics for SSc that help select the most appropriate patients, identify patients at increased risk, or monitor treatment effectiveness.

Creative

  • Case Studies Recruit research participants with a behavioral condition to receive either an investigational behavioral intervention or a behavioral intervention in clinical use.
  • Infographic Create a quick visual representation of information, data or knowledge.
  • Product Marketing Bring a product to market.

Data Science/Bioinformatics

  • Biostatistical Design Use statistics to ensure appropriate pre-clinical and clinical study design.
  • Clinical Biomarker Analysis An approach to finding markers that change in response to a drug or that identify a group that responds favorably to a specific therapy. These can be omics, molecular, histologic, radiologic, etc.
  • Clinical Companion Diagnostics Analysis The process of finding patients who are likely to respond positively to a drug and designing a diagnostic tool to identify this group of patients before or with a therapy.
  • Clinical Data Analysis Analysis that helps you make sense of your clinical data
  • Clinical Data Management A process that includes acquiring, validating, storing, protecting, and processing required data to ensure the accessibility, reliability, and timeliness of the data.
  • Clinical Data Science and Modeling A process that helps make sense of your clinical data
Show all 68 in Data Science/Bioinformatics 62 more
  • Clinical Data Warehousing and Interoperability Data warehousing is the process of collecting, storing, and managing large volumes of structured data from different sources to support analysis and decision-making, while interoperability refers to the ability...
  • Clinical Imaging Diagnostic Analysis An analytical approach to analyzing biological images for diagnostic purposes.
  • Clinical In Silico Drug Dynamics The process to understand drug dynamics by computer analysis and simulation.
  • Clinical In Silico Genomics/Transcriptomics Data Analysis A process that helps make sense of your omics data
  • Clinical Machine Learning/AI Complex analytical approaches to find patterns and make predictions in drug discovery projects
  • Clinical Responder Analysis, Patient Stratification The process of identifying patients that are more likely to respond positively to a drug.
  • Clinical Software Tools Software designed to serve the needs of clinical research groups.
  • Clinical Trial Integration Analysis The process of combining data from multiple clinical trials to understand categories of drugs and drug behavior in a more global way.
  • Discovery Bioinformatics Different analytical approaches that make, store, and analyze complex biological data.
  • Discovery Biomarker Analytics An approach to finding markers that change in response to a drug or that identify a group that responds favorably to a specific therapy. These can be omics, molecular, histologic, radiologic, etc.
  • Discovery Compound Screening Analytics Screening of an entire compound library directly against the drug target or in a more complex assay.
  • Discovery Data Analysis Analysis that helps you make sense of your discovery data
  • Discovery Data Integration The process of combining different complex data types together to make it easier to understand or analyze.
  • Discovery Data Management A process that includes acquiring, validating, storing, protecting, and processing required data to ensure the accessibility, reliability, and timeliness of the data for its users.
  • Discovery Data Science and Modeling A process that helps make sense of your discovery data
  • Discovery Databases Databases specifically designed for drug discovery use.
  • Discovery Drug Response Simulation Analytics Simulation of how a drug responds in different environments, from molecular to population studies.
  • Discovery In Silico Drug Dynamics Develop In Silico model of a drug candidate with a biological system with applications such as Pro-drug Predictions, ADME-PK Due Diligence, Brain-Barrier Permeability Simulation, Drug Absorption Simulation, In Silico...
  • Discovery In Silico Genomics/Transcriptomics Data Analysis A process that helps make sense of your Genomics/Transcriptomics data
  • Discovery In Silico Proteome Analysis Used to understand the global protein environment, specifically drug-protein interactions.
  • Discovery Machine Learning/AI Complex analytical approaches to find patterns and make predictions in drug discovery projects.
  • Discovery Omics Analytics A process to analyze various omics data (genomics, transcriptomics, proteomics, metabolomics, etc.) This can include the integration of different omics data. Helps to better understand the molecular environment...
  • Discovery Predictive Analytics Analytical approaches to predict how a drug target behaves in a given environment.
  • Discovery Software Tools Software designed to serve the needs of discovery research groups.
  • Discovery Statistical and Mathematical Modeling Use mathematical variables and equations to establish relationships between data.
  • FAIR data strategy consulting FAIR data strategy consulting involves guiding organizations to adopt data management practices that ensure their data is Findable, Accessible, Interoperable, and Reusable, thereby enhancing data usability and value.
  • Graph-Based Patient Journey Analysis Graph-based patient journey analysis is a method of visualizing and analyzing the pathways patients take through healthcare systems using graph structures, enabling insights into patient experiences, care patterns...
  • In Silico ADME-PK Consultation Consult with experts for ADME-PK data analysis or predictive modelling design in different in vivo or in vitro states.
  • In Silico ADME-PK Predictions Use computer software to simulate in vivo physiological conditions of animals or humans to predict ADME-PK properties.
  • In Silico Cancer Genomics/Cancer Transcriptomics Analysis Interpret DNA sequencing and microarray data for cancer studies.
  • In Silico Drug-Drug Interactions Use computational tools to predict pharmaceutical, pharmacodynamic or pharmacokinetic drug-drug interactions to maximize drug regimen safety.
  • In Silico Epigenetic Compound Library Screening Use computer-aided methods to discover new compounds against key regulators of epigenetic signaling.
  • In Silico Nucleic Acid Microarray Analysis Use software to visualize and evaluate gene activity in response to various stimuli.
  • In Silico Pro-drug Predictions Use computer simulation to assess pro-drug absorption and conversion to predict pharmacokinetic properties.
  • In Silico Protein Microarray Analysis Use software to visualize and evaluate protein function and expression on a large scale.
  • In Silico Protein Modification Analysis Use computational methods to predict the behavior of modified proteins.
  • In Silico Protein Sequence Analysis Use software to predict protein structural and functional features and secondary structure components.
  • iVAX technology Design epitope driven vaccines through a web-based toolkit.
  • Mechanism of Action 3D Animation Brings the science of molecular biology to life through interactive educational experiences.
  • Microarray Data Analysis Visualize and analyze microarray data and facilitate data analysis for large experiments.
  • Microsatellite Analysis for Normal Tumor Instability (MANTIS) Classify samples by MSI status utilizing NGS data.
  • NLP Processing for Unstructured Clinical Notes NLP processing for unstructured clinical notes involves using natural language processing techniques to extract, analyze, and interpret valuable information from free-text medical records, enabling improved clinical...
  • Proteome Data Analysis Find tools for analysis of homology and similarity, protein function and structural properties.
  • RWE/HEOR Data Management A process that includes acquiring, validating, storing, protecting, and processing required data to ensure the accessibility, reliability, and timeliness of the data.
  • RWE/HEOR Data Science and Modeling A process that helps make sense of your clinical data
  • RWE/HEOR Drug Response Analysis A process to understand how a population is responding to a drug, specifically if there are any adverse events.
  • RWE/HEOR Drug/Therapy Discontinuation Analysis An analysis to understand patient behavior. Are the drugs taken on time, do the patients discontinue use, and if so how long after starting, etc.
  • RWE/HEOR Machine Learning/AI Complex analytical approaches to find patterns and make predictions in RWE/HEOR projects
  • RWE/HEOR Market Analysis A process to understand how a drug is performing in the market and possible opportunities in the market
  • RWE/HEOR Software Tools Software designed to serve the needs of RWE/HEOR research groups.
  • Translational Bioinformatics Different analytical approaches that make, store, and analyze complex biological data.
  • Translational Biomarker Discovery An approach to finding markers that change in response to a drug or that identify a group that responds favorably to a specific therapy. These can be omics, molecular, histologic, radiologic, etc.
  • Translational Data Analysis Analysis that helps you make sense of your translational data
  • Translational Data Curation Generally, human curation of acquired data to assess the quality and reliability of different data.
  • Translational Data Harmonization and Integration Process to combine different data together for better understanding and analysis of the integrated data.
  • Translational Data Knowledge Extraction Analytical approaches to extract data from different sources like publications, databases, etc.&nbsp;
  • Translational Data Management A process that includes acquiring, validating, storing, protecting, and processing required data to ensure the accessibility, reliability, and timeliness of the data.
  • Translational Data Science and Modeling A process that helps make sense of your translational data
  • Translational In Silico Genomics/Transcriptomics Data Analysis A process that helps make sense of your omics data
  • Translational Machine Learning/AI Complex analytical approaches to find patterns and make predictions in drug discovery projects.
  • Translational Omics Analytics A process to analyze various omics data (genomics, transcriptomics, proteomics, metabolomics, etc.) This can include the integration of different omics data. Helps to better understand the molecular environment...
  • Translational Software tools Software designed to serve the needs of translational research groups.

Developmental and Reproductive Toxicology (DART)

  • Bioelectronics Evaluate an application (e.g. device) that integrates biological materials and micro and nano-electronics.
  • Early-Life Stage Toxicity Test Use survival and growth metrics of embryos or larvae to predict effects or find maximum acceptable value of a toxin.
  • Embryo-Fetal Development (EFD) Study (Segment II) Test drug candidate in Segment II toxicology services.
  • Embryo-Fetal Development (EFD) Study (Segment II) - Mouse Conduct a study to determine the effect of compound exposure on the pregnant mouse and the developing fetus.
  • Embryo-Fetal Development (EFD) Study (Segment II) - Other Species Conduct a study to determine the effect of compound exposure on the pregnant animal and the developing fetus.
  • Embryo-Fetal Development (EFD) Study (Segment II) - Rabbit Conduct a study to determine the effect of compound exposure on the pregnant rabbit and the developing fetus.
Show all 20 in Developmental and Reproductive Toxicology (DART) 14 more
  • Embryo-Fetal Development (EFD) Study (Segment II) - Rat Conduct a study to determine the effect of compound exposure on the pregnant rat and the developing fetus.
  • Enhanced Pre/Post-Natal Development Study (ePPND) - Monkey / Non-human Primate Conduct a study that combines in utero and postnatal assessments of your compound in monkeys/non-human primates.
  • Fertility and Embryonic Development Study (Segment I) Test drug candidate in Segment I toxicology services.
  • Fertility and Embryonic Development Study (Segment I) - Mouse Conduct a study to determine the effect of your compound on the estrous cycle, spermatogenesis/male reproductive organs, fertility of parents, and development of the embryo in mice.
  • Fertility and Embryonic Development Study (Segment I) - Other Species Conduct a study to determine the effect of your compound on the estrous cycle, spermatogenesis/male reproductive organs, fertility of parents, and development of the embryo in other species.
  • Fertility and Embryonic Development Study (Segment I) - Rat Conduct a study to determine the effect of your compound on the estrous cycle, spermatogenesis/male reproductive organs, fertility of parents, and development of the embryo in rats.
  • In Vitro Alternative Model for Assessing Reproductive Toxicity Laboratory-based methods used to evaluate the potential harmful effects of substances on reproduction without using live animals.
  • Juvenile Toxicity Study - Dog / Canine Conduct a study to determine the differences in toxicity between immature and mature systems in dogs.
  • Juvenile Toxicity Study - Other Species Conduct a study to determine the differences in toxicity between immature and mature systems in other species.
  • Juvenile Toxicity Study - Rat Conduct a study to determine the differences in toxicity between immature and mature systems in rats.
  • Pre/Post-Natal Development (PPND) Study (Segment III) - Mouse Conduct a study to quantify the effect of your compound on fetal development, parturition, and post-natal development in mice.
  • Pre/Post-Natal Development (PPND) Study (Segment III) - Other Species Conduct a study to quantify the effect of your compound on fetal development, parturition, and post-natal development in other species.
  • Pre/Post-Natal Development (PPND) Study (Segment III) - Rat Conduct a study to quantify the effect of your compound on fetal development, parturition, and post-natal development in rats.
  • Reproductive Toxicology Study adverse sexual function and fertility and examine teratogenicity of compounds.

Discovery Chemistry

  • Activity Prediction Identify possible chemical hits based on the known three-dimensional structure of a protein.
  • Bio-Layer Interferometry Octet BLI is a label-free, real-time technology used to measure biomolecular interactions by detecting changes in optical interference patterns, offering insights into binding kinetics, affinity, and concentration.
  • Bioactive Research Tools Find bioactive peptides, bioactive lipids, bioactive materials like glass, paper, and polymers and nanotechnology.
  • Bioanalytical Lab Services Bioanalytical Lab Services
  • Building Blocks Find chemicals used for creating new compound chemotypes and HTS libraries.
  • Certified Standards Find certified standards for assays, tests and services.
Show all 59 in Discovery Chemistry 53 more
  • Chemical Protein Stability Assay (CPSA) Chemical Protein Stability Assay is a proprietary cell lysate‐based chemical protein denaturation technology to confirm protein target engagement. This is accomplished by assessing binding-induced stabilisation...
  • Chiral Synthesis Synthesize a compound by a method that favors formation of a specific enantiomer or diastereomer.
  • Compound Docking Identify potential compound hits based on the 3D structure of a target protein.
  • Compound Finding Service Enter the compound name, CAS # or SMILES string in the box below or upload an Excel, Word or SD file with a list of compounds.
  • Compound Management Buy, maintain and process compound libraries, natural product libraries and building blocks.
  • Compound Purchase Buy compounds, building blocks or compound libraries.
  • Compound Purchase Consulting Buy compounds, building blocks or compound libraries.
  • Compound Synthesis Synthesize small molecule candidates for use in hit followup, lead optimization and medicinal chemistry.
  • Compound Synthesis Services (IP-sensitive) Synthesize small molecule candidates for use in hit followup, lead optimization and medicinal chemistry.
  • Custom Building Blocks Find or synthesize mg to kg amounts of chemical building blocks, scaffolds and reactive intermediates.
  • Custom Libraries Find or synthesize mg to kg amounts of target-specific and target-agnostic compounds for HTS and biological profiling.
  • Custom Synthesis Find or synthesize mg to kg amounts of target-specific and target agnostic compounds for HTS and biological screening.
  • Discovery Computational Chemistry Model the interaction of a drug candidate with protein targets such as kinases, GPCRs, receptors, ion channels or enzymes.
  • Discovery Molecular Modeling and Simulation Analytics Computational methods to model and study the behavior of molecules, from small chemical systems to large biological molecules.
  • DNA Encoded Library (DEL) capabilities The rapid screening of vast chemical libraries by encoding millions of small molecules with unique DNA sequences, facilitating the identification of potential drug candidates.
  • Ecarin Clotting Time (ECT) Monitor the anti-coagulation effects of new drugs or clinical therapies.
  • Elemental Analysis Determine the elemental composition of compounds, biomolecules, and pharmaceuticals.
  • Extractable and Leachable Assessment Quantify potential impurities from container closures & packaging.
  • File Equity On-Demand (Screening Compounds & Monomers) Initiate a new request supported by a Pfizer Sourcing Group for File Equity On-Demand (Screening Compounds & Monomers)
  • Fragment Libraries Find fragment libraries for screening against a protein or cellular target.
  • Haloalkane Derivatives Acquire chemicals that are haloalkane derivatives.
  • Hit to Lead (H2L) Evaluate, perform limited optimization and identify small molecule hits from high throughput screens.
  • HTS Libraries Find targeted and broad collections of chemical compounds for high throughput screening and ADMET applications.
  • Hydrogen Forward Scattering Spectrometry Use ion scattering to determine the hydrogen ion concentration in thin films.
  • Impurity Synthesis Use high resolution MS or NMR to eliminate intermediates or organic byproducts and determine impurity content.
  • In Silico Lead Optimization Use in silico design to enhance the ADME-PK properties of candidate drugs to maximize efficacy and safety.
  • In Silico Metabolite Predictions Conduct in silico assessment of metabolite pharmacokinetic properties and potential exposure effects.
  • Large Scale Purification Purify gram to kilogram amounts of recombinantly-expressed or wild-type proteins.
  • LCMS Analysis Physically separate substances using liquid chromatography and mass spectrometry.
  • Leachable and extractable testing Leachable and extractable testing
  • Leaching and Aged Leaching Assess the leaching potential of products with studies that follow the formation and movement of metabolites or show restricted leaching under simulated use conditions.
  • Lead Optimization Perform chemical structural changes to improve preclinical drug candidate.
  • Library Design & Evaluation Use structural knowledge to design target-focused compound libraries for screening.
  • Method Development and Validation Develop and validate methods for synthesis and scale up of drug candidates.
  • Natural Product Screening Screen large natural product collections for therapeutic activity.
  • Near-infrared (NIR) Spectroscopy Non-destructive, fast analytical method, that measures molecular overtone and combination vibrations, commonly used for rapid, in-line, or on-line composition analysis
  • Pharmaceutical Research Chemicals Acquire chemicals that are prospective new drug entities.
  • Pharmacophore Modeling Use computer models to identify hits based on structural similarity to known active compounds.
  • Polyethylene Glycols (PEGS) Acquire polyethylene glycols (PEGS) to use as ingredients in consumer healthcare products.
  • QSAR Analysis Develop quantitative structure–activity relationship models for drug design.
  • Radiochemical Synthesis Radiolabel small molecules, peptides, cytotoxics or antibody drug conjugates for DMPK analysis.
  • Stable Isotope Synthesis Label drug candidates with stable isotopes that simplify compound tracking and distribution studies.
  • Structure Activity Relationship (SAR) Analyze the relationship between the structure of a compound and its biological activity.
  • Structure Property Relationship (SPR) Determine the functionality of a compound through the analysis of it's structure.
  • Target-Focused Compound Libraries Find activity-based libraries directed towards a protein or cell signaling target.
  • Time of Flight Mass Cytometry (CyTOF™) Detect and quantify up to 34 different proteins simultaneously on a single-cell level.
  • Trace Elemental Analysis Identify organic and inorganic elements in foods and dietary supplements at ppm to sub-ppt levels.
  • Transporters Selectively screen for compounds with good permeability in the intestine, skin, or blood-brain barrier using drug transporter a...
  • USP Testing Analytical Reagents Acquire chemical reagents, solution concentrates and volumetric solutions used to evaluate items in USP testing.
  • USP-NF Grade Chemicals Acquire chemicals that comply with United States Pharmacopeia and National Formulary standards.
  • UV and IR Profiling Analyze the integrity of a compound or large biomolecule.
  • Vibrational Spectroscopy Analytical technique that measures the interaction of infrared radiation with matter to study molecular vibrations
  • Virtual Screening Use software algorithms to virtually screen millions of potential compounds and peptides for binding.

Disease Models

  • Acute Kidney Failure Models Measure therapeutic endpoints in animal models of acute kidney failure.
  • Acute Liver Failure Models Measure therapeutic endpoints in animal models of acute liver failure.
  • Acute Lung Injury Models Measure therapeutic endpoints in animal models of acute lung injury.
  • Artery On-A-Chip Platform Assess small blood vessels under near-in vivo conditions.
  • Arthritis Models Measure therapeutic endpoints in animal models of arthritis.
  • Atopic Dermatitis Models Measure therapeutic endpoints in animal models of atopic dermatitis.
Show all 113 in Disease Models 107 more
  • Auto-immune Hepatitis Models Measure therapeutic endpoints in animal models with auto-immune hepatitis.
  • Autoimmune Models Measure therapeutic endpoints in animal models with autoimmune disorders.
  • Bacterial Infection Models Measure therapeutic endpoints in animal models of bacterial infection.
  • Behavioral Testing Models Investigate sensory-motor and emotional functions, social behavior and day-night activity.
  • Blood Models Test for therapeutic efficacy of drug candidates in blood disorder models.
  • Bone Models Measure therapeutic endpoints in animal models of bone disorders.
  • Cardiovascular Metabolics Models Measure therapeutic endpoints in animal models of cardiovascular disorders.
  • Cardiovascular Models Test the therapeutic efficacy of drug candidates in cardiovacular disease models.
  • Cartilage Repair Models Measure therapeutic endpoints in animal models of cartilage repair.
  • Cataract Models Measure therapeutic endpoints in animal models of cataracts.
  • Chronic Kidney Disease Models Measure therapeutic endpoints in animal models of chronic kidney disease.
  • Circadian Profiling Models Measure sleep phase shift, body temperature, induction of melatonin secretion and clock protein activation.
  • Cognition Models Measure therapeutic endpoints in animal models of cognition.
  • Comparative Pharmacology Compare drug responses across species for improved reliability in translational studies.
  • Cough Models Test the therapeutic efficacy of drug candidates in cough models.
  • Critical Care Models Diagnose and manage life-threatening conditions requiring sophisticated organ support and invasive monitoring.
  • Cyp2f2 Knockout Mouse Study Cyp2f2-mediated lung metabolism.
  • db db Diabetic Mice Test for therapeutic efficacy of drug candidates in diabetic mouse models.
  • Demyelination Models Measure therapeutic endpoints in animal models with demyelination pathology.
  • Dermatology Models Measure therapeutic endpoints in animal models of dermatological disorders.
  • Diabetic Retinopathy Models Assess therapeutic efficacy of drug candidates in diabetic retinopathy models of disease.
  • Disease Simulation Modeling Disease Simulation Modeling
  • Drug-Induced Liver Injury (DILI) Toxicity Assays Use biochemical, cell-based or in vivo assays to measure toxicity from drug-induced liver injury.
  • Dry Eye Models Measure therapeutic endpoints such as tear induction, TBUT, Schirmer strips (tear volume) and cornea staining.
  • Electroencephalogram EEG Models Record electrical activity along the scalp of animal models or human patients.
  • Electrophysiology Models Measure voltage change on a variety of scales from single ion channels to whole organs.
  • Emesis Models Measure therapeutic endpoints in animal models of emesis.
  • Endometriosis Models Measure therapeutic endpoints in animal models of endometriosis.
  • Excitotoxicity Models Measure therapeutic endpoints in animal models with excitotoxic pathology.
  • Experimental Epilepsy Models Use chronic or induced animal models of epilepsy to test your drug candidate for therapeutic efficacy.
  • Fecal Microbiota Transplantation (FMT) - Mouse Use germ-free mice to evaluate the properties of complex or defined gut microbiota following fecal microbiota transplantation (FMT). Axenic (germ-free) mice transplanted with donor microbiota can be utilized to assess...
  • General Pain Models Measure therapeutic endpoints in animal models of general pain.
  • Genitourinary Models Find urogenital models for cystometry, interstitial cystitis, endometriosis, spinalized rats and chronic kidney disease.
  • Hair Growth Models Measure dermal histology, skin thickness, % anagen induction, hair proliferation and other hair growth markers.
  • Hematopoiesis Models Measure therapeutic endpoints in animal models of hematopoiesis.
  • Hepatitis B Virus Models Measure therapeutic endpoints in animal models of Hepatitis B virus infection.
  • Hepatitis C Virus Models Measure therapeutic endpoints in animal models of Hepatitis C virus infection.
  • Huntington's Disease Models Measure therapeutic endpoints in animal models of Huntington's disease.
  • IGA Glomerulonephritis Models Measure therapeutic endpoints in animal models of IgA glomerulonephritis.
  • In Vivo Physiologic Monitoring Monitor and collect data from conscious, freely moving laboratory animals.
  • In Vivo Technologies Models Carry out EEGs, cognition assessment, microdialysis, electrophysiology, MRI, ultrasound and tomographic analysis.
  • Infectious Disease Models Test therapeutic efficacy of drug candidate in infectious disease model.
  • Inflammation Models Measure therapeutic endpoints in animal models for inflammation.
  • Inflammatory Bowel Disease Models Measure IBD symptom severity, cytokine levels and body weight, and evaluate IHC and Ariol images.
  • Inflammatory Pain Models Measure therapeutic endpoints in animal models of inflammatory pain.
  • Irritant Models Measure therapeutic endpoints in animal models of skin irritation.
  • Ischemia Models Measure therapeutic endpoints in animal models of ischemia.
  • Kidney Transplant Models Measure therapeutic endpoints in kidney transplant models.
  • Liver Disease Animal Models Measure therapeutic endpoints in animal models with liver disease.
  • Liver Fibrosis Models Measure liver fibrosis using therapeutic endpoints such as collagen assessment, TUNEL staining and inflammatory markers.
  • LPS Acute Response Models Measure therapeutic endpoints in acute models of inflammation.
  • LPS Lung Inflammation Models Measure therapeutic endpoints in animal models of inflammation.
  • Macular Degeneration Models Use a single animal species to create one or more models for eye disease.
  • Malaria Models Measure therapeutic endpoints in animal models of malaria.
  • Menorrhagia Models Measure therapeutic endpoints in animal models of menorrhagia.
  • Microbiome-Based Skin Disease Technology Modify the skin microbiome and deliver therapeutic proteins to the target.
  • Microdialysis Models Measure the effect of drug candidates on neurotransmission in rat or mouse models.
  • Microsurgery in Rodents Outsource microsurgeries projects required for testing new therapies on a rodent model.
  • Morris Water Maze Investigate spatial learning and memory in rodents.
  • Myelination Models Measure therapeutic endpoints in animal models with induced myelination, remyelination or developmental myelination.
  • Neuroscience Models Test therapeutic efficacy of drug candidate in neurological disease model.
  • Non Obese Diabetic Mice Use a single animal species to create one or more disease models for diabetes.
  • Ob/ob Mouse Use a single animal species to create one or more disease models obesity and angiogenesis.
  • Obese Mice Use a single animal species to create one or more disease models for diet-induced obesity and type II diabetes.
  • Obese Primates Use a single animal species to create one or more disease models for diet-induced obesity and type II diabetes.
  • Object Recognition Measure spatial navigation, working memory and cognitive function in animal models.
  • Obstructive Sleep Apnea Rat Study pathologic cardiac changes of obstructive sleep apnea (OSA) in a rat model.
  • Ocular Inflammation Models Measure ocular inflammation in models of eye disorders such as uveitis and keratitis.
  • Olfactory Testing Models Measure therapeutic endpoints in animal models of olfactory function.
  • Ophthalmic Models Test drug candidates in glaucoma, macular degeneration, keratitis, uveitis and CMV retinitis models.
  • Optogenetics (rodent behavioral testing) Use light to selectively control the molecular events in cells of living organisms.
  • Osteoarthritic Pain Models Measure therapeutic endpoints in animal models of osteoarthritic pain.
  • Osteoarthritis Models Measure therapeutic endpoints in animal models of osteoarthritis.
  • Osteoporosis Models Measure therapeutic endpoints in animal models of osteoporosis.
  • Otitis Media Models Measure therapeutic endpoints in animal models of otitis media.
  • Otology Models Measure vertigo, tinnitus, otitis media and hearing loss in animal models.
  • OVA Lung Inflammation Models Measure therapeutic endpoints in animal models of inflammation.
  • Pain Endpoints Models Measure therapeutic endpoints in animal models of pain.
  • Pain Model Consulting Expert advice to better evaluate and understand pain thresholds and phenomena within living organisms. Can be used to evaluate pain associated with specific diseases or injuries affecting the sensory and nervous systems.
  • Pain Models Test therapeutic efficacy of drug candidate in pain model.
  • Parkinson's Disease Models Measure therapeutic endpoints in animal models of Parkinson's disease.
  • Pigmented Rabbit Use a single animal species to create one or more disease models for eye cancer.
  • Plasmodium-Infected Mosquitoes Order live sporozoite-infected Anopheles stephensi mosquitoes.
  • Precision Cut Lung Slices (PCLS) Use a phenotypically accurate model of lung behavior for screening and target validation.
  • Pulmonary Fibrosis Models Measure therapeutic endpoints in animal models of pulmonary fibrosis.
  • Receptor Binding Models Measure the binding and distribution of drugs and biologics in animal tissues.
  • Receptor Occupancy Models Determine the effective dose and concentration needed to reach effective levels in a given tissue.
  • Respiratory Models Test therapeutic efficacy of drug candidate in respiratory disease model.
  • Schizophrenia Models Measure therapeutic endpoints in animal models of schizophrenia.
  • Sclerosis ALS Models Measure therapeutic endpoints in animal models of sclerosis.
  • SHR/NCrl Rat Use a single animal species to create one or more disease models fior hematopoesis.
  • Skin Graft Models Measure therapeutic endpoints in animal models of skin grafts.
  • Sleep and Circadian Biology Systems to collect and analyze data related to sleep and circadian rhythms
  • Spinal Cord Injury Models Measure therapeutic endpoints in models of spinal cord injury.
  • Streptozotocin Rats Use a single animal species to create one or more disease models for Type 1 diabetes.
  • Stroke Models Measure therapeutic endpoints in animal models of stroke.
  • Systemic Lupus Erythematosus Models Measure therapeutic endpoints in animal models of immune disorders such as SLE and lupus.
  • Thrombosis Models Measure therapeutic endpoints in animal models of thrombosis.
  • Tinnitus Models Measure therapeutic endpoints in animal models of tinnitus.
  • Tissue Rejection Models Measure therapeutic endpoints in animal models of tissue rejection.
  • Ventricular Tachycardia Models Measure therapeutic endpoints in animal models of ventricular tachycardia.
  • Video Behavior Monitoring Systems to collect continuous video for use in behavioral research
  • Viral Infection Models Measure therapeutic endpoints in animal models of viral infection.
  • Visceral Pain Models Measure therapeutic endpoints in animal models of visceral pain.
  • Weanling Rat Use a single animal species to create one or more disease models for anemia.
  • Wound Healing Models Measure therapeutic endpoints in animal models of wound healing.
  • Xenografts Evaluate drug candidate in tissue graft or organ transplant model.

DNA & RNA

  • AAV (Adeno Associated Virus) Production Clone into Adeno Associated Virus (AAV) expression vectors
  • Amplicon - HLA Typing Use an amplicon sequencing method to identify allelic variation within the HLA genes.
  • Amplicon 16s rRNA Sequencing Identify and compare bacteria present within a given sample.
  • Amplified Fragment Length Polymorphism Detection Detect DNA polymorphisms based upon restriction enzyme digestion and PCR.
  • ATAC-seq ATAC-seq
  • Bisulfite Seq DNA Methylation Analysis Determine DNA methylation status at single-base resolution
Show all 118 in DNA & RNA 112 more
  • Bisulfite Sequencing (RRBS) Analyze genome-wide methylation profiles on a single nucleotide level.
  • Capillary Electrophoresis Separate ng quantities of DNA to single base resolution.
  • cDNA cloning & subcloning Move cDNA fragments between different cloning vectors.
  • cDNA library construction Generate a library of recombinant cDNA clones.
  • Cell Free DNA Assay Detect known mutations and discover new ones in cell-free plasma DNA.
  • ChIP-Sequencing Use chromosome immunoprecipitation to identify DNA-protein binding sites in a genome.
  • ChIP-sequencing Profiling Identify where a protein is binding to DNA on a genome-wide scale.
  • Chromatin Analysis Analyze DNA-Histone interactions and modifications
  • Chromatin Interaction Analysis-Paired End Tag Sequencing Sequence DNA using Chromatin Conformation Capture (3C) together with Chromatin Immunoprecipitation (ChIP).
  • Cloning/Subcloning Clone or Subclone nucleotide sequence or gene.
  • CRISPR Using advanced CRISPR technology, add or delete base pairs at a specifically targeted DNA loci.
  • CRISPR Epigenetic Activator Use the CRISPR Epigenetic Activator for epigenetic modification of genes of interest.
  • CRISPR-Cpf1 System Use the CRISPR-Cas9 alternative for mammalian genome editing.
  • CRISPRscan Design efficient sgRNAs for CRISPR-Cas9 targeting in vivo.
  • Customized Non-mutant Library Construct RNAi, Indexed and PCR-free libraries.
  • ddPCR-Based Plasma Genotyping Perform noninvasive tumor genotyping.
  • De Novo Genome Sequencing Determine the DNA sequence of uncharacterized genomes.
  • De Novo Transcriptome Sequencing Identify new genes without the need for a reference genome sequence.
  • Degradome Sequencing Use parallel analysis of RNA ends (PARE) to detect miRNA targets and analyze patterns of RNA degradation.
  • Digital Polymerase Chain Reaction Obtain improved absolute target quantification and rare allele detection compared to conventional qPCR.
  • DNA Extraction Extract DNA from an original source.
  • DNA Fragmentation DNA fragmentation is the physical breaking of a DNA molecule into smaller pieces
  • DNA Hydroxy Methylation Seq Use epigenetic services to analyze genome-wide DNA hydroxymethylation.
  • DNA Library Screening Screen genomic or cDNA libraries for positive clones.
  • DNA Mutagenesis Introduce insertions, deletions and substitutions into DNA clones.
  • DNA Products Find DNA products including gDNA, cDNA clones, vectors and constructs from mice, insects, yeast, bacteria and viruses.
  • DNA Reagents Request information or a price quote for DNA Reagents services
  • DNA Sequencing Determine the nucleotide sequence of DNA samples.
  • DNA Synthesis Produce DNA fragments for microarrays, PCR, cloning and expression studies.
  • DNA-lipid interaction analysis Investigate cellular dynamics based on changes in fluorescent properties.
  • DNA/RNA Extraction & Purification DNA/RNA Extraction & Purification.
  • DTG-Seq™ Evaluate the efficiency and distribution of CRISPR mutations at on-target sites.
  • Exome Sequencing Determine protein-coding nucleotide sequences in a DNA sample.
  • Expression Profiling Measure the the expression of thousands of genes at once to create a global picture of cellular function.
  • Gene/Oligo Synthesis Synthesize oligonucleotide or gene for microarrays, RT-PCR and PCR cloning.
  • Genome Editing Use CRISPR, ZFN, TALEN or AAV gene targeting for targeted gene mutations and creation of transgenics.
  • Genomic DNA cloning Clone and propagate genomic DNA inserts of 5-50kb.
  • Genomic DNA Purification Isolate genomic DNA from cells or tissue samples.
  • Genotyping Examine a DNA sequence to identify specific genetic varients .
  • GenScript Punchout Catalog Punchout catalog for Genscript. This includes commercial technologies related to synthetic biology, immunotherapy, antibody design, chemical synthesis & bioinformatics.
  • HCR™ RNA-FISH Detect and visualize RNA expression in situ
  • HISAT Use a fast and sensitive spliced alignment program for mapping RNA-seq reads.
  • Hybridization SNP Genotyping Use complementary regions of DNA duplexes to detect variations in target DNA sequences.
  • In Situ Hybridization Localize specific nucleic acid targets using labeled complementary probes.
  • Integrated Genomics Package Process an entire Genomics Pipeline Project including: Sample Preparation, Target Enrichment, NGS Instrumentation, and Data Analysis from our Bundle of Suppliers
  • Kinetic Fingerprinting (SiMREPS) Identify and count single nucleic acids.
  • Knockout/Knockin Cell Lines Develop Knockout/Knockin Cell Line.
  • Linear Based RNA Amplification Perform rapid non-PCR RNA amplificaton.
  • Long Read Sequencing Long read sequencing is used in genomics to sequence long fragments of DNA, enabling the ability to span complex regions of the genome.
  • Metagenomic Sequencing Sequence genetic material recovered directly from environmental samples
  • Methylation Analysis Determine genomic methylation patterns and analyze methylation in tumors and treated samples.
  • Methylation Specific PCR Determine the methylation status of a CpG site without the need for base-specific endonucleases.
  • miRNA sequencing Identify miRNAs by Next Generation Sequencing and bioinformatic analysis.
  • mRNA synthesis Transcribe mRNAs in vitro and add modifications such as polyadenylation and guanine capping.
  • mtDNA Sequencing Use next-generation sequencing (NGS) technology to detect and analyze mitochondrial mutations.
  • Multiplex Cellular miRNA Assay Use Firefly™ technology for multiplex cellular microRNA profiling.
  • Mutant Library Generate a library of variants of a single gene.
  • Nanostring nCounter Use single molecule imaging to count molecules directly and without enzymatic amplification.
  • NGS: Next Generation Sequencing Sequence millions of template DNA molecules in parallel.
  • Non-Bisulfite DNA Methylation Analysis Analyze DNA methylation by methods such as differential enzymatic cleavage or affinity capture
  • non-coding RNA Synthesis Prepare non-coding RNA in vitro.
  • Nucleic Acid Hybridization Use a nucleic acid probe to identify complementary sequences.
  • Oligo Synthesis Produce oligonucleotides for microarrays, RT-PCR and PCR cloning.
  • PCR Mutagenesis Use polymerase chain reaction to create mutations in a cloned gene.
  • Plant RNA Interference Inhibit the expression of specific or detrimental plant genes to enhance crop growth, yield or stress tolerance.
  • Plant siRNA Design Create selective and potent small interfering RNA constructs for plant gene analysis or crop improvement.
  • Plasmid DNA Preparation and Extraction Prepare plasmid DNA starting from E. coli cell pellets, transformed colonies or DNA samples.
  • Plasmid Retention Assay Determine the percentage of cells in a sample that contain plasmids with a selectable marker.
  • PLAYR (Proximity Ligation Assay for RNA) Quantify 40 or more different mRNAs and proteins simultaneously in single cells.
  • Poly (A) tail Length Profiling (PAL-Seq) Conduct high-throughput sequencing of individual mRNA poly (A) tails.
  • Polymerase Chain Reaction (PCR) Amplify a DNA sequence by PCR.
  • qPCR Analysis Measure the accumulation of PCR products in real time.
  • Quantitative RT PCR Use quantitative reverse transcription polymerase chain reaction to measure absolute and relative mRNA abundance.
  • RAD Sequencing Examine a small percentage of the target genome.
  • Recombinant Nucleosomes Use as substrates in histone methyltransferase or acetyltransferase assays.
  • Reporter Genes Use for in vivo and in vitro screening of gene expression and cell signaling.
  • Ribosome Profiling Determine which mRNAs are being actively translated using next generation sequencing and specialized messenger RNA (mRNA)
  • RNA Amplification Produce RNA from pre-clinical and clinical samples for use in gene expression studies.
  • RNA Extraction Isolate total RNA or mRNA from cells or tissues
  • RNA Interference Use small sequences of RNA that correspond to the targeted gene product to inhibit mRNA translation.
  • RNA oligo synthesis Design and synthesize miRNAs, siRNAs and other non coding RNAs
  • RNA Profiling Quantify the expression levels of mRNA transcripts, enabling the determination of gene expression patterns.
  • RNA Reagents Request information or a price quote for RNA Reagents services
  • RNA Sequencing Use Next Generation Sequencing techniques to Identify RNA transcripts, examine differential expression patterns and analyze splice variants.
  • RNA Sequencing/Resequencing Identify RNA transcripts, examine differential expression patterns and analyze splice variants.
  • RNA Services Whether you’re isolating total RNA for whole genome expression analysis by microarray or setting up high content screening by s...
  • RNAi Pathway Analysis Use high-throughput RNAi genetic screens to elucidate relevant signaling pathways.
  • RNAscope In Situ Assays Profile single-cell gene expression in situ.
  • RNAseq and DNAseq library preparation and sequencing DNA/RNA sequencing and preparations
  • Sanger Sequencing Sequence single strand DNA fragments using DNA Polymerase.
  • Sequence Based Methylation Analysis Detect DNA methylation sites within cytosine-phosphate-guanine (CpG) dinucleotides at single base-pair resolution.
  • shRNA Synthesis Design shRNA constructs that produce stable knockdown of the corresponding mRNA.
  • Single Cell ATAC Sequencing Single Cell Assay for Transposase-Accessible Chromatin Sequencing is a genomic technique used to study the accessibility of chromatin at the single-cell level.
  • Single Cell RNA Sequencing Quantify mRNA variants in a single cell.
  • Single Molecule Real Time Sequencing Monitor the incorporation of fluorescently conjugated nucleotides within zero-mode waveguide (ZMW) chambers.
  • siRNA Synthesis Produce high quality siRNAs for gene silencing studies.
  • SNP Characterization Identify single nucleotide polymorphisms to make genetic associations, analyze disease SNPs and determine LOH.
  • Spatial Transcriptomics Determine the sub-cellular localization of mRNA molecules. Use this to identify cellular heterogeneity in tissues, tumors, immune cells and the subcellular distribution of transcripts.
  • Target Gene Expression Measure expression of a target gene at the protein, RNA and DNA level.
  • Targeted Bisulphite Sequencing Reveal changes in DNA methylation associated with nuclear reprogramming.
  • Targeted Sequencing/Resequencing Detect variations in a genome subset.
  • TCR Repertoire Sequencing Analyze the T cell receptor repertoire by means of next-generation sequencing.
  • Tissue Microarray Screen large numbers of tissues for the presence or absence of specific molecular markers.
  • Tissue of Origin® Assess the expression profile of 2,000 genes to determine the primary site of metastatic cancer in FFPE samples.
  • Total RNA Sequencing Identify novel RNA transcripts and detect gene expression changes.
  • Transcription Activator Like Effector Nucleases Genome Editing Induce site-specific DNA double-strand breaks.
  • Transcriptome Transfer (TIPeR) Use TIPeR method for converting one type of cell into another, by transfection with RNA reflecting the target cell type transcriptome.
  • TransIT-X2® Dynamic Delivery System Use a novel, polymeric system for the efficient delivery of plasmid DNA and/or siRNA/miRNA.
  • Whole Genome Amplification (WGA) Amplify an entire genome from a single cell.
  • Whole Genome Bisulphite Seq Profile genome-wide DNA methylation.
  • Whole Genome Profiling Develop sequence-based physical maps for the assembly of genomes.
  • Whole Genome Sequencing Determine the entire genetic make-up of an organism.

Drug Development

  • Assay Development Consulting Request consultant services measuring the activity of a drug or biochemical in an organism or organic sample.
  • Bioinformatics Consulting Consulting Services for the science of collecting and analyzing complex biological data
  • Cellular Immunology Consulting Immunological activities of cells in experimental or clinical situations
  • Chemistry, Manufacturing and Controls (CMC) Consulting Consultant services related to the development of pharmaceutical and biopharmaceutical drug products that are consistently effective, safe and high quality for consumers.
  • Chemoinformatics Consulting The use of computer and informational techniques applied to a range of problems in the field of chemistry.
  • Consulting Services Work with consultants who provide expert advice in various areas of research and technology.
Show all 17 in Drug Development 11 more
  • Laboratory Operations Consulting Request consulting services through the Genius Consulting Network™, Scientist.com provides your organization with immediate access to expert consultants with the experience and leadership skills to drive complex...
  • Large Molecule Drug Development Consulting Develop large molecule drugs and complex biologics that have a therapeutic effect.
  • Medicinal Chemistry Consulting Apply chemistry training to the process of synthesizing new pharmaceuticals.
  • Pathophysiology Consulting Request services related to Pathophysiology Consulting
  • Pharmacogenetics Consulting Access genomic services required for clinical trials, such as genotyping, genetic variation testing and DNA isolation.
  • Pharmacology Consulting Request consulting services related to pharmacology and the chemical properties, biological effects, and therapeutic uses of drugs.
  • Safety Pharmacology Consulting Consulting services that help with the detection of potential undesirable pharmacodynamic effects of chemical entities on physiological functions.
  • Small Molecule Drug Development Consulting Request consulting services related to small molecule development.
  • Structural Chemistry Consulting Expert advice to evaluate the functions of specific chemicals based on their constructions and systems.
  • Target Validation Consulting Help to demonstrate that modification of target activity has potential therapeutic benefits.
  • Toxicology Consulting Use models to assess acute and sub-acute toxicity as well as chronic and sub-chronic toxicity.

Drug Metabolism and Pharmacokinetics (DMPK)

  • Biomarkers DMPK Biomarker DMPK and gene analysis services are critical tools in evaluating patients and discovery of new therapeutics.

Effectiveness

  • Antimicrobial Pharmacodynamics Ascertain the effectiveness of an antimicrobial compound and test levels of antibiotic resistance against specific bacterial pathogens.
  • Bioequivalence Studies for Veterinary Drugs Assess the expected biological equivalence of two proprietary preparations of a veterinary drug.
  • Field Dose Confirmation Studies Conduct an in vivo study to confirm the effectiveness of a selected drug dose in actual field conditions.
  • Field Dose Determination Studies Examine the effectiveness of various therapeutic concentrations and durations against natural infections under a variety of field conditions.
  • In Vitro Dose Determination Tests Determine the most appropriate effective drug dosage regimen(s) in vitro.
  • Laboratory Dose Confirmation Studies Conduct in vivo studies to confirm the effectiveness of a selected drug dose in the lab.
Show all 9 in Effectiveness 3 more
  • Laboratory Dose Determination Studies Compare the effectiveness of three non-zero therapeutic concentrations for various durations to a non-medicated control group, and a non-medicated uninfected control group.
  • Minimum Bactericidal Concentration (MBC) Test Assess the bactericidal activity of a test compound.
  • Veterinary Clinical Field Trials Conduct single- or multi-site clinical trials according to VICH/GCP guidelines in livestock, poultry, and domestic pet species.

Environmental Assessment

  • Digital Vivarium® Platform Monitor and record a range of animal metrics by applying sensors and monitoring technology to animal cages.
  • Environment Fate Studies Evaluate the behavior of veterinary drugs and additives under controlled field and lab conditions.
  • Hydrolysis Studies Meet international regulatory guidelines with fully compliant hydrolysis testing.
  • Soil Dissipation Studies Find out how products degrade and dissipate in soil under typical use conditions.
  • Terrestrial Effects Studies Assess the exposure and adverse effects of veterinary antibiotics to terrestrial ecosystems.
  • Veterinary Environmental Assessment Assess whether environmental impacts may occur from the manufacture, use, or disposal of veterinary drugs.

Farm & Livestock Solutions

  • Animal Feed Analysis Test the content and quality of nutrients and biologically active substances in animal feeds. Some analysis that is conducted on feed include; dry matter, crude ash, ash insoluble in acid (sand), crude protein, crude...
  • Composite Soil Sampling Obtain multiple and random soil samples to create a single larger specimen for analysis.
  • Food Pathogen Testing of Listeria, salmonella, campylab, 0157E coli.
  • Herd Productivity Improving reproductive efficiency, productions yields, maintenance of healthy animals by routine biosecurity screening and testing.
  • OECD 121: Estimation of the Adsorption Coefficient (Koc ) on Soil and on Sewage Sludge using High Performance Liquid Chromatography (HPLC) This Test Guideline describes an experimental method using HPLC for the estimation of the adsorption coefficient Koc in soil and in sewage sludge.
  • Phosphorus Buffering Index Assess the ability of soil to bind phosphorus to predict availability for plant uptake.
Show all 25 in Farm & Livestock Solutions 19 more
  • Processing Techniques Investigation of mechanisms and kinetics of specific reactions for the improvement and stability of bioactive compounds.
  • Serology/Immunology Testing for BSE/TSE
  • Soil Acidity Testing Determine soil acididty to assess plant suitability or amend soil pH.
  • Soil Alkalinity Testing Determine soil alkalinity to assess plant suitability or amend soil pH.
  • Soil Cation Exchange Capacity Estimate the ability of soil to retain or release various cations and predict its water-holding capacity.
  • Soil Chemigation Services Use the irrigation system to improve delivery efficiency of agrochemicals.
  • Soil Dichloro-diphenyl-trichloroethane (DDT) Testing Detect the presence of DDT with its metabolites and quantify the components identified in the sample.
  • Soil Environmental Testing Measure environmental contaminants using soil sample analysis.
  • Soil Fertility Testing Evaluate soil growth potential based on nutrient deficiencies or toxicities.
  • Soil Fumigation Services Apply precise soil treatments to reduce soil-borne pests and maximize crop yield.
  • Soil Organic Matter Testing Evaluate soil organic matter to enable long-term soil health and optimal crop yield.
  • Soil Salinity Testing Measure total soluble salt content of a soil sample to inform corrective action.
  • Soil Soluble Salts Test Identify the soluble salt components of a soil sample to direct remedial steps.
  • Soil Testing Use various tests to characterize a soil sample.
  • Soil Vapor Surveys Evaluate sub-surface soil gases to detect leaks, assess a contamination or monitor the progress of clean-ups.
  • Test Service Listing For requesting a general service listing via Scientist.com.
  • Total Fusarium Test Quantify total fusarium infection by different fusarium species present in a single seed or foliar sample.
  • Viral Molecular Diagnostic Determination of genetic markers for virus identification. Detect common infectious agents and foreign animal diseases that may threaten animal or human health.
  • Virology Virus isolation for identification of new and emerging viruses.

Food Safety & Regulations

  • Anaerobic Plate Count Determine the total anaerobic bacteria present in a food or contact-surface sample.
  • Carbohydrate Testing Determine the types and concentrations of carbohydrates in foods for nutritional labeling, quality control, and for identifying possible adulteration.
  • Clostridium perfringens Tests Ensure food and water safety by detecting the presence of C. perfringens, its spores or the toxins in samples.
  • Dietary Enzyme Testing Verify actual enzyme activity in the final dietary product.
  • Dietary Exposure & Intake Assessments Estimate how much of a food chemical a population, or population sub-group, consumes.
  • E.coli 0157 Tests Isolate and identify the presence of a distinct variant of the E.coli species or its potent toxin in food, water or contact-surface samples.
Show all 23 in Food Safety & Regulations 17 more
  • E.coli spp. Testing Use molecular, immunological or cultured methods to detect the presence of E.Coli species in samplings from food, water, contact surfaces or another source.
  • FDA Food Nutrition Facts Label Testing Analyze a food or dietary product for food labelling purposes as required by the FDA or USDA.
  • Free Coagulase Test Use a tube test to determine whether or not the S.aureus species is present in Staphylococcus isolates from a sample.
  • Listeria monocytogenes Tests Assess product samples or the direct contact surfaces for a specific and prevalent Listeria species capable of growth at low temperatures.
  • Listeria spp. Testing Use molecular, immunological or cultured methods to identify potential growth sites for all species of the Listeria genus.
  • Methylmercury Analysis Ensure methylmercury concentration in products is below the maximum allowable limits for consumer safety.
  • Norovirus spp. Testing Use molecular, immunological or microscopic methods to detect and quantify Norovirus species in food, water or contact-surface samples.
  • Phthalates Analysis Determine the absence of phthalates in food and dietary supplements.
  • Pseudomonas aeruginosa Testing Use molecular, immunological or cultured methods to confirm the presence or absence of P.aeruginosa in samples from food, water or processing surfaces.
  • Pseudomonas spp. Testing Detect the presence and abundance of various cold-tolerant Pseudomonas species that cause or contribute to spoilage in meat, poultry, seafood, dairy or beverages.
  • Salmonella spp. Testing Use molecular, immunological or cultured methods to identify the presence of Salmonella species in food or contact-surface samples.
  • Shigella spp. Testing Use molecular, immunological or cultured methods to detect various species of Shigella in food samples.
  • Spiral Plate Count Use precise and automated plating to create a modified counting grid to measure bacterial concentration of a sample with improved efficiency.
  • Total Coliform Testing Measure the bacterial content of a sample to assess food safety, efficacy of sanitation methods or handling practices.
  • Total Viable Count (TVC) Estimate the total living microbial populations present in a food or beverage sample to guarantee product quality.
  • USDA Certification Ensure compliance with USDA regulations by an accredited certifying agent for quality assurance and brand marketing.
  • Water Activity Determine water activity in consumer healthcare products involving a USP or FCC monograph.

General in vivo Toxicology

  • Avian Toxicology Investigation Use toxicity tests to predict avian exposure risk, assess exposure effects or confirm product safety for registration.
  • Carcinogenicity Study - Mouse Conduct a repeat dose, chronic carcinogenicity study in mice to determine the tendency of your compound to produce tumors.
  • Carcinogenicity Study - Rat Conduct a repeat dose, chronic carcinogenicity study in rats to determine the tendency of your compound to produce tumors.
  • Dose Range Finding Study - Dog /Canine Conduct a study to determine the dose range of your compound in dogs/canines.
  • Dose Range Finding Study - Mouse Conduct a study to determine the dose range of your compound in mice.
  • Dose Range Finding Study - Other Species Conduct a study to determine the dose range of your compound in other species.
Show all 25 in General in vivo Toxicology 19 more
  • Dose Range Finding Study - Rat Conduct a study to determine the dose range of your compound in rats.
  • Effective Dose (ED), 50% Toxicity Test Quantify the diluted toxin needed to induce sub-lethal effects upon constant exposure in half of test organisms.
  • General Toxicology Use in vivo models to assess acute and sub-acute toxicity as well as chronic and sub-chronic toxicity.
  • IV Toxicology Test the toxicological effect of IV delivery of drug candidate.
  • Mammalian Toxicology Use toxicity testing models to carry out required FDA or REACH safety testing.
  • Nonclinical Study Management Provide nonclinical study management services to pharmaceutical and biotech companies. The services can be customized to meet the clients needs.
  • Nonclinical Study Monitoring Provide nonclinical study monitors throughout the US and Canada to monitor in vivo and in vitro studies are CROs
  • Oral Toxicology Use toxicity studies in animals to evaluate the oral toxicity of a drug candidate.
  • Repeat Dose Toxicity Study - Dog / Canine Conduct a repeat dose study in dogs to determine the toxicity and toxicokinetic behavior of your compound.
  • Repeat Dose Toxicity Study - Monkey / Non-human Primate Conduct a repeat dose study in monkey/non-human primates to determine the toxicity and toxicokinetic behavior of your compound.
  • Repeat Dose Toxicity Study - Mouse Conduct a repeat dose study in mice to determine the toxicity and toxicokinetic behavior of your compound.
  • Repeat Dose Toxicity Study - Other Species Conduct a repeat dose study in other species to determine the toxicity and toxicokinetic behavior of your compound.
  • Repeat Dose Toxicity Study - Rat Conduct a repeat dose study in rats to determine the toxicity and toxicokinetic behavior of your compound.
  • Short-Term Toxicity Tests Acquire preliminary data about the concentrations, exposure duration and effects of a toxin on organisms.
  • Single Dose Acute Toxicity Study - Dog / Canine Conduct a single dose study in Dogs and Canines to determine the toxicokinetic behavior of your compound.
  • Single Dose Acute Toxicity Study - Monkey / Non-human Primate Conduct a single dose study in Monkeys and Non-human Primates to determine the toxicokinetic behavior of your compound.
  • Single Dose Acute Toxicity Study - Mouse Conduct a single dose study in Mice and Murines to determine the toxicokinetic behavior of your compound.
  • Single Maximum Tolerated Dose (MTD) Mouse Study Use mouse models to determine the MTD of a drug candidate by a single administration in a 7 day period.
  • Single Maximum Tolerated Dose (MTD) Rat Study Use rat models to determine the MTD of a drug candidate by a single administration in a 7 day period.

General Marketing

  • Database Management Software Facilitate the collection, tracking and processing of biological facts, statistics and observations.

HEOR

  • Burden of Illness/Disease Strategy and study related to assessing the impact (economic, non-economic) of disease on health outcomes in a country, region, community, patient, or health system.
  • Clinical Outcome Assessments (Non-Patient Reported) Measure a patient's symptoms, mental state and level of disease condition-related impact on daily life.
  • Clinical Outcomes Measures patient's symptoms, mental, or physical effects of a disease or condition on how the patient functions, recorded by practitioner, provider, or instrument (not by patient).
  • Comparative Effectiveness The generation and synthesis of evidence that compares the benefits and harms of alternative methods to prevent, diagnose, treat, and monitor a clinical condition or to improve the delivery of care.
  • Cost Benefit Analysis Economic evaluation in which costs and benefits (outcomes) are expressed in monetary units, to determine if the benefits of an intervention outweigh the costs.
  • Cost Effectiveness Analysis Compare alternative treatments that lead to similar health outcomes.
Show all 15 in HEOR 9 more
  • Decision Analytic Modeling Assess effects, costs and economic outcomes of treatment. These include cost-effectiveness models and budget impact models.
  • Health Economics and Outcomes Research (HEOR) Evaluate data collected during drug development to maximize the value of a therapeutic product.
  • HEOR Adherence Studies Strategy or study that assess extent to which patients or subjects follow recommendations for prescribed intervention; may include compliance assessment, as well as reasons related to actual or potential non-adherence.
  • Patient Reported Outcomes (PRO) Assessment of health outcomes directly reported by the patient who experienced it, without interpretation of the patient's response by a clinician.
  • Patient Treatment Patterns Assessment of treatment processes and patterns within clinical practice.
  • Resource Utilization Descriptive and/or analytical review of a treatment that investigate the marketing, distribution, prescription, and use of drugs in populations. Endpoints to be assessed are the medical, social, and economic outcomes.
  • Systematic Literature Review Summarizes the results of research (that meet pre-defined eligibility criteria for inclusion) and provides a high level of evidence on the outcomes assessed.
  • Systematic literature review Summarizes the results of research (that meet pre-defined eligibility criteria for inclusion) and provides a high level of evidence on the outcomes assessed.
  • Therapy Switch Insight into the reasoning of patients switching treatments and the outcomes of the switch.

Human Biological Samples

  • 3D InSight™ Liver Microtissues Perform in vitro assessment of islet function for efficacy and toxicity testing.
  • Biospecimen Finder Explore listings of Human Biological Samples from the suppliers on the scientist.com HBS database
  • Biospecimens With Clinical Longitudinal Data Obtain remnant biospecimens annotated with matrix/collection data, demographics, primary diagnosis, and co-morbidities, lab test results, and medication history.
  • BronchoAlveolar Lavage (BAL) Acquire fresh/frozen normal bronchial lavage based on patient demographics and history.
  • Cell Line and Cellular Services Promotion for Cells and Cell lines
  • Custom FFPE cell line blocks Custom IHC compatible FFPE cell line blocks and sections
Show all 100 in Human Biological Samples 94 more
  • Custom PDX models For requesting Custom PDX models
  • Existing PDX models For requesting Existing PDX models
  • HBS Alzheimer's Acquire fresh, frozen, or fixed Alzheimer's tissues or other related Alzheimer's HBS.
  • HBS Amyotrophic Lateral Sclerosis (ALS) For requesting HBS Amyotrophic Lateral Sclerosis (ALS).
  • HBS Asthma For requesting HBS Asthma.
  • HBS Autoimmune Diseases For requesting Autoimmune Diseases HBS.
  • HBS Bacterial Infections Provision of HBS Bacterial Infections samples
  • HBS Cardiovascular Disease Request tissue samples and Bio-specimen samples from patients with Cardiovascular Disease
  • HBS Chronic Obstructive Pulmonary Disease (COPD) Acquire fresh, frozen, or fixed COPD tissue or for requesting other COPD human biospecimen samples.
  • HBS Diabetes For requesting HBS Diabetes.
  • HBS Fungal Infections Provision of HBS Fungal Infections samples
  • HBS Genetic Diseases For requesting Genetic Diseases HBS
  • HBS Healthy/Controls For requesting HBS Healthy/Controls
  • HBS HepB positive For requesting HBS HepB positive.
  • HBS HepC positive For requesting HBS HepC positive
  • HBS HIV positive For requesting HBS HIV positive
  • HBS Huntington's For requesting HBS Huntington's.
  • HBS Kidney Disease Request samples from patients with Kidney Disease
  • HBS Leukemia For requesting HBS Leukemia
  • HBS Liver Disease Request samples from patients with Liver Disease.
  • HBS NASH For requesting HBS NASH
  • HBS Neurological Diseases For requesting Neurological Diseases HBS
  • HBS NSCLC For requesting HBS NSCLC
  • HBS Oncology For requesting Human biospecimens from Oncology indications
  • HBS Parkinson's For requesting HBS Parkinson's
  • HBS Viral Infections For requesting Viral Infection HBS
  • HBS: Human Biological Samples Request human biosamples including tissues, blood, serum, bone marrow, tissue microarrays, etc.
  • HBS: Human Biological Samples - VMS Request human biosamples including tissues, blood, serum, bone marrow, tissue microarrays, etc.
  • Human 3D cultures Provision of 3D culture of Human Primary Cells
  • Human Adult Stem Cells Acquire human stem cells isolated from various adult tissues.
  • Human Amniotic Fluid Acquire fresh/frozen normal amniotic fluid based on patient demographics and history.
  • Human Aqueous Humor Acquire fresh/frozen normal aqueous humor based on patient demographics and history.
  • Human Ascites Acquire fresh/frozen Ascites based on patient demographics, disease stage, treatment and history.
  • Human Bile Acquire fresh/frozen normal bile based on patient demographics and history.
  • Human Biofluids Acquire fresh/frozen biofluids based on patient demographics, disease stage, history and treatment.
  • Human Biopsy Cell Models Request human biopsy cell models.
  • Human Blood Acquire fresh/frozen human blood based on patient demographics, disease stage, history and treatment.
  • Human Blood by-products For requesting Human Blood By-products
  • Human Bone Marrow Aspirates Acquire fresh/frozen Bone Marrow mononuclear cells based on patient demographics, disease stage, treatment and history.
  • Human Bone Marrow Cells Acquire fresh, frozen, or fixed normal bone marrow based on patient demographics and history.
  • Human Breast Milk Acquire fresh/frozen normal breast milk based on patient demographics and history.
  • Human Buffy Coats Acquire fresh/frozen Buffy Coats based on patient demographics, disease stage, treatment and history.
  • Human Cell Lysates For requesting human Cell lysates.
  • Human Cell Products For requesting human cell by products like proteins, lysates, lysosomes etc
  • Human Cerebral Spinal Fluid (CSF) Acquire fresh/frozen normal cerebrospinal fluid based on patient demographics and history.
  • Human CMA Request Human Cell MicroArray
  • Human COT-1 DNA COT-1 DNA is isolated from human placental tissue
  • Human DNA Acquire human DNA.
  • Human DNA & RNA Acquire fresh/frozen Human DNA & RNA based on patient demographics, disease stage, treatment and history
  • Human Endothelial Cells Endothelial cells are specialized epithelial cells that form a single layer lining the inner surface of all blood vessels and lymphatic vessels
  • Human Epithelial Cells Human epithelial cells are the most abundant cell type in the body and form the outer layer of skin and line various internal organs, including the digestive and respiratory tracts.
  • Human Exosomes Request services related to the creation and development of human exosomes
  • Human Eyes For requesting Human Eyes Samples
  • Human Fecal Matter Acquire fresh/frozen normal feces based on patient demographics and history.
  • Human Fibroblasts Human Fibroblasts play a vital role in forming connective tissue
  • Human Fixed Tissue Acquire Human fixed tissue based on patient demographics, disease stage, history and treatment.
  • Human Fresh Tissue For requesting fresh human tissue
  • Human Frozen Tissue For requesting frozen human tissue.
  • Human Hepatocytes Acquire human hepatocytes isolated from the liver.
  • Human HSC's For requesting human sourced hematopoetic stem cells
  • Human Immortalized Cell Culture For requesting human cells Cell Lines typically refer to legacy immortalised cells, that can be cultured and passaged “indefinitely” Primary Cells are cells that have been isolated from fresh tissue (or cultures) that...
  • Human iPSC's For requesting human sourced induced pluripotent stem cells.
  • Human Leukopaks Obtain enriched leukapheresis-derived products from normal peripheral blood.
  • Human Mammary Epithelial Cells Acquire human epithelial cells isolated from the mammary gland.
  • Human Melanocytes Human Melanocytes are pigment-producing cells primarily found in the skin, hair follicles, and eyes
  • Human Microsomes Acquire microsomes derived from the endoplasmic reticulum of hepatic cells
  • Human MSC's For requesting human sourced mesenchymal stem cells.
  • Human Myoblasts Human Myoblasts are a type of immature white blood cell that forms in the bone marrow
  • Human Nasal Fluid Acquire fresh/frozen normal nasal fluid based on patient demographics and history.
  • Human Neural Stem Cells Acquire human neural stem cells isolated from brain tissue.
  • Human Organoids Test immuno-oncology drugs and therapies on fresh, unpropagated 3D tumor organoids to evaluate efficacy and understand drug mechanism of action. Understand the intact tumor immune microenvironment, cytotoxic efficacy...
  • Human Organs-On-Chips Use Organs-On-Chips for target identification and validation, target-based screening, and phenotypic screening.
  • Human Peripheral Blood Mononuclear Cells (PBMCs) Acquire fresh/frozen normal PBMCs based on patient demographics and history.
  • Human Plasma Acquire fresh/frozen human plasma
  • Human Primary Cells Acquire fresh/frozen human primary cells based on patient demographics, disease stage, history and treatment. Cell Lines typically refer to legacy immortalised cells, that can be cultured and passaged “indefinitely”...
  • Human Red Blood Cells Acquire fresh/frozen normal red blood cells based on patient demographics and history.
  • Human RNA Acquire fresh/frozen Human RNA based on patient demographics, disease stage, treatment and history.
  • Human Saliva Acquire fresh/frozen normal saliva based on patient demographics and history.
  • Human Semen Acquire fresh/frozen normal semen based on patient demographics and history.
  • Human Serum Acquire fresh/frozen normal serum based on patient demographics and history.
  • Human Sputum Acquire fresh/frozen normal sputum based on patient demographics and history.
  • Human Synovial Fluid Acquire fresh/frozen normal synovial fluid based on patient demographics and history.
  • Human Tears Acquire fresh/frozen Tears based on patient demographics, disease stage, treatment and history.
  • Human TMA For requesting Human Tissue MicroArrays
  • Human Umbilical Cord Blood For requesting Human Umbilical Cord Blood.
  • Human Urine Acquire fresh/frozen normal urine based on patient demographics and history.
  • Human Vaginal Fluid/ Swab Acquire fresh/frozen normal vaginal fluid based on patient demographics and history.
  • Human Vitreous Humor Acquire fresh/frozen normal vitreous humor based on patient demographics and history.
  • Human Whole Blood Acquire fresh/frozen normal whole blood based on patient demographics and history.
  • Human Whole Organs Procure non-transplantable whole human organs or tissues, healthy or diseased, for medical research and development.
  • Leukopaks Acquire leukapheresis-derived enriched leukocyte preparation from peripheral blood of normal healthy subjects.
  • Lipoma Human Fixed Tissue Acquire fixed Lipoma tissue based on patient demographics, disease stage, treatment and history.
  • Liquid Biopsy Test and detect either circulating tumor cell-associated biomarkers or circulating tumor DNA.
  • Tumor Cells Acquire tumor cells (either human or animal)

In Vitro ADME

  • Blood Brain Barrier Measure movement of drugs from circulating blood to brain extracellular fluid.
  • Caco-2 Cell Permeability Measure passive diffusion of drugs across Caco2 cell monolayers.
  • Cell Fractionation Isolate organelles and subcellular components.
  • Cell Permeability and Absorbance Models Cell Permeability and Absorbance Model assay.
  • Compound Distribution Determine the metabolic fate of a drug candidate in tissue and organs of diseased and normal animal models.
  • Conjugate Detection Measure the conjugation of endogenous small molecules to drug candidates after in vivo administration.
Show all 46 in In Vitro ADME 40 more
  • CYP Induction Detect increases in the expression of various isoforms of cytochrome P450 (CYP450).
  • CYP Inhibition Assay Assess the inactivation and inhibition of cytochrome P450 (CYP450) in microsomes isolated from primary human hepatocytes or liver.
  • CYP Isozyme Mapping Determine the isozymes of cytochrome P450 (CYP450) involved in the metabolism of a drug candidate.
  • Cytochrome P450s Assess the inhibition or induction of the various isozymes of cytochrome P450s by drug candidates.
  • Drug Distribution Studies Determine the metabolic fate of compounds within tissues, organs and plasma.
  • Drug Drug Interactions Determine whether a substance affects the activity of a drug when both are administered together.
  • GI Fluid Stability Determine dosing and turnover of drug candidates in gastrointestinal fluids.
  • HT ADME (High-Throughput Absorption, Distribution, Metabolism and Excretion) Analyze the process and effects of a chemical that is ingested by an organism using an advanced technological screening process. Use for drug...
  • Human Blood Brain Barrier on a Chip (BBBoC) Create a blood–brain barrier multicellular model to test drug delivery to the brain.
  • In Vitro ADME in Vitro ADME services
  • Intestinal Permeability Use Caco 2 and MCDK cells to assess mono-directional drug transport by passive diffusion in culture.
  • Isotopic Labeling Track labeled isotopes through a metabolic pathway or cell by measuring mass, vibrational mode or radioactive decay.
  • Membrane Transporters Use Caco 2 cells to assess bi-directional drug transport in the presence or absence of P-glycoprotein (P-gp) inhibitors.
  • Metabolic Stability Measure metabolic vulnerability to drug metabolizing enzymes using cell-free, cell-based and in vivo assays.
  • Metabolic Stability in Hepatocytes Assess the susceptibility of drugs to metabolism by Phase I (CYP450) and Phase II enzymes in liver cells.
  • Metabolic Stability in Microsomes Assess the susceptibility of drugs to metabolism by Phase I (CYP450) and Phase II enzymes in liver microsomes.
  • Metabolite Generation Analyze the formation of drug metabolites after administration of drug to an animal model or patient.
  • Metabolite Identification Identify drug metabolites that are formed after administration of drug to an animal model or patient.
  • Metabolite Identification and Profiling Estimate drug candidate metabolites after administration of drug to an animal or human subject.
  • Metabolite Quantification Quantify drug metabolites formed after drug administration to an animal model or patient.
  • Metabolite Structural Elucidation Use analytical tools to characterize metabolite structure.
  • Metabolite Synthesis Synthesize drug metabolites that are formed after administration of drug to an animal model or patient.
  • Multidrug Resistance Identify potential causes of drug-drug interactions.
  • N Acetyl Transferase Detect NAT induction and identify any acetylated-drug conjugates that are formed.
  • Nasal Permeability Test for passive diffusion and active transport in nasal permeability models.
  • No Label Methods Use mass spectrometry to detect and identify non-radiolabeled drug intermediates in pre-clinical samples.
  • Non Isotopic Labeling Track unlabeled macromolecules through a metabolic pathway or cell.
  • Ocular Permeability Measure passive diffusion and active transport of drugs across confluent ocular epithelial cells.
  • Permitted Daily Exposure (PDE) Evaluate the health based exposure limits or permitted daily exposure of different medicinal products in shared facilities during manufacturing.
  • PharmacoScan - A Pharmacogenomics Tool Understand how genetic variation affects drug absorption, distribution, metabolism, and excretion (ADME) in a microarray plate.
  • Phase I Metabolism Use enzymes such as cytochrome P450 oxidases to introduce reactive or polar groups into xenobiotics.
  • Phase II Metabolism Use transferase enzymes such as glutathione S-transferases to conjugate phase I xenobiotics to polar compounds.
  • Plasma Stability Assay Determine degradation rate of drug candidates in plasma.
  • Protein Binding Ultrafiltration Measure the rate at which unbound drug passes through a dialysis membrane that models epithelial barrier pore size.
  • Radiolabeled Tracers Use radiolabeled drug metabolites as radiotracers for measuring desired physiological processes.
  • Reactive Metabolite Ensure that your drug candidate is not generating toxic reactive metabolites in vivo.
  • Red Blood Cell (RBC) Partitioning (Blood/Plasma Ratio) Measure the distribution of a compound between red blood cells and plasma.
  • Reference Standards Find reference standards for assays, tests and services.
  • Skin Permeability Use human skin models to determine transdermal delivery and percutaneous absorption of pre-clinical drugs.
  • Sulfotransferase Detect sulfotransferase (SULT) induction and the formation of sulfonated-drug conjugates.

In Vitro Assays

  • 3D Cell Microscopy Assay Investigate cellular and subcellular events in three dimensional 3D cultures by using fluorescence microscopy.
  • 3Screen™ 3D In Vitro Services 3Screen™ Platform enables complete 3D cell culture characterization.
  • Annexin V Apoptosis Assay Detect and quantify apoptotic cells based on loss of membrane asymmetry.
  • Anti-thrombin Assays Use clotting and chromogenic assays to detect and classify anti-thrombin deficiency.
  • Antivirals Measure anti-viral activity in biochemical and cell assays.
  • Apoptosis Assays Detect apoptotic events that lead to programmed cell death.
Show all 72 in In Vitro Assays 66 more
  • Apoptotic Cell Staining Detect apoptotic cells in culture.
  • Assay Development Construct or create new assays or modify existing ones.
  • Assay Kits Can't find what you're looking for? Click here to submit a request to multiple vendors for assay kits.
  • Basophil Activation Test A Basophil Activation Test (BAT) is a lab test that measures basophil (a type of white blood cell) activation in response to potential allergens
  • Biosensor Assays Evaluate biological activity of new compounds, detect toxic metabolites or monitor biomarkers.
  • BrdU S-Phase Analysis Assess cell division or apoptosis by measuring thymidine-analog label incorporation during DNA replication.
  • Caspase Assay Detect early to mid stage apoptosis or differentiate apoptosis from necrosis.
  • Cell Based Assays Apply compounds to cells and test for cellular phenotypes and effects on gene expression
  • Cell Based Assays Consulting Expert advice to evaluate the functions of specific chemicals based on their constructions and systems.
  • Cell Cycle Assays Measure cell cycle markers and the molecular events that control cell cycle progression.
  • Cell Painting Cell painting is multiplexed image-based assay used to investigate subtle changes in cellular homeostasis
  • Cell Proliferation Measure cell number, cell viability and cell division.
  • Cell-based Assay Development Develop new cell based assays or modify existing ones.
  • Cell-based Screening Assays Apply compounds to cells and test for cellular phenotypes and effects on gene expression
  • Cytometric Bead Array (CBA) FACS Analysis Use flow cytometry and antibody-coated beads to simultaneously detect multiple target proteins.
  • ELISpot Assay and Testing Detect low levels of antigens.
  • Endpoint Dilution Assay (TCID50) Assay Determine the viral titer to induce cell death in half the cell population of an inoculated tissue culture.
  • Epidermal Sensitization Assay (EpiSensA): OECD 442D Validated in vitro skin sensitization
  • Epigenetic Profiling In Vitro Assays Test for epigenetic modifications and indicator levels via in vitro assays.
  • Fully Automated Assays Develop and perform assays that require no manual steps
  • Glucose Release Assay Determine free glucose levels in biological samples.
  • Glucose Uptake Measure glucose uptake in cultured cells using GLUT4 signaling assays.
  • Glycobiology Study the structure biosynthesis and biology of carbohydrates
  • Glycomics Glycomics is the comprehensive study of glycans, in a biological system, such as a cell or organism
  • High Content Screening Analyze whole cells or components of cells with simultaneous readout of several parameters.
  • HTS Assay Development Develop assays to use in high throughput screening.
  • Human Custom TMA For requesting Human Custom Microarray Services
  • Human Immuno-deficiency Virus Infection CDx Design and validate companion diagnostics for HIV infection that help select the most appropriate patients, identify patients at increased risk, or monitor treatment effectiveness.
  • Hydroxyproline Assays Use biochemical, cell based or in vivo assays to quantify hydroxyproline or collagen in a sample.
  • Immunofocus™ Predict the response to anti PD1/PDL1 directed therapies.
  • ImmunoSEQ Assay Unmask the identity of millions of T- and B-cell receptors in a single sample using bias-controlled multiplex PCR amplification, high-throughput sequencing, and sophisticated bioinformatics.
  • In Vitro Assay Development Develop innovative assay and screening methods outside a living organism to enable a wide range of pre-clinical activities.
  • In Vitro CAR-T Therapy Chimeric Antigen Receptor T-cell therapy: specialized form of immunotherapy
  • In Vitro Efficacy Test Use in vitro models to test the efficacy of your products.
  • In Vitro Human Cell Assays Request in vitro human cells for assays
  • In Vitro SPF (Sun Protection Factor) Testing Use in vitro test methods to measure the UVA protection performance of sun protection products.
  • Inflammation Assays Identify and validate pro- and anti-inflammatory molecules, recruitment inhibitors and chemotaxis modulators.
  • International Normalized Ratio (INR) Testing Use standardized methods to measure prothrombin clotting time.
  • Invasion Assays Monitor and quantify the ability of cultured cells to permeate real or artificial biological barriers.
  • Lipid Detection Use in vitro methods to identify lipid droplets and any associated proteins.
  • Lipolysis Measure the hydrolysis of triglycerides into glycerol and free fatty acids.
  • Luciferase Reporter Assay Evaluate promoter activity by measuring light output from the luciferase enzyme.
  • Microbiology Study microbes and their role in human health.
  • Monoamine Transporter Assays Measure monoamine neurotransmitter uptake in cultured cells.
  • MTT Test Measure the viability of living cells via mitochondrial dehydrogenase activity.
  • OnTarget™ ctDNA Analysis Detect and monitor circulating tumor DNA in blood with OnTarget™ enrichment technology.
  • Organoid Screening Assay Evaluate the effects of various substances, such as drugs or genetic modifications, on organoids.
  • Oxidative Burst Examine the release of reactive oxygen species (ROS) from neutrophils and other immune cells.
  • Pathogen Assays Detect and distinguish viral, bacteria and fungal strains and species.
  • Pathology Services Pathology Services
  • Pathway Mapping Define mechanisms of action by analyzing protein pathways affected by drug treatment.
  • Phenotype Assays Measure effects of drug candidate on the morphology or function of cells and whole animals.
  • Porcine Cornea Reversibility Assay (PorCORA) Measure corneal damage and recovery in excised porcine corneas.
  • PrimeFlow™ RNA Assay Reveal the unique kinetics of mRNA and protein in the same cell and identify expression differences as they change over time in response to stimulus.
  • Reactive Species Assays Use biochemical, cell-based or in vivo assays to detect and evaluate the effects of reactive species.
  • Reporter Virus Particles (RVPs) - Dengue Neutralization Assay Use Dengue Reporter Virus Particles to measure neutralizing antibodies against each of the four Dengue serotypes.
  • SARS-CoV-2 (COVID-19) Assays Search for Available SARS-CoV-2 Assays
  • Serine Protease Assay Detect apoptosis by measuring protease activity.
  • Sprouting Assay Use a cell-based assay to monitor the formation of angiogenic outgrowths.
  • Stem Cell Differentiation Microscopy Assay› Elucidate mechanisms of stem cell renewal and differentiation in vitro using fluorescence microscopy.
  • Thrombin Generation Tests Measure the tendency of a plasma sample to form thrombin upon the initiation of coagulation.
  • Tube Formation Assay Monitor the in vitro formation of three dimensional 3D tube structures.
  • Viral Clearance Assays Measure the capacity to remove or inactivate infectious agents during the manufacturing process.
  • Virus Detection Assays Use ultra-sensitve methods to reliably detect low level viruses.
  • Von Willebrand Factor Analysis Detect and classify the Von Willebrand disease sub-type.
  • WBAL (Whole Body AL) Whole Body Autoradioluminography (WBAL) and related services can assist you in determining the metabolic fate of your test agen...

In Vitro Pharmacology

  • Anaplastic lymphoma kinase (ALK) Assays Use biochemical, cell based or in vivo assays to measure ALK enzyme activity.
  • Aptamer Products Obtain pre-made aptamers for specific target binding.
  • ATP Competitive Study Determine whether or not a compound is competitive with ATP.
  • B-Cell Lymphoma 2 (BCL-2) Assays Use biochemical, cell based or in vivo assays to measure BCL-2 protein activity.
  • Calcium Channel Assays Use biochemical, cell-based or in vivo assays to measure calcium channel activity.
  • Cellular Thermal Shift Assay Use a novel biophysical assay for in situ drug target engagement and mechanistic biomarker studies.
Show all 78 in In Vitro Pharmacology 72 more
  • Chloride Channel Assays Use biochemical, cell-based or in vivo assays to measure chloride channel activity.
  • Cytotoxic T-Lymphocyte Antigen-4 (CTLA-4) Assays Use biochemical, cell based or in vivo assays to measure CTLA-4 receptor activity.
  • Dehydrogenase Assays Measure dehydrogenase activity in biochemical and cell-based assays.
  • Drug Target Assays Gain insight into the selectivity and mode-of-action of a compound's pharmacological targets.
  • Extracellular signal Regulated Kinase Assays Use biochemical, cell based or in vivo assays to measure ERK enzyme activity.
  • Fibroblast Growth Factor Receptor (FGFR) Assays Use biochemical, cell based or in vivo assays to measure FGF receptor activity.
  • G-Protein Coupled Receptor (GPCR) Assays Detect ligand binding, receptor dimerization and downstream signal transduction events.
  • Glucose Transporter Assays Use biochemical, cell-based or in vitro assays to measure glucose transporter activity.
  • High Throughput Screening Conduct millions of chemical, genetic or pharmacological tests in a short period of time.
  • Histone Acetyltransferase (HAT) Assays Use biochemical, cell-based or in vivo assays to measure histone acetyltransferase activity.
  • Histone Deacetylase (HDAC) Assays Use biochemical, cell-based or in vivo assays to measure histone deacetylase activity.
  • HuGEMM - Immuno-Oncology Model Evaluate human-specific therapeutics for checkpoint inhibitors, including anti-human PD-1, anti-human PDL-1, and anti-human CTLA-4 antibodies.
  • Human BCL Assays Use biochemical, cell-based or in vivo assays to measure BCL activity.
  • Human Epidermal growth factor Receptor (HER) Assays Use biochemical, cell based or in vivo assays to measure HER receptor activity.
  • Immuno-oncology Assays Use biochemical, cell based or in vivo assays to measure the activity of immuno-therapy targets.
  • Immuno-oncology Targets Develop drugs that take advantage of the immune system to target cancer cells.
  • In Vitro Bone Models Measure osteoclast activity and bone formation in human or rat osteoclasts.
  • In Vitro Cardiovascular Models Measure stimulation and inhibition of lipolysis, adipogenesis and endothelial cell migration.
  • In Vitro Diabetes Models Measure insulin stimulation of glucose uptake and metabolism of lipids including cholesterol and triglycerides.
  • In Vitro Disease Models Screen pre-clinical candidates without the use of live animals.
  • In Vitro Enzyme Activity Assay Development Develop new in vitro enzyme activity assays or modify existing ones.
  • In Vitro Excitotoxicity Models Use in vitro models to measure therapeutic endpoints associated with excitotoxic pathology.
  • In Vitro Eye Models Measure cytokine production, cell viability, apoptosis and wound healing.
  • In Vitro Fertilization Models Measure oocyte maturation, embryo development in culture and sperm fertilizing ability.
  • In Vitro Hemolysis Assay Evaluate the toxicity of a drug, metabolite or excipient by hemolytic release of hemoglobin in the plasma.
  • In Vitro Hepatotoxicity Assays Use in vitro assays to measure hepatoxicity-related activities.
  • In Vitro Hypoxia Models Use in vitro models to measure therapeutic endpoints associated with hypoxia.
  • In Vitro Neural Models Use cultured neurons, neuronal progenitor cells and stem cell differentiation to create cellular models of neurological disease.
  • In Vitro Oncology Models Use cell-based and biochemical models of cancer.
  • Ion Channels Use fluorometry, electrophysiology and radiometric binding assays to measure ion channel activity.
  • Kinase Assays Measure activity of over 500 kinases in biochemical or cell-based assays.
  • Liposome Immunoassay Use immuno-liposomes for improved signal intensity and detection sensitivity compared to enzyme and fluorescent immunoassays.
  • Mammalian Target of Rapamycin Complex Assays Use biochemical, cell based or in vivo assays to measure mTORC enzyme activity.
  • Methyltransferase Assays Use biochemical, cell-based or in vitro assays to measure methyltransferase activity.
  • Mitogen/Extracellular signal-regulated Kinase (MEK) Assays Use biochemical, cell based or in vivo assays to measure MEK enzyme activity.
  • Mutant B-Raf Assays Use biochemical, cell based or in vivo assays to measure mutant B-Raf enzyme activity.
  • Nitric Oxide Synthase Assays Measure nitric oxide synthase activity by biochemical or cellular assays.
  • Nuclear Receptor Assays Measure nuclear receptor activity in biochemical and cell assays.
  • Nucleoside Transporter Assays Use biochemical, cell-based or in vivo assays to measure nucleoside transporter activity.
  • Oxidase Assays Use biochemical, cell-based or in vivo assays to measure oxidase activity.
  • PARP Assays Use biochemical, cell-based or in vivo assays to measure PARP activity.
  • Peptide Transporter Assays Use biochemical, cell-based or in vivo assays to measure peptide transporter activity.
  • Peroxidase Assays Measure peroxidase activity in bacterial and mammalian cells.
  • Phosphatase Assays Use biochemical, cell-based or in vitro assays to measure phosphatase activity.
  • Phosphatidylinositol 3-Kinase (PI3K) Assays Use biochemical, cell based or in vivo assays to measure PI3K enzyme activity.
  • Phosphodiesterase Assays Measure phosphodiesterase activity in biochemical and cell-based assays.
  • Polymerase Assays Measure polymerase activity in biochemical and cell-based assays.
  • Potassium Channel Assays Use biochemical, cell-based or in vivo assays to measure potassium channel activity.
  • Programmed Cell Death-1 (PD-1) Assays Use biochemical, cell based or in vivo assays to measure PD-1 receptor activity.
  • Programmed Death-Ligand 2 (PD-L2) Assays Use biochemical, cell based or in vivo assays to monitor competitive or non-competitive binding of PD-L2 ligand.
  • Protease Assay Measure protease activity in biochemical and cell-based assays.
  • Protein Kinase B (Akt) Assays Use biochemical, cell based or in vivo assays to measure Akt enzyme activity.
  • Protein Targets Protein Targets are of pharmaceutical interest for drug discovery purposes.
  • Protein/Enzyme Targets For requesting Protein/Enzyme Targets
  • Raf Assays Use biochemical, cell based or in vivo assays to measure Raf enzyme activity.
  • RAS Assays Use biochemical, cell based or in vivo assays to measure RAS enzyme activity.
  • Reversibility Study Determine whether or not a compound inhibits an enzyme reversibly.
  • Selectivity Profiling Determine the specificity of a ligand for its target by testing it against a large panel of related target proteins.
  • SELEX Select and identify highly specific aptamers with binding affinities comparable to traditional antibodies.
  • Sodium Channel Assays Use biochemical, cell-based or in vivo assays to measure sodium channel activity.
  • Solute-Linked Carrier (SLC) Transporter Inhibition Assays Use biochemical, cell-based or in vivo assays to measure solute-linked carrier transporter activity.
  • Solute-Linked Carrier (SLC) Transporter Substrate Identification Use biochemical, cell-based or in vivo assays to identify solute-linked carrier transporter substrates.
  • Substrate Competitive Study Determine whether or not a compound is competitive with a substrate.
  • Target Characterization Characterize potential drug targets during the drug discovery process.
  • Target Identification Identify the target(s) of a biologically active substance.
  • Target Validation Demonstrate that modification of target activity has potential therapeutic benefits.
  • Time Dependent Study Determine whether or not a compound binds to an enzyme in a time-dependent manner.
  • Transporter Assays Use biochemical, cell-based or in vitro assays to measure transporter target activity.
  • Ubiquitin Ligase Assays Measure ligase enzyme activity in the presence of cofactors or chemical modifiers.
  • UDP-glucuronosyltransferases (UGT) Inhibition Assays Use biochemical, cell-based or in vivo assays to measure UDP-glucuronosyltransferase activity.
  • Vascular Endothelial Growth Factor (VEGF) Assays Use biochemical, cell based or in vivo assays to monitor competitive or non-competitive binding of VEGF ligand.
  • Vascular Endothelial Growth Factor Receptor (VEGFR) Assays Use biochemical, cell based or in vivo assays to measure VEGF receptor activity.

In Vitro Toxicology

  • ADCC and CDC Assay Services Measure toxicity of antibodies.
  • Cardiac Channels Measure the arrhythmia producing potential of test compounds.
  • Cardiomyocyte Toxicity Assess cytotoxic effects of pre-clinical compounds on cardiomyocytes.
  • Cardiotoxicity Evaluate the effect of a compound on heart electrophysiology and muscle function.
  • Cardiovascular Toxicology Measure the toxic effects of pre-clinical compounds.
  • CH50 Assays Measure the functional activity of the classical complement activation pathway in serum or other fluid samples.
Show all 20 in In Vitro Toxicology 14 more
  • Cytotoxicity Test for effects on cell viability and proliferation
  • Cytotoxicity Testing Determine whether a cosmetic product or ingredient is toxic to in vitro cell cultures.
  • Endothelial Cell Toxicity Assess the cytotoxic effects of pre-clinical compounds on the vascular system.
  • Epidermal Cell Toxicity Measure toxicity by quantifying the number of live/dead cells, cell membrane integrity and glutathione (GSH) levels.
  • Genotoxicity Evaluate potential of a compound to cause mutations and chromosomal aberations
  • Hematopoietic Cell Toxicity Examine cytotoxic effects of pre-clinical compounds or biologics on adult stem cells.
  • HepaRG Cells Obtain terminally differentiated and cryopreserved hepatic cells that retain many characteristics of primary human hepatocytes.
  • Hepatocyte Toxicity Assess the cytotoxic effects of pre-clinical compounds on hepatocytes purified from patients and animal models.
  • hERG Inhibition Measure the arrhythmia-producing potential of test compounds.
  • Microelectrode Array Cardiotoxicity Assays Use microelectrode array to measure cardiotoxicity-related activities.
  • Perfused Heart Examine cardiac contractile strength (inotropic effects), heart rate (chronotropic effects) and vascular effects.
  • Short Time Exposure (STE) Test Use in vitro eye irritation tests to assess cytotoxicity in SIRC cells (rabbit corneal cell line).
  • Tubule Epithelial Cell Toxicity Assess the cytotoxic effects of pre-clinical compounds on the kidney.
  • Zebrafish Embryo Toxicity Use a single animal species to create one models of toxicity.

In Vivo ADME

  • Absorption studies Study the factors determning how efficiently a compound may enter the bloodstream.
  • Chronic Bile Duct Cannulation (BDC) Study - Dog / Canine Conduct a bile duct cannulation (BDC) study in dogs/canines to support the absorption, distribution, metabolism and excretion profiling of your compound.
  • Chronic Bile Duct Cannulation (BDC) Study - Monkey / Non-human Primate Conduct a bile duct cannulation (BDC) study in monkeys/non-human primates to support the absorption, distribution, metabolism and excretion profiling of your compound.
  • Chronic Bile Duct Cannulation (BDC) Study - Other Species Conduct a bile duct cannulation (BDC) study in other species to support the absorption, distribution, metabolism and excretion profiling of your compound.
  • Chronic Bile Duct Cannulation (BDC) Study - Rat Conduct a bile duct cannulation (BDC) study in rats to support the absorption, distribution, metabolism and excretion profiling of your compound.
  • Expired Air Study - Mouse Conduct a study to collect expired air and monitor its radioactivity content in mice.
Show all 29 in In Vivo ADME 23 more
  • Expired Air Study - Other Species Conduct a study to collect expired air and monitor its radioactivity content in other species.
  • Expired Air Study - Rat Conduct a study to collect expired air and monitor its radioactivity content in rats.
  • In Vivo Radiolabeled Metabolism Determine the qualitative and quantitative metabolism and/or degradation of an active ingredient in animals.
  • Mass Balance Study - Dog / Canine Conduct a study to investigate the plasma pharmacokinetics and excretion of your compound as well as total radioactivity in dogs/canines.
  • Mass Balance Study - Minipig Conduct a study to investigate the plasma pharmacokinetics and excretion of your compound as well as total radioactivity in minipigs.
  • Mass Balance Study - Monkey / Non-human Primate Conduct a study to investigate the plasma pharmacokinetics and excretion of your compound as well as total radioactivity in monkeys/non-human primates.
  • Mass Balance Study - Other Species Conduct a study to investigate the plasma pharmacokinetics and excretion of your compound as well as total radioactivity in other species.
  • Mass Balance Study - Rat Conduct a study to investigate the plasma pharmacokinetics and excretion of your compound as well as total radioactivity in rats.
  • Milk Secretion Study - Other Species Conduct a study to determine the extent of milk secretion of your radioactive compound in other species.
  • Milk Secretion Study - Rat Conduct a study to determine the extent of milk secretion of your radioactive compound in rats.
  • Ocular Distribution Study - Dog / Canine Conduct a study to determine the distribution of your compound in ocular tissues of the dog/canine.
  • Ocular Distribution Study - Monkey / Non-human Primate Conduct a study to determine the distribution of your compound in ocular tissues of the monkey/non-human primate.
  • Ocular Distribution Study - Other Species Conduct a study to determine the distribution of your compound in ocular tissues of other species.
  • Ocular Distribution Study - Rabbit Conduct a study to determine the distribution of your compound in ocular tissues of the rabbit.
  • Ocular Distribution Study - Rat Conduct a study to determine the distribution of your compound in ocular tissues of the rat.
  • Placental Transfer Study - Other Species Conduct a study to determine the extent of placental transfer in other species by assessing the radioactivity of your compound in fetal tissue and maternal blood.
  • Placental Transfer Study - Rabbit Conduct a study to determine the extent of placental transfer in rabbits by assessing the radioactivity of your compound in fetal tissue and maternal blood.
  • Placental Transfer Study - Rat Conduct a study to determine the extent of placental transfer in rats by assessing the radioactivity of your compound in fetal tissue and maternal blood.
  • Qualitative Whole Body Autoradiography Request information or a price quote for Qualitative WBA services
  • Quantitative Whole Body Autoradiography (QWBA) Determine the tissue distribution of a radiolabeled compound in Rodent and Non-Rodent Species.
  • Quantitative Whole Body Autoradiography (QWBA) - Non-rodent Species Conduct a study to determine the tissue distribution of your compound radiolabeled compound in non-rodent species.
  • Quantitative Whole Body Autoradiography (QWBA) - Rodent Species (Mouse, Rat) Conduct a study to determine the tissue distribution of your compound radiolabeled compound in rodent species.
  • Tissue Distribution Study the tissues in which a compound or its metabolites, accumulate.

In Vivo Pharmacokinetics

  • Cardiac Safety Assessment Assess cardiotoxicity using microelectrode assay technology.
  • In Vivo Immunogenicity Study An in vivo immunogenicity study evaluates a substance's ability to trigger an immune response within a living organism.
  • In Vivo Pharmacokinetics Run pharmacokinetic studies in animals that measure a drug's absorption, distribution, metabolism and excretion (ADME).
  • In Vivo PK Consulting Expert advice on pharmacokinetics and how specific drugs affect the body to determine function, effectiveness, dosage size, etc…
  • Integrated In Vivo Services Package Process an entire In Vivo Project including: Dose Formulation, PK Screening, ADME-Profiling, Toxicology, Safety Pharmacology, DART, IND Filing from our bundle of suppliers.
  • Mass Balance Elucidate excretory pathways and organ distribution of a parent drug and metabolites
Show all 24 in In Vivo Pharmacokinetics 18 more
  • Maximum Tolerated Dose (MTD) Studies Determine Maximum Tolerated Dose (MTD) of a drug candidate in either a single or repetitive dosing study in a rodent (typically mouse or rat).
  • Mouse Efficacy Monotherapy Use mouse models to determine the anti-cancer efficacy of a drug candidate compared to a positive control.
  • Ocular Pharmacokinetic (PK) Screening - Dog / Canine Conduct a pharmacokinetic screening study in dogs/canines that measures the absorption, distribution, metabolism and excretion of your compound following ocular administration.
  • Ocular Pharmacokinetic (PK) Screening - Monkey / Non-human Primate Conduct a pharmacokinetic screening study in monkeys/non-human primates that measures the absorption, distribution, metabolism and excretion of your compound following ocular administration.
  • Ocular Pharmacokinetic (PK) Screening - Other Species Conduct a pharmacokinetic screening study in other species that measures the absorption, distribution, metabolism and excretion of your compound following ocular administration.
  • Ocular Pharmacokinetic (PK) Screening - Rabbit Conduct a pharmacokinetic screening study in rabbits that measures the absorption, distribution, metabolism and excretion of your compound following ocular administration.
  • Ocular Pharmacokinetic (PK) Screening - Rat Conduct a pharmacokinetic screening study in rats that measures the absorption, distribution, metabolism and excretion of your compound following ocular administration.
  • Pharmacokinetic (PK) Screening Measure the absorption, distribution, metabolism and excretion of a compound.
  • Pharmacokinetic (PK) Screening - Dog / Canine Run pharmacokinetic studies in dogs that measure a drug’s absorption, distribution, metabolism and excretion.
  • Pharmacokinetic (PK) Screening - Minipig Run pharmacokinetic studies in minipigs that measure a drug’s absorption, distribution, metabolism and excretion.
  • Pharmacokinetic (PK) Screening - Monkey / Non-human Primate Conduct a pharmacokinetic screening study in monkeys/non-human primates that measures the absorption, distribution, metabolism and excretion of your compound.
  • Pharmacokinetic (PK) Screening - Mouse Run pharmacokinetic studies in mice that measure a drug's absorption, distribution, metabolism and excretion.
  • Pharmacokinetic (PK) Screening - Other Species Run pharmacokinetic studies in large animals that measure a drug's absorption, distribution, metabolism and excretion.
  • Pharmacokinetic (PK) Screening - Rat Run pharmacokinetic studies in rats that measure a drug's absorption, distribution, metabolism and excretion.
  • Rat Efficacy Combination Use rat models to determine the anti-cancer efficacy and potential synergy of a drug candidate with a standard drug treatment.
  • Rat Efficacy Monotherapy Use rat models to determine the anti-cancer efficacy of a drug candidate compared to a positive control.
  • Repetitive Maximum Tolerated Dose (MTD) Mouse Study Use mouse models to determine the MTD of a drug candidate by repetitive administrations for 7 days.
  • Repetitive Maximum Tolerated Dose (MTD) Rat Study Use rat models to determine the MTD of a drug candidate by repetitive administrations for 7 days.

Lab Supplies, Facilities, and Equipment

  • Biobanking Store and track biological samples.
  • Crop Storage Management Monitor storage conditions to reduce crop deterioration and protect against pest infestation.
  • eMolecules Punchout Request the catalog of eMolecules.com. This catalog includes compound screening, chemical building blocks and primary antibody supply chains.
  • Lab Equipment Installation & Calibration Install new or refurbish used laboratory equipment and calibrate to reference standards.
  • Lab Equipment Maintenance & Repair Conduct repairs for laboratory equipment or routine and preventative maintenance.
  • Lab Equipment Maintenance Agreement Design contracts for laboratory equipment evaluation and maintenance requirements.
Show all 12 in Lab Supplies, Facilities, and Equipment 6 more
  • Lab Equipment Mechanical Design Obtain custom laboratory equipment modification and/or production.
  • Lab Equipment Rental Rent various scientific equipment commonly used in the laboratory.
  • Laboratory Equipment Manufacture The manufacture of laboratory equipment or glassware
  • Rent-to-Purchase Lab Equipment Obtain rent-to-purchase laboratory equipment and the corresponding contracts.
  • Research Diets for Laboratory Animals Custom mixing and formulation of laboratory animal diets.
  • Tissue Directory and Coordination Centre UKCRC Tissue Directory and Coordination Centre Integration with Scientist.com

Management Optimization & Development Strategies

  • Agronomy Management specialization in such areas as crop rotation, irrigation and drainage, soil fertility.
  • Big Data Computational assistance with analysis of large data sets to reveal patterns, trends and associations
  • EPA Registration of Pesticides Provide consultation for the registration of pesticides for sale, distribution and use.
  • Labeling Requirements of GMOs and Pesticides Consultation for ensuring the safe and proper labeling of GMOs and Pesticides for commercial use
  • Natural Resource Management Crop management; forecasting, and use of mathematical and computer modeling programs
  • OECD Regulatory Development Consultation in safety testing, chemical notification and registry within OECD.
Show all 9 in Management Optimization & Development Strategies 3 more
  • REACH Regulation Design Consultation for products within the European Union
  • Strategic Planning for Sales of Pesticides Consultation in the regulation of sale, use and testing of pesticidal substances produced in plants and microbes according to FIFRA.
  • Weed and Pest Control BMP for site specific control of pests and weeds

Market Access

  • Academy of Managed Care Pharmacy (AMCP) Dossier Summary document that presents clinical, economic, and humanistic value of an intervention and associated disease state with the supporting evidence, formulated from the perspective of a particular stakeholder...
  • Communication & Advertisement Distribution of a range of materials, through various communication channels, to highlight a message containing scientific-related topics
  • Emerging Market Opportunities Analyze risks and opportunities in new markets and ensure patients have timely and continued access to new treatments.
  • Environmental Analysis Research or strategy related to understanding the market (size, competition, reimbursement, challenges, etc.) and is a tool used to understand if a product can be launched in the market.
  • Formulary & Reimbursement Strategy Develop strategy and narrative to gain formulary access on insurance plans.
  • Health Technology Assessment (HTA) Preparation/Strategy Dossier Development Perform evidence preparation and/or create strategies for the systematic evaluation of the properties, effects, and/or impacts of health care technology.
Show all 19 in Market Access 13 more
  • Health Technology Assessment Submission (HTA Submission) Analyze the medical, social, ethical, humanistic, and economic considerations of a drug, medical device, or clinical procedures. Submissions are sent to regulatory agencies with different requirements that govern...
  • Life Science Reports Life Science reports
  • Market Access - HTA Landscape Assessment Conduct a HTA landscape assessment to evaluate the direct and indirect impact of health technology on a specific region.
  • Market Access Materials Find general strategies and methods used to market a pharmaceutical product or device.
  • Market Research & Business Intelligence Run market feasibility studies, establish customer needs, improve product performance and analyze competition.
  • Marketing and Commercialization Identify, promote and prove the value of a particular drug to key stakeholders.
  • Payer Toolkit Communicate product value to payers utilizing digital and mobile technology (For example, Payer-Facing iPad Models).
  • Pharmaceutical Reports Pharmaceutical Reports
  • Population Health Analytics Aggregation of patient data across multiple health information technology resources, the analysis of that data into a single, actionable patient record, and the actions through which care providers can improve both...
  • Pricing Strategy Develop value story tailored to a payer audience that will determine the appropriate price for treatment.
  • Study Start Up Consulting Request for RWE/HEOR/Market Access&nbsp;Study Start Up Consulting
  • Value Based Agreements or Outcomes-Based Contracts Collaborate with payer or provider to develop a reimbursement plan outside of the traditional fixed cost-per-unit that ties reimbursement or price to actual health outcomes.
  • Value Dossiers Development Summary document that presents clinical, economic, and humanistic value of an intervention and associated disease state with the supporting evidence, formulated from the perspective of a particular stakeholder...

Medical Communications

  • 1:1 KEE Engagement Management Compliant, individualized planning and documentation of scientific exchange meetings between Medical Science Liaisons (MSLs) and Key External Experts (KEEs).
  • Abstracts Request services related to the writing and review of abstracts
  • Adverse Events Reports Collecting, documenting, and forwarding reports of side effects or safety issues experienced by patients to the pharmacovigilance team for regulatory reporting.
  • Advisory Boards Logistical and content support for organizing panels of external experts to gather critical strategic insights and feedback on therapeutic and product development plans.
  • All Medical Meeting Materials and Content End-to-end service providing slide decks, handouts, training guides, and logistics required to run an internal or external medical meeting successfully.
  • Animated Content Development of diverse visual, interactive digital assets like infographics, data visualizations, and short animations to explain complex medical and scientific concepts simply.
Show all 107 in Medical Communications 101 more
  • Business-Facing Communications Create and distribute press releases or business- facing communications.
  • Case Reviews Review medical cases from Clinical Trials.
  • Commercial Blog Development Develop commercial blogs for medical goods and devices.
  • Communication Plan Communications plan enables organizations and corporations to effectively deliver information to appropriate stakeholders and customers.
  • Competitive Intelligence Develop a coordinated competitive intelligence program which contains a systematic collection and analysis of information from multiple sources about a specific business's industry.
  • Congress Assets Development of all visual, printed, and digital materials needed for a medical congress, including posters, booth graphics, and digital screens.
  • Congress Listening/Insights Report Systematic collection, analysis, and summary of key discussions, scientific trends, competitor movements, and data presented at major medical congresses.
  • Congress Planning Comprehensive logistical and content management for a company's participation in major medical conferences, including booth design, abstract submission, and staff briefing.
  • Consensus reports Develop and submit a report that is a comprehensive examination by an expert panel of a scientific or medical issue.
  • Creation of Non promotional Education/Awareness Content Development of scientifically rigorous, balanced materials (like disease state primers or journal clubs) aimed purely at enhancing clinical understanding, not driving product use.
  • Creation/Maintenance of Scientific Narrative and Lexicon Establishing and managing a unified set of core messages and terminology used across all company communications to ensure consistent scientific understanding.
  • Data Monitoring Committee (DMC) / Statistical Analysis Center (SAC) Find organizations in order to ensure patient safety and scientific integrity
  • Data Visualization Visualize data collected from clinical trials and/or clinical research.
  • Delegate Logistics Managing the travel, accommodation, registration, and related administrative needs for attendees of investigator meetings, advisory boards, or congresses.
  • Development of non promotional Medical Education Plan Creation of a strategic, compliant framework outlining educational needs, target audiences, content objectives, and tactical deployment of medical materials without promoting a product.
  • Digital Opinion Leader (DOL) Mapping and Engagement Planning Systematic process to identify and compliantly plan engagement with influential digital experts (e.g., social media, online forums) within the medical and scientific community.
  • Direct to Patients (D2P) A healthcare model where pharmaceutical companies or other healthcare providers engage directly with patients.
  • Disease Care Pathway Transformation Partner with health systems to analyse disease pathways across primary and secondary care. Identify pain points and partner with health system stakeholders to solve pain points, leading to better patient...
  • Disease or Drug-Related Literature Curation, development, and compliant distribution of written materials (e.g., abstracts, manuscripts, summaries) related to a specific illness or medicinal product.
  • Distribution Strategy & Channel Recommendations Developing plans for how and where medical content (e.g., publications, training, MOA videos) will be efficiently delivered to the target healthcare audience.
  • Educational Content Development Comprehensive development of diverse, multi-channel content assets that offer education and information about a specific therapeutic area or medicinal product.
  • Educational Impact Analysis Measurement and evaluation of non-promotional activities to determine the change in healthcare professionals' knowledge, attitude, or behavior resulting from the education.
  • eLearning Modules Development Development of interactive, self-paced digital courses that allow learners (internal staff or external HCPs) to master scientific content or therapeutic knowledge remotely.
  • Expertise in Adult Learning Principles Applying instructional design methods (like andragogy) to training and educational materials to maximize retention, application, and skill development for mature learners.
  • Fact/Reference Checks Rigorous verification of all scientific claims, data points, and quotations against original source materials to ensure medical and regulatory accuracy.
  • Faculty and/or Steering Committee Management Oversight and compliant coordination of expert groups involved in clinical trials, publication steering, or educational program development.
  • Gap Analysis Compare the actual performance of an organization or corporation with potential or desired performance, as ways to effectively analyze resource management or allocation.
  • HCP Recruitment Compliant identification and engagement of appropriate healthcare professionals (HCPs) for advisory boards, speaker programs, or clinical trial participation.
  • HEOR/Value Publications Writing and submission of manuscripts and abstracts focusing on Health Economics and Outcomes Research (HEOR) data, which demonstrate the economic and value proposition of a therapy.
  • Home Nursing Home nursing provides medical and personal care to individuals in their own homes
  • IME/CME Content Creation of independent or continuing medical education materials, such as accredited courses or grand rounds presentations, to enhance the knowledge of healthcare professionals.
  • Internal Evidence Providing organized access and summaries of unpublished company-held data (e.g., clinical study reports) to internal medical and scientific teams.
  • Investigational Medicinal Product Dossier (IMPD) and Investigational New Drug (IND) Dossier Develop and submit Investigational Medicinal Product Dossier (IMPD) and Investigational New Drug (IND) Dossier
  • KEE Identification, Mapping & Engagement Planning Systematic process to identify, categorize, and strategically plan outreach to Key External Experts (KEEs) based on their influence, specialization, and research activity.
  • KOL Engagement & Management Building and maintaining compliant, value-driven relationships with Key Opinion Leaders (KOLs) to collaborate on scientific exchange and clinical education initiatives.
  • Landscape Analysis Find a cohesive and consistent view of your main organization. Develop initiatives in analyzed areas of operations and analyze chosen key aspects of them.
  • Layperson Clinical Trial Result Dissemination Layperson clinical trial result dissemination involves translating complex clinical trial findings into clear, accessible language so that non-experts can easily understand the outcomes and implications.
  • Linguistic Validation Ensure translations of patient questionnaires, like those used in clinical trials, are both accurate and culturally appropriate for the target audience
  • Literature Audits A systematic review and assessment of all published and unpublished scientific literature related to a product or therapeutic area for compliance or strategic purposes.
  • Literature Monitoring Ongoing, systematic surveillance and analysis of published scientific literature to track emerging data, competitor activities, and changes in clinical understanding.
  • Manuscript Co-Authorship and Publications Planning Manuscript co-authorship and publications planning involve collaborating among researchers to write, organize, and strategize the submission and publication of scientific findings in academic journals, ensuring proper...
  • Market & Competitor Analyses Evaluating the current therapeutic landscape, identifying unmet needs, and assessing the scientific positioning and data of competitor products.
  • Mechanism of Disease (MOD) & Mechanism of Action (MOA) Videos Production of dynamic, scientifically accurate animated videos illustrating how a disease develops (MOD) and how a drug therapeutically affects the body (MOA).
  • Medical Academy Training Developing structured, curriculum-based training programs for internal medical affairs teams, focusing on scientific, therapeutic, and compliance knowledge mastery.
  • Medical Affairs Services for non-promotional scientific exchange, supporting the dissemination of accurate medical data and the development of educational content.
  • Medical Affairs Dossiers Develop medical affairs dossiers such as Global Value Dossiers or AMCP Dossiers.
  • Medical Communications Master Class Design and execution of in-depth, high-level educational sessions led by top Key Opinion Leaders (KOLs) focusing on advanced clinical or scientific topics.
  • Medical Devices Biological Evaluation Report Audit Conduct a bio-compatibility evaluation of medical devices within the human body.
  • Medical Education & Training Creation, development, production and dissemination (internally and externally) of non-promotional disease and treatment-related materials that educate specifically with medicine or healthcare.
  • Medical Infographics Creation of visually engaging, concise graphic summaries to rapidly convey complex clinical data, scientific concepts, or statistical results.
  • Medical Information Encompasses both regulatory and non-regulatory medical writing. This function delivers balanced, evidence-based responses for reactive medical inquiries and develops strategic, proactive medical information platforms...
  • Medical Information Booth Materials Creation of scientifically accurate, pre-approved documents and visuals for staff to use when answering unsolicited questions at congress exhibition booths.
  • Medical Information: Sites and Programs Developing online educational platforms or live programs that provide HCPs and patients with comprehensive, compliant, and current medical information.
  • Medical letters, Emails & Customized Responses Drafting accurate, balanced, and compliant answers to unsolicited scientific and medical inquiries from healthcare professionals or consumers.
  • Medical Literature Reviews Systematic searching, appraisal, and synthesis of published scientific literature to generate evidence-based reports on a specific topic, disease, or treatment.
  • Medical Publications Make clear and accurate presentations of scientific and technical data.
  • Medical Q&As Developing pre-approved, standardized documents containing accurate, balanced answers to anticipated scientific inquiries about a product or disease.
  • Medical Science Liaison (MSL) External Presentation Develop and design Medical Science Liaison External Presentations.
  • Medical Science Liaison (MSL) Support Support services for Medical Science Liaisons (MSL).
  • Medical Science Liasion (MSL) Training Training for medical science liaisons who want to work in pharmaceutical, biotechnology, medical device, and managed care companies.
  • Medical Standard A specialized governance and compliance function responsible for the final technical and regulatory certification of all scientific materials.
  • Medical Website/Hub Design Design and maintenance of a compliant online portal serving as a repository for scientific publications, educational resources, and medical information for external stakeholders.
  • Medical Writing and Editing Communicate scientific, technical and health-related information to a range of audiences.
  • Medical Writing and Editing/Manuscript Development Communicate scientific, technical and health-related information to a range of audiences.
  • Medicinal Product Non- Clinical Outcome Determine potential outcomes for products in a non-clinical setting.
  • Meeting and Events A gathering of people with a shared purpose, often for business or organizational goals
  • Moderation (by Therapeutic Experts or BHBIA-Certified Moderators) Professional facilitation of qualitative sessions by trained moderators with therapeutic expertise or compliance certification. Ensures data quality and regulatory adherence during interviews or focus groups.
  • New Product/Indication Launch Planning Strategic development of the medical affairs communication road map and activities necessary to support the successful introduction of a new therapy or approved use.
  • Nominated Signatory for Technical Review and Regulatory Sign-off Official, qualified medical or scientific professional responsible for reviewing and approving materials to ensure compliance with regulatory and legal standards.
  • Other Medical Affairs Videos Develop and design Medical Affair videos that are explainer videos and or augmented/virtual reality experiences.
  • Patient Advocacy Group Engagement Compliant collaboration and information sharing with non-profit organizations that represent patient communities to understand their needs and provide education.
  • Patient Narratives Compliant collection and use of individual patient stories to illustrate the impact of a disease or treatment, often for training or empathy-building purposes.
  • Payer Directed Communication Tools (other than Dossiers) Request services related to payer directed communication tools.
  • Pharmacodynamic/ Pharmacokinetic Reports Create Pharmacodynamic/ Pharmacokinetic reports to report to the appropriate regulatory bodies.
  • Postcast Production Production of audio content featuring expert interviews, clinical data reviews, or scientific discussions, providing easily digestible learning for healthcare professionals (HCPs).
  • Poster Design and Development Design and Develop Posters for Poster Symposiums and conferences to effectively convey science information.
  • Poster Symposia, Summits, Product Theaters, etc. Support Comprehensive planning and execution support for organized, large-scale medical meetings and events used to present and discuss clinical data and research.
  • Pre-Prints Develop and submit Pre-prints
  • Press Materials Associated with Key Publications Development of compliant communications such as press releases or media alerts for journalists and stakeholders, summarizing the data published in a major scientific journal.
  • Proactive and Reactive Medical Affairs Assets Development of both planned educational materials and responsive documents used by Medical Affairs to address scientific information gaps.
  • Protocol and Study Reports Write protocol and study reports, specifically relating to the drafting, writing, and editing of Clinical Safety Reports.
  • Publication Writing Create further publication documents. Investigational device exemptions (IDEs) BLAs, MAA, PMA, eCTDs, informed consents, CMC and manufacturing reports, orphan drug designations (ODD), briefing books.
  • Publications Plan Development & Management Strategic planning and oversight of all research dissemination activities, including outlining target journals, timelines, authors, and compliance for clinical data publications.
  • Quality Control/ Quality Assurance Documents Develop quality control or quality assurance documents.
  • Regulatory Audit Supports Providing documentation, responses, and expert assistance to ensure preparedness and successful outcomes during inspections by regulatory bodies.
  • Regulatory Submissions and Compliance Draft, format, and submit documents to Pharmaceutical approval agencies according to documentation and guidelines. This includes documents such as NDAs, INDs, SUSARs, AE reporting, RMPs, and PSURS.
  • Requests from HCPs or PharmDs and Patients Management and processing of unsolicited scientific, medical, and technical information inquiries from external stakeholders through a compliant medical information system.
  • Review Article/ Submission Drafting and managing the process of submitting an objective, comprehensive summary of the current literature on a disease or treatment area to a peer-reviewed journal.
  • Risk Management Anticipate, prevent and resolve non-compliance issues.
  • Sales Training Request services related to Sales Training of medical goods and devices.
  • Sales Training Modules Develop and distribute sales training modules.
  • Sales Training Webinar Slide Decks Develop slide decks for sales training webinars.
  • Scientific Platform Develop a rigorous approach to creating a core story (grounded in the scientific literature) for a product. This involves identifying core concepts that address disease states, clinical needs, and product-related...
  • Scientific Positioning Strategic development of the evidence-based argument that defines how a drug or therapy is distinct, superior, or beneficial relative to competitors in the market.
  • Scientific Share of Voice Measurement Quantitative analysis tracking the volume and nature of a company's, or a competitor's, scientific discussion across publications and medical meetings.
  • Scientific Training Solutions Developing comprehensive educational programs and materials to ensure internal teams, field medical staff, or external partners are fluent in the therapeutic area and product data.
  • Strategic Medical Communication Development & Planning High-level planning to define the core scientific messages and the tactical strategy needed to effectively convey clinical data to key stakeholders over time.
  • Survey to KEE’s, External Expert Mapping Conducting compliant research and analysis to identify, categorize, and gather feedback from influential external medical and scientific experts.
  • Target Product Profile (TPP) A sponsor prepared document which summarizes the drug development program that is described in terms of the labelling concepts. This profile is a communication method used between the FDA and sponsor which can be used...
  • Therapy Area Disease Insights Report Creation of a comprehensive analysis of the current scientific, clinical, and competitive landscape within a specific therapeutic area.
  • Toxicology Reports Create pre-clinical toxicology reports.

Medical/Commercial

  • Health & Pharmacoeconomics Identify, measure and compare the cost-benefit ratio of products and services.
  • Life Cycle Assessment (LCA) Analyze the lifecycles of the products and services with regard to their environmental impacts.

Model Development

  • 3D Blood-Brain Barrier Model Use an in vitro 3D blood–brain barrier model for real-time visualization of cellular and barrier functions.
  • Animal Model Development Create new systems for profiling pre-clinical therapeutics, devices, and surgical techniques.
  • Animal Precision-Cut Lung Slice Model Acquire a fresh phenotypically-accurate model to study animal lung behavior.
  • Custom Model Development Develop a custom disease model.
  • Disease Model Database For sourcing disease models.
  • Fresh Functional Human Tissue Contractile Force Assays Use fresh functional human tissue to assess contractile force with various compounds.
Show all 40 in Model Development 34 more
  • Fresh Functional Human Tissue Efficacy Assays Use fresh functional human tissue to assess pre-clinical efficacy of test compounds.
  • Fresh Functional Human Tissue Ion Channel Activity Assays Use fresh functional human tissue to assess ion channel activity with various compounds.
  • Fresh Functional Human Tissue Muscle Contraction Assays Use fresh functional human tissue to assess muscle contraction with various compounds.
  • Fresh Functional Human Tissue Muscle Relaxation Assays Use fresh functional human tissue to assess muscle relaxation with various compounds.
  • Fresh Functional Human Tissue Permeability Assays Use fresh functional human tissue to assess tissue permeability with various compounds.
  • Fresh Functional Human Tissue Safety Assays Use fresh functional human tissue to assess pre-clinical safety of test compounds.
  • Fresh Functional Human Tissue Vascular Permeability Assays Use fresh functional human tissue to assess vascular permeability with various compounds.
  • Fresh Functional Human Tissue Vasoconstriction Assays Use fresh functional human tissue to assess vasoconstriction with various compounds.
  • Fresh Functional Human Tissue Vasodilation Assays Use fresh functional human tissue to assess vasodilation with various compounds.
  • Human Organ System (HOS) - An Oral Modeling Device Study human oral physiology to develop improved oral care products using Draper's human organ system (HOS) technology.
  • Human Precision-Cut Intestinal Slice Model Acquire a fresh phenotypically-accurate model to study human intestinal behavior.
  • Human Precision-Cut Liver Slice Model Acquire a fresh phenotypically-accurate model to study human liver behavior.
  • Human Precision-Cut Lung Slice Model Acquire a fresh phenotypically-accurate model to study human lung behavior.
  • In Silico PK-PD Modeling Quantitative modeling and simulations correlation of pharmacokinetic and pharmacodynamic endpoints in support of preclinical and clinical development.
  • Japanese White Rabbit Use a single animal species to create one or more disease models for metastatic cancer, hematopoiesis and anemia.
  • Juvenile Toxicology Assess developmental and reproductive defects due to neurobehavioral, skeletal and muscle growth effects.
  • Knockin Mice Make targeted insertion of a gene of interest into a specific gene locus to create transgenic mice.
  • Knockout Mice Create transgenic mice that are genetically engineered to inactivate a gene or set of genes.
  • Lewis Rat Use a single animal species to create one or more disease models for metastatic cancer, hematopoiesis and anemia.
  • NMRI Mouse Use a single animal species to create one or more disease models for cachexia and hemophilia.
  • Non-Human Primate Models Use a single animal species to create one or more disease models.
  • PBMC Humanized Mice Study and evaluate compounds for infectious diseases and graft rejection.
  • PiggyBac Transgenic Mouse Service Obtain single-copy transgenic embryos with consistent expression of any desired transgene.
  • Pre-clinical Animal Surgery Conduct surgey in animals used as pre-clinical models.
  • Pseudopregnant CD1 Mouse Use a single animal species to create gene-modified mouse models.
  • Pulmonary Hypertension Animal Model Study the pathology of pulmonary arterial hypertension (PAH) and investigate potential therapies.
  • SCID Mouse Use a single animal species to create one or more disease models for spontaneous and metastatic cancer and cachexia.
  • SCID/BG Mouse Use a single animal species to create one or more disease models for metastatic cancer.
  • Sprague Dawley Rat Use a single animal species to create one or more disease models for cachexia.
  • Standard Models Create new animal disease models or modify existing models to study specific diseases, side-effects or symptoms.
  • Surgical Models Create new animal models using techniques such as vascular catherization, soft tissue procedures or device implants.
  • Transgenic Models Create animal models engineered for use in a specific therapeutic area.
  • Zebrafish Animal Model Model human disease and development in zebrafish.
  • Zucker Rat Use a single animal species to create one or more disease models for cachexia.

Nanotechnology

  • Custom Nanostructures Fabricate materials in the form of spherical particles, nano-tubes, wires, rods, discs, flakes, prisms or dispersions.
  • Drug Delivery Technology Create microstructures that enhance drug metabolism properties.
  • Liposomes Create artificial spherical vesicles that can be used as a vehicle for administration of drugs.
  • Metal/Metal Oxide Nanoparticle Synthesis Use nanoparticles for drug and gene delivery, imaging, analyte detection, labeling and DNA structure determination.
  • Nanofabrication Enable the construction of functional structures with nanoscale dimensions.
  • Nanofabrication Deposition and Growth Selectively accumulate ultra-thin films with desired physical properties.
Show all 12 in Nanotechnology 6 more
  • Nanoparticle Conjugation and Functionalization Modify biomolecules to enhance structure and function.
  • Nanoparticle Synthesis Create nano-level structures with unique features.
  • Nanoporous Microspheres Nanoporous microspheres are particles with diameters in the micrometer range that can be made from various synthetic materials. Use for chromatographic separations, catalysis, energy storage, tissue engineering...
  • Nanostructured Lipid Carriers Formulate nanostructered lipid carriers used in drug delivery systems.
  • Nanotubes and Nanowires Use nanosensors, electrical probes for biological membranes and transistors for lab-on-chip applications.
  • Silica/Polystyrene/Organic Nanoparticle Synthesis Synthesize nanoparticles with distinctive composition, size, shape and surface chemistry.

Neurotoxicology

  • Single Dose Acute Neurotoxicity Study - Other Species Conduct a single dose study in other species to determine the neurotoxicty of your compound.
  • Single Dose Acute Neurotoxicity Study - Rat Conduct a single dose study in rats to determine the neurotoxicty of your compound.

New Product Development

  • Honey Residue Testing Identify the presence of pesticide, bee repellant or antibiotics residues in honey to ensure product safety.
  • Off Flavour Analysis Off Flavour Analysis involves detecting and assessing undesirable tastes and odors in food and drinks to maintain quality and safety standards.
  • Quantitative Descriptive Food Analysis Apply a variety of methods to quantify the sensory properties of distinct product attributes.
  • Sensory Training Sensory Training helps individuals improve their ability to assess and appreciate the flavors and qualities of what they taste or sample.
  • Time-Intensity Food Analysis Evaluate perceived intensity of a product attribute at intervals over a defined time with expert panelists.
  • Vitamins Analysis Analyze vitamins in foods and dietary supplements either by HPLC or titration.

Non-Human Biospecimen

  • Dog / Canine Biofluids Acquire fresh or frozen biofluids including but not limited to whole blood, plasma, serum, CSF, milk, urine, feces, bile, semen, aqueous humor, vitreous humor, saliva, tears, etc.
  • Dog / Canine Cells Acquire fresh or frozen cells including but not limited to RBCs, WBCs, PBMCs, endothelial cells, T cells, fibroblasts, hepatocytes, splenocytes, etc.
  • Dog / Canine Tissues Acquire fresh or frozen tissues including but not limited to those from the central nervous system, endocrine system, gastrointestinal system, integumentary system, reproductive system, lymphatic system, etc.
  • Goat Cells, Tissues, and Biofluids Acquire fresh or frozen cells, tissues, and biofluids including but not limited to whole blood, PBMCs, tissue slides, etc.
  • Guinea Pig Biofluids Acquire fresh or frozen biofluids including but not limited to whole blood, plasma, serum, CSF, milk, urine, feces, bile, semen, aqueous humor, vitreous humor, saliva, tears, etc.
  • Guinea Pig Cells Acquire fresh or frozen cells including but not limited to RBCs, WBCs, PBMCs, endothelial cells, T cells, fibroblasts, hepatocytes, splenocytes, etc.
Show all 27 in Non-Human Biospecimen 21 more
  • Guinea Pig Tissues Acquire fresh or frozen tissues including but not limited to those from the central nervous system, endocrine system, gastrointestinal system, integumentary system, reproductive system, lymphatic system, etc.
  • Llama Cells, Tissues, and Biofluids Acquire fresh or frozen cells, tissues, and biofluids including but not limited to whole blood, PBMCs, tissue slides, etc.
  • Monkey / Non-Human Primate / NHP Biofluids Acquire fresh or frozen biofluids including but not limited to whole blood, plasma, serum, CSF, milk, urine, feces, bile, semen, aqueous humor, vitreous humor, saliva, tears, etc.
  • Monkey / Non-Human Primate / NHP Cells Acquire fresh or frozen cells including but not limited to RBCs, WBCs, PBMCs, endothelial cells, T cells, fibroblasts, hepatocytes, splenocytes, etc.
  • Monkey / Non-Human Primate / NHP Tissues Acquire fresh or frozen tissues including but not limited to those from the central nervous system, endocrine system, gastrointestinal system, integumentary system, reproductive system, lymphatic system, etc.
  • Mouse Biofluids Acquire fresh or frozen biofluids including but not limited to whole blood, plasma, serum, CSF, milk, urine, feces, bile, semen, aqueous humor, vitreous humor, saliva, tears, etc.
  • Mouse Cells Acquire fresh or frozen cells including but not limited to RBCs, WBCs, PBMCs, endothelial cells, T cells, fibroblasts, hepatocytes, splenocytes, etc.
  • Mouse Tissues Acquire fresh or frozen tissues including but not limited to those from the central nervous system, endocrine system, gastrointestinal system, integumentary system, reproductive system, lymphatic system, etc.
  • Non-Human Biospecimen Finder Explore listings of Non-Human Biological Samples from the suppliers on the scientist.com NHBS database.
  • Pig / Minipig / Porcine Biofluids Acquire fresh or frozen biofluids including but not limited to whole blood, plasma, serum, CSF, milk, urine, feces, bile, semen, aqueous humor, vitreous humor, saliva, tears, etc.
  • Pig / Minipig / Porcine Cells Acquire fresh or frozen cells including but not limited to RBCs, WBCs, PBMCs, endothelial cells, T cells, fibroblasts, hepatocytes, splenocytes, etc.
  • Pig / Minipig / Porcine Tissues Acquire fresh or frozen tissues including but not limited to those from the central nervous system, endocrine system, gastrointestinal system, integumentary system, reproductive system, lymphatic system, etc.
  • Rabbit Biofluids Acquire fresh or frozen biofluids including but not limited to whole blood, plasma, serum, CSF, milk, urine, feces, bile, semen, aqueous humor, vitreous humor, saliva, tears, etc.
  • Rabbit Cells Acquire fresh or frozen cells including but not limited to RBCs, WBCs, PBMCs, endothelial cells, T cells, fibroblasts, hepatocytes, splenocytes, etc.
  • Rabbit Tissues Acquire fresh or frozen tissues including but not limited to those from the central nervous system, endocrine system, gastrointestinal system, integumentary system, reproductive system, lymphatic system, etc.
  • Rat Biofluids Acquire fresh or frozen biofluids including but not limited to whole blood, plasma, serum, CSF, milk, urine, feces, bile, semen, aqueous humor, vitreous humor, saliva, tears, etc.
  • Rat Cells Acquire fresh or frozen cells including but not limited to RBCs, WBCs, PBMCs, endothelial cells, T cells, fibroblasts, hepatocytes, splenocytes, etc.
  • Rat Serum Order Rat Serum
  • Rat Tissues Acquire fresh or frozen tissues including but not limited to those from the central nervous system, endocrine system, gastrointestinal system, integumentary system, reproductive system, lymphatic system, etc.
  • Xenopus Cells, Tissues, and Biofluids Acquire fresh or frozen cells, tissues, and biofluids including but not limited to whole blood, PBMCs, tissue slides, oocytes, etc.
  • Zebrafish Cells, Tissues, and Biofluids Acquire fresh or frozen cells, tissues, and biofluids including but not limited to whole blood, PBMCs, tissue slides, sperm, etc.

Old Category HEOR, RWE, Market Access

  • Commercialization and Marketing Identify, promote and prove the value of a particular drug to key stakeholders.
  • Data - Other Extract insights and patterns from large and complex datasets.
  • Data Analytics Analyze data clinical trial data.
  • Non-Interventional Studies Examine different aspects of drug usage, including efficacy and safety, under real-life conditions.
  • Patient reported outcomes (PRO) Assessment of health outcomes directly reported by the patient who experienced it, without interpretation of the patient's response by a clinician.
  • Patient-Reported Outcome Studies Get self-reported information regarding the personal health status of an individual.
Show all 9 in Old Category HEOR, RWE, Market Access 3 more
  • RWE/HEOR/Market Access Disease/Clinical Outcomes Study the course of disease and the possible outcome of disease, including expected frequency.
  • RWE/HEOR/Market Access Hybrid Study Combine different methodologies (retrospective, prospective, registries, chart or claims review, electronic medical/health records) to gain insights into real world patient behavior or drug use.
  • RWE/RWD Enriched Studies Combine different methodologies (retrospective, prospective, registries, chart or claims review, electronic medical/health records) to gain insights into real world patient behavior or drug use.

Oncology Models

  • 3D Triculture Breast Cancer Model Use tricultures of breast cancer cell lines, hMSCs, and endothelial tubules for evaluating breast cancer progression.
  • Angiogenesis Models Measure therapeutic endpoints in animal models of angiogenesis.
  • Animal Hypoxia Models Measure therapeutic endpoints in hypoxic animal models.
  • Athymic Mouse Use a single animal species to create one or more disease models for cachexia and spontaneous cancer.
  • Cachexia Models Measure therapeutic endpoints in animal models of cachexia.
  • CAR-T Efficacy In Vivo assessment of CAR-T and CAR-NK efficacy in a humanized mouse
Show all 33 in Oncology Models 27 more
  • Digestive System PDX Patient derived xenografts relating to organs and components of the digestive system. This includes, but is not limited to the Stomach, Intestines, Liver, Colon, Colorectal samples and Gastric samples.
  • Endocrine System PDX Patient derived xenografts related to the endocrine system. PDX related to glands controlling hormone regulation such as the Pituitary glands, Thyroid Glands, Adrenals, and Pancreas.
  • Endocrine System Xenograft Xenografts derived from organs and glands of the Endocrine system. This include samples from the Pituitary Gland, Thyroid, and Adrenals.
  • Ex-Vivo PDX Screening Ex-vivo PDX screening is used to evaluate the effectiveness of various drugs on tumor cells.
  • Experimental Metastatic Models Measure therapeutic endpoints in animal models of experimental metastatic cancer.
  • Hematological Cancer PDX Design and validate companion diagnostics for hematological cancer that help select the most appropriate patients, identify patients at increased risk, or monitor treatment effectiveness.
  • Immuno-PDX Utilize the patient-derived xenograft for drug response profiling and biomarker discovery of immuno-oncology drug candidates.
  • Leukemia PDX Measure therapeutic endpoints in patient-derived xenografts of leukemia.
  • Murine Adenocarcinoma 16 (MAC16) Murine Test for therapeutic efficacy of drug candidates in muscle wasting models.
  • Muscle Wasting Models Measure therapeutic endpoints in animal models of muscle wasting.
  • NCG Model Study tumor biology and immuno-oncology in the CRISPR/Cas9-generated immunodeficient mouse model.
  • Nervous System PDX Patient derived xenografts relating to the components of the Nervous System. This includes PDX from the Brain, Spinal Cord, and Nerves.
  • Nervous System Xenografts Xenografts relating to the Nervous system. This includes samples from the Head, Neck, Brain, and Nerves.
  • Noble Rat Use a single animal species to create one or more disease models for hematopoiesis.
  • Oncology Derived PDX Patient derived xenografts derived from various oncological samples. This includes, but is not limited to, samples from Lymphoma, Melanoma, and Leukemia.
  • Oncology Models Use model organisms to test the therapeutic efficacy of cancer drug candidates.
  • Oncology Xenografts Xenografts derived from oncological samples.
  • Oral Xenograft Measure therapeutic endpoints in oral cancer models as well as cancer models related to the Pharynx.
  • Ovarian Cancer Mouse Measure therapeutic endpoints in animal models of ovarian cancer.
  • Random-Bred Guinea Pig Our vendor services provide high-quality guinea pig models worldwide, for a large number of research applications. The Random-...
  • Renal Xenograft Measure therapeutic endpoints in renal models of cancer.
  • Reproductive System PDX Patient derived xenografts relating to reproductive systems. This includes PDX from reproductive organs such as the Ovaries, Cervix, Breasts, Testes, Prostate, and Scrotum.
  • Reproductive System Xenografts Xenografts relating and derived from the reproductive systems. This includes samples from the ovaries, cervix, vulva, uterus, testes, scrotum, and prostate.
  • T11 (Breast Cancer) Measure therapeutic endpoints in animal models of breast cancer.
  • Urinary System PDX Patient Derived Xenografts relating to organs that comprise the Urinary system. This includes, but is not limited to, samples from the Kidneys, Liver, and Bladder.
  • Urinary System Xenografts Xenografts derived from organs of the Urinary system. This includes, but is not limited to, xenografts from the Bladder, Kidney, and Urethra.
  • Xenograft Models Measure therapeutic endpoints in cancer models using tumor cells transplanted from a donor of a different species.

Other Specialty Toxicology

  • Biosafety Testing Consulting Expert advice to conduct safe and responsible biological procedures and practices.
  • Biosafety Testing In Vitro Test biologics, raw materials, lot release and viral safety
  • Cutaneous Phototoxicity Study - Guinea Pig Conduct a study in guinea pigs to determine if a toxic response is elicited after the initial exposure to your compound and subsequent exposure to light.
  • Cutaneous Phototoxicity Study - Mouse Conduct a study in mice to determine if a toxic response is elicited after the initial exposure to your compound and subsequent exposure to light.
  • Cutaneous Phototoxicity Study - Other Species Conduct a study in other species to determine if a toxic response is elicited after the initial exposure to your compound and subsequent exposure to light.
  • Cutaneous Phototoxicity Study - Rat Conduct a study in rats to determine if a toxic response is elicited after the initial exposure to your compound and subsequent exposure to light.
Show all 25 in Other Specialty Toxicology 19 more
  • Hypoaspis Toxicity Tests Use Hypoaspis mortality to measure the short-term impact of a single or multiple exposure(s) to a test chemical.
  • Larval Honey Bee Toxicity Test (Repeated Exposure) Use repeated agrochemical feeding exposures measured at defined intervals to assess fatality in larval honey bees.
  • Larval Honey Bee Toxicity Test (Single Exposure) Use a single agrochemical feeding exposure to determine lethality or sub-lethal toxicity in larval honey bees.
  • Microbial Testing Test samples for microorganisms, identify species, do bioburden analysis and measure endotoxin levels (LAL).
  • Microdilution Testing Simultaneously quantify the susceptibility of a microbial species or strain to multiple anti-microbial agents.
  • Ocular Phototoxicity Study - Other Species Conduct a study to determine the extent to which your compound is capable of producing phototoxic side effects in ocular tissues of other species.
  • Ocular Phototoxicty Study - Rat Conduct a study to determine the extent to which your compound is capable of producing phototoxic side effects in ocular tissues of rats.
  • OECD 245: Honey Bee (Apis Mellifera L.), Chronic Oral Toxicity Test (10-Day Feeding) This Test Guideline describes a chronic oral toxicity test on adult worker honey bees under laboratory conditions over an exposure period of 10 days.
  • Ototoxicity Study - Monkey / Non-human Primate Conduct a study in monkeys/non-human primates to determine the potential for your compound to cause hearing loss.
  • Ototoxicity Study - Mouse Conduct a study in mice to determine the potential for your compound to cause hearing loss.
  • Ototoxicity Study - Other Species Conduct a study in other species to determine the potential for your compound to cause hearing loss.
  • Phototoxicity Determine whether drug treatment causes light-activated toxic effects.
  • Raw Materials Testing Verify that raw materials are sterile and not contaminated by mycoplasma, virus or other microorganisms.
  • Residual DNA Analysis Measure contaminants found in therapeutics like biologicals and biosimilars that are produced in cells.
  • Semi-Static Acute Toxicity Test Measure toxicity endpoints in aquatic organisms exposed to renewed test solutions at defined intervals of an experiment.
  • Static Acute Toxicity Test Measure toxicity endpoints in aquatic organisms exposed to a non-renewed test solution for the entire experiment.
  • Tumorigenicity Testing Test tumor-forming properties of cell products.
  • United States Pharmacopeia (USP) Testing Use USP standards to ensure quality of pharmaceuticals, supplements and food ingredients.
  • Viral Testing Characterize viral products for functional activity and possible contamination.

Pharmacology

  • In Vivo Pharmacology Study the effects of drug candidates in animal models
  • In Vivo Services Suppliers that house animals of any species.

Pharmacovigilance

  • Adverse Event (AE) and Serious Adverse Event (SAE) Reporting Report unfavourable and unintended events (e.g.: abnormal laboratory results, symptoms or disease associated with treatments) to regulatory bodies via the FDA's Adverse Event Reporting System (FAERS) or other...
  • Aggregate Safety Data Review Cumulative summary of safety information regarding the collection, analysis, and submission of aggregated safety data to health authorities at specified intervals.
  • GLP/GCP Risk Diligence Services GLP/GCP Risk Diligence Services
  • GxP Compliance Monitoring Ensure products or services adhere to a set minimum standard.
  • IND/CTA Authoring and Publishing Services IND/CTA authoring and publishing services involve preparing, compiling, and submitting Investigational New Drug (IND) applications or Clinical Trial Applications (CTA) to regulatory authorities, ensuring compliance...
  • Local Pharmacovigilance Support in International Markets Connect with Pharmacovigilance professionals to uphold the National pharmacovigilance guidelines and regulations.
Show all 17 in Pharmacovigilance 11 more
  • Periodic Safety Update Reports (PSURs) / Periodic Benefit-Risk Evaluation Reports (PBRERs) Preparation of safety reports to report adverse events that occurred during a specified time period. Evaluate if safety profile of treatment has changed since last report.
  • Pharmacovigilance Audits and Inspections Ensure companies meet their obligations to comply with pharmacovigilance guidelines and report adverse events. Some guidelines include: - having personnel, systems and facilities in place to meet their...
  • Pharmacovigilance Case Processing Collect, synthesize, and report adverse events (AE) and adverse drug reactions (ADR) data to allow for successful data analysis, scientific assessment and decision-making based on the safety data associated...
  • Pharmacovigilance Literature Surveillance Conduct systematic and ongoing review of scientific and medical literature to identify new information about the safety profile of a drug. This process is crucial for detecting adverse drug reactions (ADRs) that may...
  • Pharmacovigilance Training and Education Training and education related to pharmacovigilance guidelines and adherence to EMA, FDA, and other regulatory bodies' documentation
  • Regional Regulatory Consulting Regional regulatory consulting provides expert guidance on local regulatory requirements and processes to help companies navigate and comply with the specific rules and standards of different geographical regions...
  • Risk Management Plans (RMPs) Develop Risk Management plans (RMPs) that include information on a medicine's safety profile and plans for further pharmacovigilance activities designed to gain greater knowledge. These documents also explain how...
  • Risk-Based Monitoring Planning and Implementation Risk-based monitoring planning and implementation involve creating and executing a strategy that prioritizes monitoring resources based on the potential risks to patient safety and data quality in clinical trials...
  • Safety Advisory Committees Collaborate with global experts to support safety surveillance monitoring and provide guidance on the safety of medicines and vaccines.
  • Safety Data Management Safety data management involves the collection, analysis, and reporting of data related to the safety of a drug. Including preparing and submitting safety reports to regulatory authorities, which may include periodic...
  • Signal Detection and Management Capture pre-determined safety signals or indicators from a variety of sources to ensure the safety of the product post clinical trial. This includes the review of various sources such as ICSRs, EVDAs, FAERS, and other...

Primary Market Research

  • Adherence, Satisfaction, and Switch Behavior Studies Explores factors driving treatment compliance, satisfaction, and switching behavior. Guides patient support initiatives and product differentiation.
  • Advanced Analytics (Regression, Clustering, Factor Analysis) Applies complex statistical techniques to uncover hidden relationships and drivers. Generates predictive insights to inform decision-making and optimization.
  • Advertising Testing (qual/quant) Assesses reactions to creative advertising materials using both qualitative and quantitative methods. Supports refinement of campaign assets before launch.
  • AI-Assisted Transcription/Insight Coding Uses machine learning to accelerate transcription and qualitative analysis. Reduces turnaround time while maintaining analytical depth.
  • Asset Prioritization Studies Assesses stakeholder interest and unmet need across multiple assets in development. Helps pipeline teams allocate investment and identify lead candidates.
  • Behavioral Segmentation Groups stakeholders based on their actions and choices rather than demographics. Enables precise targeting and tailored intervention strategies.
Show all 70 in Primary Market Research 64 more
  • Brand Tracking and Awareness Monitors brand familiarity, favorability, and performance over time among target audiences. Used to guide campaign adjustments and market strategy.
  • Claim Testing - Market Research Validates whether specific product claims are believable, relevant, and persuasive. Ensures alignment with compliance and value messaging.
  • Clinical Trial Investigators Engagement with experienced investigators to test trial feasibility, enrollment strategies, and protocol design. Delivers operational insights to enhance trial execution and recruitment.
  • Competitive Intelligence and Message Recall Measures awareness of competitor messaging and materials among stakeholders. Informs counter-positioning and promotional strategy.
  • Competitive Landscape Research Maps competitor products, positioning, trial activity, and perception among stakeholders. Delivers inputs for SWOT analysis and differentiation strategy.
  • Conjoint analysis / Discrete Choice Modeling (DCM) Respondents evaluate hypothetical product profiles with varying features to identify trade-offs. Delivers utility scores for product attributes and preference shares to guide product and pricing strategy.
  • Cross-Functional Readouts and Workshops Interactive sessions to share findings and align stakeholders across functions. Enhances cross-team decision-making and execution planning.
  • Data Cleaning and Statistical Modeling Prepares raw datasets for analysis through validation, normalization, and advanced modeling. Ensures accuracy and enables robust, reproducible insight generation.
  • Detail Aid and Promotional Materials Testing Tests visual aids and promotional content with HCPs for clarity, accuracy, and persuasiveness. Delivers insights for regulatory compliance and effectiveness.
  • Digital Ethnography and Online Communities Uses online platforms to capture real-time insights from stakeholder communities. Enables flexible, cost-effective longitudinal engagement.
  • Digital Journey Explores the online behaviors and decision-making patterns of stakeholders. Informs digital strategy, content placement, and platform selection.
  • Early Concept Testing Evaluates initial ideas or positioning strategies with target audiences before refinement. Provides go/no-go input and direction for further development.
  • Endpoint Relevance Testing Tests how meaningful proposed trial endpoints are to stakeholders, especially payers and regulators. Informs protocol refinement and evidence strategy.
  • Ethnographic research (in-home, diary studies) Observational or self-reported research capturing real-world experiences in home or daily life contexts. Provides authentic behavioral data used for patient journey mapping and product usability evaluation.
  • Facial Coding Analyzes facial expressions during exposure to stimuli to detect emotional reactions. Provides real-time feedback on engagement and sentiment.
  • Focus groups (in-person/virtual) Facilitated group discussions to evaluate reactions to concepts, messages, or services. Produces consensus insights and contrasting views used to refine strategy, materials, or offerings.
  • Forecast Input Generation Provides validated data points for input into financial or epidemiologic models. Supports accurate revenue, market share, and volume forecasting.
  • GDPR, HIPAA, BHBIA, EphMRA Compliance Ensures compliance with data privacy, ethical, and regional marketing research regulations. Mitigates legal risk and builds trust with participants and clients.
  • Generalists and specialists (e.g., oncologists, neurologists) Research targeting both broad-practice physicians and specialists to understand treatment preferences, diagnostic challenges, and clinical decision-making. Provides comparative insights for segmentation, messaging...
  • Growth Potential Quantifies market size, penetration rates, and uptake forecasts for new products or categories. Guides business development and portfolio prioritization.
  • In-depth interviews (IDIs) One-on-one qualitative interviews conducted with key stakeholders to explore beliefs, decision drivers, and unmet needs. Delivers rich narrative data to inform trial design, product positioning, and message development.
  • Interpretation and Real-Time Translation for Live Interviews Live translation during interviews or advisory boards to enable multilingual engagement. Supports seamless international research execution.
  • Iterative concept/message testing with interim adjustments Tests concepts or materials in cycles with refinements after each round based on feedback. Delivers optimized content that evolves with stakeholder input.
  • Journey Mapping (Patient, HCP, Payer) Visual representation of stakeholder experiences across disease or treatment timelines. Identifies pain points, decision triggers, and opportunities for engagement or support.
  • Launch Readiness Assessments Evaluates internal and external preparedness for product launch, including sales force, market awareness, and access environment. Identifies gaps and supports launch planning.
  • Lifecycle Extension Concept Testing Tests ideas for extending the commercial life of a product (e.g., new formulations, indications). Supports long-term planning and investment decisions.
  • Market Opportunity Assessments Quantifies addressable market size, unmet needs, and competitive landscape. Supports go/no-go decisions and commercial forecasting.
  • MaxDiff and TURF analysis MaxDiff ranks item preference while TURF identifies combinations that maximize reach across segments. Used to prioritize features, benefits, or communications for maximal impact.
  • Message / Claims testing Iterative research to assess clarity, relevance, and impact of key messages. Delivers validated communications that align with stakeholder expectations.
  • Message recall and aided/unaided awareness studies Studies that assess brand or campaign awareness with and without prompts. Data is used to measure campaign reach, retention, and comparative brand effectiveness.
  • Mobile Diary Apps and Wearable-Enabled Studies Collects behavioral and health data through mobile and wearable technologies. Generates passive and active data streams for real-world insights.
  • Name Testing - Market Research Tests product or brand names for memorability, appropriateness, and appeal across markets. Supports final naming decisions and regulatory readiness.
  • Neuro-Linguistic Research Explores subconscious reactions to language and messaging using biometric or neuro tools. Enhances emotional resonance and message impact.
  • Online/phone surveys Quantitative questionnaires deployed via web or telephone to gather feedback from large, targeted populations. Results offer statistically significant insights for trend analysis, segmentation, and tracking.
  • Packaging Testing (qual/quant) Evaluates visual appeal, usability, and compliance potential of packaging designs. Data supports regulatory submissions and user-centered design.
  • Payer and HTA Expectations Research Engages payers and HTA bodies to uncover evidence needs, pricing thresholds, and access drivers. Informs clinical and economic evidence generation planning.
  • Pediatric and Geriatric Populations - Market Research Research focused on age-specific needs and barriers in child or elderly populations, including caregivers and healthcare providers. Informs development of age-appropriate interventions, trial design, and support...
  • Persona Development Synthesizes qualitative and quantitative data to build detailed, actionable profiles of stakeholder archetypes. Supports targeted communications and segmentation strategies.
  • Pharmacy and Therapeutics (P&T) Committee Members - Market Research Research with formulary decision-makers to understand access requirements, value perceptions, and evidence expectations. Guides dossier development and value communication.
  • Policy Influencers - Market Research Qualitative or quantitative research with stakeholders who shape or advise on healthcare policy. Supports early stakeholder mapping and access scenario planning.
  • Positioning and Value Proposition Testing Tests various positioning statements and value messages with target audiences. Refines messaging to maximize resonance and differentiation.
  • Primary Market Research Primary market research, such as, focus groups, surveys, interviews and data collection field services.
  • Product Landscape and Unmet Needs Reports Synthesizes secondary data and expert input into landscape maps and gap analyses. Informs asset development and positioning.
  • Psychological Research Explores cognitive and emotional drivers of stakeholder behavior. Informs persuasive communication and behavior change strategies.
  • Recruitment Messaging Evaluation Evaluates how well trial recruitment materials resonate with patients or referring physicians. Optimizes clarity and appeal to improve enrollment rates.
  • Regional and National Health Authorities - Market Research Interviews or surveys with government payers and HTA decision-makers to assess reimbursement criteria and policy landscapes. Used to shape market access strategies and prepare for pricing negotiations.
  • Sales Force Effectiveness Testing Assesses how well sales teams deliver key messages and influence prescribing behavior. Supports training and performance improvement.
  • Segmentation and Profiling Divides target audiences into distinct groups based on attitudes, behaviours, or demographics. Informs tailored messaging and targeting strategies.
  • Semiotics Analyzes symbols, language, and imagery to understand how meanings are constructed. Guides brand identity, packaging, and campaign design.
  • Sequential qual-quant studies Combines initial qualitative exploration with follow-up quantitative validation. Ensures both depth and scale in evaluating concepts, needs, or strategies.
  • Simulation Models (e.g., uptake models) Builds dynamic frameworks to simulate adoption, market share, or treatment behavior over time. Supports forecasting and strategic scenario planning.
  • Strategic Recommendations for Brand Teams Delivers synthesized insights and data-driven strategic guidance to commercial teams. Supports brand planning and lifecycle management.
  • Survey Programming and Testing (e.g., Confirmit, Decipher) Technical implementation of survey instruments with logical flow and error checking across platforms. Delivers validated and tested surveys ready for field deployment.
  • Target Product Profile (TPP) Testing Tests stakeholder reactions to hypothetical product profiles across key attributes. Guides clinical development prioritization and access positioning.
  • Thematic Analysis Qualitative coding of transcripts or notes to identify recurring themes, patterns, and insights. Produces structured findings used to develop narratives and recommendations.
  • Touchpoint Analysis Maps where and how stakeholders interact with a brand or service across the journey. Identifies high-impact opportunities for engagement.
  • Tracking - Market Research Longitudinal studies that monitor key metrics like awareness, usage, and satisfaction over time. Supports campaign optimization and lifecycle planning.
  • Trade & Shopper Testing Assesses how buyers interact with packaging, pricing, and placement in retail environments. Supports point-of-sale strategy and product success.
  • Transcription and Translation (Multilingual) - Market Research Accurate transcription and translation of qualitative research data into target languages. Delivers clean, comparable transcripts for analysis across markets.
  • Trial Feasibility and Design Preference (HCP/patient) Gathers stakeholder input on protocol practicality, site selection, and enrollment design. Reduces recruitment barriers and aligns trials with real-world practice.
  • Unmet Need and SoC Validation Assesses perceived gaps in current standards of care and the need for new interventions. Supports value proposition development and market shaping.
  • UX-Testing Evaluates the usability and functionality of digital interfaces with real users. Delivers actionable insights to improve user experience.
  • Virtual Reality Simulations (e.g., Mock Detail Aids) Immersive simulations that test materials or concepts in realistic digital settings. Provides experiential feedback on content usability and engagement.
  • Volumetric Modelling Uses quantitative data and assumptions to forecast product volume, uptake, and market share. Supports revenue projections and manufacturing planning.

Processing, Packaging, & Preservation

  • Aerobic Fermentation Implement desirable microbial activity in oxygenated conditions to enhance or preserve food and beverage products.
  • Flexible Film Packaging Use flexible film to maximize packaging efficiency and minimize package material waste.
  • High Pressure Processing (HPP) Pasteurization Use non-thermal high-pressure conditions to preserve and sanitize food products while minimizing the loss of quality.
  • High Temperature-Short Time (HTST) Pasteurization Eliminate food-borne microbes by heating to a required minimum temperature of 72 degree Celsius for 15-16 seconds.
  • Liquid Blending Use automatic or semi-automatic liquid blending machinery to produce consistent mixes.
  • Molecular Distillation Use a high-vacuum short path system to purify temperature-sensitve components or enrich a distillate without using toxic separating solvents.
Show all 12 in Processing, Packaging, & Preservation 6 more
  • Non-Alcoholic Beverage Carbonation Find commercial facilities to implement effervescent properties that enhance the formulation of non-alcoholic beverages.
  • Preservation and Antioxidant Testing Ensure the foods or dietary supplements are free of preservatives and antioxidants at a potentially harmful level.
  • Pure Culture Fermentation Implement the desirable microbial activity of a specific microbial strain to enhance or preserve food and beverage products.
  • Red Meat Product Cryogenic Freezing Use low temperature modified packaging technology to retain fresh-like characteristics of red meat products.
  • Sweetness Profile Determine the types and concentrations of sugars in dietary supplements and food products.
  • UV Sterilization & Treatment Sterilize food, medical equipment and other materials using ultra-violet light technologies.

Product Development

  • Aerosol Products - Formulation Formulation services for aerosol products (e.g. hairsprays and spray antiperspirants)
  • Aerosol Products - Manufacturing Manufacturing services for aerosol products (e.g. hairsprays and spray anti-perspirants)
  • Applicators/Devices Componentry design services for applicators and devices
  • Brow & Lash Product Packaging Componentry design services for brown and lash products
  • Brows/Lashes - Formulation Formulation services for brow/lash products
  • Componentry/Packaging (Other) Other componentry/packaging design services for products in personal care
Show all 20 in Product Development 14 more
  • Dietary Supplement Manufacturing Prepare standardized and quality nutraceuticals that meet consumer regulatory standards.
  • Environmentally/Eco Friendly Componentry design services for environmental/eco-friendly products
  • Makeup Removers - Formulation Formulation services for make-up removers
  • Men's Products - Formulation Formulation for male oriented products.
  • Men's Products - Manufacturing Manufacturing for male oriented products.
  • Oral Care - Manufacturing Manufacturing services for oral care products
  • Oral Care Products - Formulation Formulation services for oral care products.
  • Over-The-Counter (Other) - Manufacturing Other manufacturing services for Over-The-Counter (OTC) products
  • Over-The-Counter/OTC (Other) - Formulation Other formulations for Over-The-Counter (OTC) products
  • Personal Care Product Development Services including the formulation, manufacturing, or designing of a personal/consumer care product or packaging.
  • Personal/Consumer Care Product or Service Request relating to the creation, testing or manufacturing of a personal care/consumer health/cosmetic product, ingredient or raw material.
  • Specialty (Other) - Formulation Other formulations for specialty products in personal care
  • Specialty (Other) - Manufacturing Other manufacturing services for specialty products in personal care
  • Wipes/Sheets Packaging Componentry design services for wipes/sheets

Product Orders

  • BioTx General Biotherapeutics analyze therapeutics and drugs via biological means and recombinant DNA. Pre-clinical sample bioanalysis and le...
  • BioTx Reagents Biotherapeutic reagents are materials required for conducting therapeutics research. CROs provide reagents for antibody, DNA, p...
  • Kits and Reagents Submit a request to multiple vendors for kits and reagents.
  • Lab Supplies Fill out the details below to request a quote:
  • Lab-on-Chip Devices Use microfluidics to handle fluids in very small volumes via microchannels etched into glass or plastic chips.

Protein Sciences

  • Adeno Associated Virus (AAV) Production Clone into AAV expression vectors and produce high titer viruses.
  • Affinity Tag Purification Purify proteins under physiological conditions at their native cellular levels.
  • Analytical Ultracentrifugation Characterize the interactions and properties of macromolecules in solution.
  • Antibody-Antigen Affinity Measurement Measure the binding kinetics of an antibody–antigen interaction.
  • Antimicrobial Peptide Synthesis Make a peptide with anti-microbial activities.
  • Bacterial Expression Produce milligram, gram and kilogram amounts of proteins.
Show all 80 in Protein Sciences 74 more
  • Carbohydrate Isolation Obtain pure monosaccharides, pure polysaccharides or related derivatives from samples.
  • Carbohydrate Isolation Protocol Development Design and optimize protocols for carbohydrate isolation.
  • Carbohydrate Structure Characterization Use analytical tools to elucidate carbohydrate structure and physiochemical properties.
  • Catalog Peptides Find peptides that have been previously used in biological research.
  • Cytokines Find recombinant cytokines or cytokine assays.
  • Dynamic Organellar Maps Compare protein maps between two experimental conditions.
  • ELISA Detect the presence of antigens recognized by antibodies or find antibodies that recognize an antigen.
  • Enzymology Enzymology studies the biochemical activity, structure, and function of enzymes. Two key area of Enzymology are Cytochrome P450...
  • Fluorescence Polarization Investigate receptor-ligand interactions, protein-DNA interactions, proteolysis and membrane fluidity.
  • Fluorophore Protein Conjugation Attach a fluorescent probe to a protein.
  • FRET/BRET Detect the location of proteins in living cells and their ability to interact with other proteins.
  • Fusion Proteins Use recombinant DNA technology to create and express proteins derived from more than one gene.
  • Host Cell Protein Analysis Measure contamination of biologics with host proteins by using sequencing, chromatography and the LAL test.
  • Immunopeptidome Profiling Identify and analyze peptides presented by MHC molecules
  • Immunoprecipitation Precipitate a protein of interest out of solution using an antibody to which it binds.
  • Insect Expression Use baculovirus infected cells or non-lytic cell systems to produce glycosylated proteins.
  • Integrated Protein Production Package Process an entire Protein Production Pipeline Project including: Gene/Oligo Synthesis, Cloning/Subcloning, Protein Expression, Protein Purification, Protein Analysis, and Protein Products from our bundle of suppliers
  • Integrated Proteomics Package Process an entire Proteomics Pipeline Project including: Sample Preparation, Target Enrichment, NGS Instrumentation, and Data Analysis from our Bundle of Suppliers
  • Intracellular Trafficking Intracellular Trafficking is when cells transport molecules and proteins from one location to another within the cell.
  • iTRAQ Use a non-gel based method to quantify thousands of proteins in a single experiment.
  • Kinase Panel Assays Work with service providers offering biochemical assays to assess the activity of multiple protein kinases simultaneously to identify and characterize kinase inhibitors, understand selectivity trends, and assess...
  • Large Scale Protein Production Produce large amounts of protein using fermentors, wave mixers, bioreactors, and large-scale purification workflows.
  • LCMS/MS Analysis Liquid chromatography–mass spectrometry is an analytical chemistry technique that combines the physical separation capabilities of liquid chromatography with the mass analysis capabilities of mass spectrometry.
  • Lentivirus Production Develop lentiviruses and production protocols.
  • Low Density Lipoprotein (LDL) Uptake Assay Investigate low density lipoprotein uptake and regulation at the cellular level.
  • Mammalian Expression Express high yields of recombinant proteins, antibodies, virus, viral-subunit proteins and gene-therapy vectors.
  • MAPPs (MHC-II-associated peptide proteomics) MAPPs, or MHC-II-associated peptide proteomics, is a mass spectrometry technique for identifying peptides from therapeutic proteins that are presented by MHC class II molecules on antigen-presenting cells.
  • Mass Photometry Perform accurate mass measurement of single molecules in solution, in their native state and without the need for labels.
  • Mass Spectrometry-Based Proteomics Detect histone post-translational modifications (hPTMs), histone variants, and interactomes at chromatin regions.
  • N-terminal Sequencing Determine the amino acid sequence of an intact protein from its N-terminus.
  • Native Protein Purification Purify native proteins from sources such as tissue & serum.
  • Neoantigen Development Develop neoantigens for oncological therapeutics for vaccine development.
  • NMR Determine molecular and protein structure, and validate sample integrity.
  • Non-Antibody Derived Protein Scaffolds Create non-antibody protein scaffolds that possess unique metabolic and therapeutic properties.
  • PEG Protein Conjugation Improve the therapeutic or pharmacokinetic properties of a protein by pegylation.
  • Peptide Array Use biologically active synthetic peptides arranged in a high density format to assess protein interaction.
  • Peptide Derivatives Acquire chemicals that are peptide derivatives.
  • Peptide Discovery Identifying and developing new peptides.
  • Peptide Synthesis Synthesize custom peptides that are long, have unusual modifications or are cyclic.
  • Peptide/Protein Based Vaccine Production Create a peptide or protein antigen for use in artificial immunization.
  • Peptide/Protein Products Purchase off-the-shelf protein or peptide products.
  • Phage Display Use in vitro screening method to identify protein binding partners.
  • Phosphorylation Analysis Identify phosphorylation sites in target proteins.
  • Polyacrylamide Gel Electrophoresis Separate biological macromolecules based on size.
  • Protein Binding Determine drug-protein binding interactions
  • Protein Chemistry Request information or a price quote for Protein Chemistry services
  • Protein Conjugation Create tagged monoclonals, polyclonal and recombinant proteins.
  • Protein Expression Produce recombinant proteins in prokaryotic or eukaryotic systems.
  • Protein Expression In Plant Cells Express recombinant proteins in plant cells.
  • Protein Identification Uncover or confirm the identity of a protein.
  • Protein Interaction Measure the interaction of a protein to other macromolecules or peptide ligands.
  • Protein Labeling Find suppliers who offer attaching detectable tags like fluorophores or enzymes to proteins
  • Protein mapping Interrogate the entire sequence of a protein.
  • Protein Post-translational Modification Analysis Measure glycosylation, phosphorylation, sulfation, ubiquitination, methylation and acetylation.
  • Protein Production Produce recombinant protein molecules in prokaryotic or eukaryotic systems.
  • Protein Products Find native and recombinant proteins and peptides.
  • Protein Purification Isolate native or recombinant proteins from a sample.
  • Protein Reagents Request information or a price quote for Protein Reagents services
  • Protein Sequencing Determine the amino acid sequence of protein or peptide.
  • Protein Services Consulting Expert advice to evaluate and analyze protein function and expression.
  • Proteomics Do large-scale experimental analysis of proteins focused on understanding structure and function.
  • QMCF Technology Perform episomal protein production using genetically modified mammalian cells and specially designed plasmids.
  • Qualitative MS Perform direct identification of molecules based on mass-to-charge ratio and fragmentation patterns.
  • Quantitative MS Quantify small and large molecules in the pg/ml range
  • Recombinant Proteins Use recombinant DNA to produce proteins in vivo or in vitro.
  • SILAC Enable incorporation of isotopic labels in proteins for mass spectrometry-based quantitative proteomics.
  • Solid Phase Peptide Synthesis Create peptides on solid supports with reduced product loss.
  • Surface Plasmon Resonance (SPR) Measure interactions of biomolecules including antibodies, vaccines, biomarkers and small molecules.
  • The MPS Discovery Engine Discover MAbs against high-value difficult membrane protein targets.
  • Virus Production Produce high titer viruses, viral expression vectors and vaccines.
  • Western Blots Detect specific proteins in a sample of tissue homogenate or extract.
  • X-Ray Crystallography Elucidate structures of biological macromolecules such as proteins and nucleic acids.
  • Yeast Expression Amplify eukaryotic proteins that contain post translational modifications.
  • Yeast Two Hybrid Search novel interactions or confirm hypothesized protein-protein interactions using pairwise assays.

Radioanalysis

  • Stand-alone Radioanalysis of Animal Pre-clinical Samples Conduct analysis of radioactive samples from preclinical radiolabeled studies.
  • Stand-alone Radioanalysis of Human Clinical Samples Conduct analysis of radioactive samples from clinical metabolism radiolabeled studies.

Raw Materials

  • Acids and Bases Acquire acids and bases to use as ingredients in consumer healthcare products.
  • Acne Active Ingredients Acquire antiacne ingredients, such as aluminum chlorohydrex and pyrilamine maleate, for making consumer healthcare products.
  • Adjusters Adjust the pH of a finished product with Spectrum's wide selection of cosmetic pH adjusters. These chemical ingredients maintain the stability of formulations and efficacy of the finished cosmetic or personal care...
  • Anti Irritants Reduce the irritation potential of other more irritating ingredients in the same product.
  • Antifungal Active Ingredients Acquire antifungal active ingredients for making consumer healthcare products.
  • Antimicrobial Active Ingredients Acquire antimicrobial active ingredients for making consumer healthcare products.
Show all 34 in Raw Materials 28 more
  • Cationics Positively charged surfactant molecules.
  • Claims Ingredients Claims-related ingredients for personal care.
  • Conditioners & Emollients (Hair & Skin Care) Acquire conditioners and emollients to use as ingredients in consumer healthcare products.
  • Drug Actives (Other) Formulate and develop products that contain active ingredients such as salicylic acid, benzoyl peroxide, azelaic acid, tacrolimus, and pimecrolimus.
  • Fillers Ingredient used to create bulk, texture or lubrication
  • Film Formers Develop products that produce a continuous film on surfaces.
  • Humectants Acquire humectants, such as glycerin, propylene glycol, and sorbitol, to use as ingredients in consumer healthcare products.
  • Ingredient Delivery Systems Ingredients that aid in the skin penetration of other active ingredients.
  • Non-Surfactant Modify the interface between solid particles and the liquid medium to improve the particles' resistance to settling.
  • Occlusives Moisturizing agent that work by forming a protective coating on the surface of your skin
  • Ophthalmic Active Ingredients Acquire ophthalmic active ingredients for making vision care products.
  • Oral Discomfort Relief Active Ingredients Acquire oral discomfort relief active ingredients for making consumer healthcare products.
  • Oral Health Care Product Ingredients Acquire ingredients for making oral healthcare products.
  • Pediculicide Active Ingredients Acquire pediculicide active ingredients for making consumer healthcare products.
  • Plasticizers Excipients designed to modify the physical properties of a basic polymer.
  • Sedative Active Ingredients Acquire sedative active ingredients for making over-the-counter medicines.
  • Sequesterants Acquire sequesterants to use as ingredients in consumer healthcare products.
  • Skin Bleach Active Ingredients Acquire skin-bleaching active ingredients, such as hydroquinone and ammoniated mercury, for making consumer healthcare products.
  • Skin Protectant Active Ingredients Acquire skin protectants as active ingredients for making consumer healthcare products.
  • Stimulant Active Ingredients Acquire stimulant active ingredients for making over-the-counter medicines.
  • Sunscreen Active Ingredients Acquire sunscreen active ingredients for making skin healthcare products.
  • Surfactants - Amphoterics, Anionics, Betaines, Ethoxylated Glycerine, Nonionics Acquire surfactants, such as amphoterics, anionics, betaines, ethoxylated glycerine, and nonionics, to use as ingredients in consumer healthcare products.
  • Topical Alcohol Ingredients Acquire isopropyl alcohol as an ingredient for making consumer healthcare products.
  • Topical Analgesic Active Ingredients Acquire topical analgesic active ingredients for making consumer healthcare products.
  • U.V. Absorbers Acquire U.V. absorbers, such as phenylbenzimidazole sulphonic acid and trolamine salicylate, to use as ingredients in consumer healthcare products.
  • Vaginal Contraceptive Active Ingredients Acquire vaginal contraceptive active ingredients for making over-the-counter medicines.
  • Vitamins and Derivatives Acquire vitamins and derivatives to use as ingredients in consumer healthcare products.
  • Weight Control Active Ingredients Acquire weight control active ingredients active ingredients for making over-the-counter medicines.

REACH Services

  • Acute Toxicity Study - Parasitic Wasps (Aphidius rhopalosiphi) This study is designed to estimate the acute toxicity of substances to Parasitic Wasps (Aphidius rhopalosiphi), including an option for reproductive toxicity.
  • Acute Toxicity Study - Predatory Mites (Typhlodromus phri) This study is designed to estimate the acute toxicity of substances to Predatory Mites (Typhlodromus phri), including an option for reproductive toxicity.
  • Acute Toxicity Study - Soil Mites This study is designed to estimate the acute toxicity of substances to Soil Mites, including an option for reproductive toxicity.
  • Dossier Prep. and Consultancy Assistance with creation of a regulatory document that contains all the Clinical, non-clinical, and CMC information of a pharmaceutical product to be approved, registered, or marketed within a specific country.
  • Ex Vivo REACH Assays Perform testing on cells or tissues cultured directly from a test organism
  • Hazard, Exposure and Risk Assessment Evaluate the known hazard of a test compound in conjunction with the expected quantity and frequency of exposure.
Show all 49 in REACH Services 43 more
  • In Vitro REACH Services Perform skin or eye irriation tests, sensitivily and geneotoxicity tests
  • In Vitro Skin Sensitization Determine whether a drug or cosmetic product may cause dermal sensitization.
  • In Vivo REACH Services Performing testing when in vitro studies cannot be used to predict biological responses
  • OECD 209: Activated Sludge, Respiration Inhibition Test (Carbon and Ammonium Oxidation) This Test Guideline is designed to assess the effects of a substance on micro-organisms from activated sludge of waste-water treatment plants by measuring their respiration rate (carbon and/or ammonium oxidation) as...
  • OECD 223: Avian Acute Oral Toxicity Test This Test guideline describes procedures designed to estimate the acute oral toxicity of substances to birds.
  • OECD 402: Acute Dermal Toxicity This method provides information on health hazard likely to arise from short-term exposure to a test chemical by dermal route.
  • OECD 403: Acute Inhalation Toxicity This method provides information on health hazard likely to arise from short-term exposure to a test article (gas, vapour or aerosol/particulate test article) by inhalation.
  • OECD 404: Acute Dermal Irritation/Corrosion This method provides information on health hazard likely to arise from exposure to liquid or solid test substance by dermal application.
  • OECD 405: Acute Eye Irritation/Corrosion This method provides information on health hazard likely to arise from exposure to test substance (liquids, solids and aerosols) by application on the eye.
  • OECD 406: Skin Sensitisation This method provides information on health hazard likely to arise from exposure to test substance via intradermical injection and/or epidermical application.
  • OECD 407: Repeated Dose 28-day Oral Toxicity Study in Rodents This method provides information on health hazard likely to arise from exposure to test substance via oral administration.
  • OECD 408: Repeated Dose 90-Day Oral Toxicity Study in Rodents This method provides information on health hazard likely to arise from exposure to test substance via oral administration.
  • OECD 410: Repeated Dose Dermal Toxicity: 21/28-day Study This study relates to the analysis, via dermal application, of the health hazard of solid or liquid test substance.
  • OECD 411: Subchronic Dermal Toxicity: 90-day Study This study relates to the analysis, via dermal application, of the health hazards of solid or liquid test substance.
  • OECD 412: Subacute Inhalation Toxicity: 28-Day Study This revised Test Guideline 412 (TG 412) has been designed to fully characterize test article toxicity by the inhalation route following repeated exposure for a limited period of time (28 days), and to provide data...
  • OECD 413: Subchronic Inhalation Toxicity: 90-day Study This revised Test Guideline 413 (TG 413) has been designed to fully characterize test article toxicity by the inhalation route following repeated exposure for a period of 90 days, and to provide data for quantitative...
  • OECD 414: Prenatal Developmental Toxicity Study This Test Guideline for developmental toxicity testing is designed to provide general information concerning the effects of prenatal exposure on the pregnant test animal and on the developing organism.
  • OECD 416: Two-Generation Reproduction Toxicity This Test Guideline for two-generation reproduction testing is designed to provide general information concerning the effects of a test substance on the integrity and performance of the male and female reproductive...
  • OECD 417: Toxicokinetics Study Obtain data on absorption, distribution, metabolism, and elimination of test substances.
  • OECD 420: Acute Oral Toxicity - Fixed Dose Procedure A principle of the method is that in the main study only moderately toxic doses are used, and the administration of doses that are expected to be lethal should be avoided. This Guideline is intended primarily for use...
  • OECD 421: Reproduction/Developmental Toxicity Screening Test The test substance is administered in graduated doses to several groups of males and females.
  • OECD 422: Combined Repeated Dose Toxicity Study with the Reproduction/Developmental Toxicity Screening Test This screening Test Guideline describes the effects of a test chemical on male and female reproductive performance.
  • OECD 423: Acute Oral toxicity - Acute Toxic Class Method The acute toxic class method set out in this Guideline is a stepwise procedure with the use of 3 animals of a single sex per step. Depending on the mortality and/or the moribund status of the animals, on average 2-4...
  • OECD 425: Acute Oral Toxicity: Up-and-Down Procedure The method permits estimation of an LD50 with a confidence interval and the results allow a substance to be classified for acute toxicity according to the Globally Harmonised System of classification and labelling...
  • OECD 426: Developmental Neurotoxicity Study A developmental neurotoxicity study will provide information on the effects of repeated exposure to a substance during in utero and early postnatal development.
  • OECD 429: Skin Sensitisation (Local Lymph Node Assay) Assess the skin sensitization potential of chemicals.
  • OECD 431: In Vitro Skin Corrosion: Human Skin Model Test The test described in this Test Guideline allows the identification of corrosive chemical substances and mixtures and it enables the identification of non-corrosive substances and mixtures when supported by a weight...
  • OECD 432: In Vitro 3T3 NRU Phototoxicity Test Test the cytotoxic effects of chemical substances and environmental samples on cell membranes.
  • OECD 436: Acute Inhalation Toxicity – Acute Toxic Class Method The method described by this Test Guideline provides information that allows hazard assessment for short-term exposure to a test article by inhalation, and allows the substance to be classified according...
  • OECD 437: Bovine Corneal Opacity and Permeability Test Method (BCOP) for Identifying Ocular Corrosives and Severe Irritants The Bovine Corneal Opacity and Permeability test method (BCOP) is an in vitro test method that can be used to classify substances as 'ocular corrosives and severe irritants'.
  • OECD 451: Carcinogenicity Studies The objective of a long-term carcinogenicity study is to observe test animals for a major portion of their life span for the development of neoplastic lesions during or after exposure to various doses of a test...
  • OECD 452: Chronic Toxicity Studies Evaluate the direct and indirect impact of prolonged and repeated toxin exposure to test organisms.
  • OECD 453: Combined Chronic Toxicity/Carcinogenicity Studies The objective of a combined chronic toxicity/carcinogenicity study is to identify carcinogenic and the majority of chronic effects, and to determine dose-response relationships following prolonged and repeated exposure.
  • OECD 471: Bacterial Reverse Mutation Test (Ames) Measure the mutagenic potential of test compounds.
  • OECD 473: In Vitro Mammalian Chromosomal Aberration Test Assess the ability of the test substance to cause structural chromosomal aberrations in cultured mammalian cells.
  • OECD 474: Mammalian Erythrocyte Micronucleus Test The mammalian in vivo micronucleus test is used for the detection of damage induced by the test substance to the chromosomes or the mitotic apparatus of erythroblasts, by analysis of erythrocytes as sampled in bone...
  • OECD 475: Mammalian Bone Marrow Chromosomal Aberration Test The mammalian in vivo chromosome aberration test is used for the detection of structural chromosome aberrations induced by test compounds in bone marrow cells of animals, usually rodents (rats, mice and Chinese...
  • OECD 476: In Vitro Mammalian Cell Gene Mutation Test (Mouse Lymphoma Assay) Determine if a compound is mutagenic by using cultured mammalian cells.
  • OECD 486: Unscheduled DNA Synthesis (UDS) Test with Mammalian Liver Cells in vivo The purpose of the unscheduled DNA synthesis (UDS) test with mammalian liver cells in vivo is to identify substances that induce DNA repair after excision and removal of a stretch of DNA containing a region of damage...
  • OECD 487: In Vitro Mammalian Cell Micronucleus Test Assess whether a test substance induces chromosomal changes in cultured cells.
  • OECD 489: In Vivo Mammalian Alkaline Comet Assay Measure the mitogenic and genotoxic potential of test compounds.
  • Pyrogen Test Find suppliers who offer safety tests to detect fever-inducing substances (pyrogens) in pharmaceutical products, medical devices, and other biological products
  • REACH Services Assist in the registration, evaluation and authorization of chemical substances.

Real World Evidence & Data

  • Claims Data & Database Analysis Analysis of care cost and quality.
  • Claims Data - Billing Includes patient demographics, insurance status, geographical location, among others.
  • Claims Data - Medical Includes hospitalization,physician visits,emergency department visits. May or may not include laboratory information including resource utilization, costs or charges, as well as ICD-9 or 10 codes.
  • Claims Data - Pharmacy Includes medications, prescription orders, payment submissions, patient adherence, among others.
  • Clinical Data Registry A study or collection of data regarding the health of patients and the care they receive over different time periods.
  • Clinical Phenotype Data Obtain phenotypic data and observations on patients such as the clinical manifestation of the disease, clinical and behavioral parameters, symptoms, and laboratory test results.
Show all 39 in Real World Evidence & Data 33 more
  • Cohort Study Investigating the causes of disease to establish links between risk factors and health outcomes.
  • Data - Electronic Health Record (EHR) Digital version of a patient's medical or health chart containing demographic, clinical, medical, and other treatment information.
  • Data Asset Validation Tools for validating that patient data and source has been accurately recorded.
  • Data Merging Tools for combining various data sets into a single data set. Includes data consolidation.
  • Exploratory Study Explore study design, outcomes, data-collection method, and selection of population for a topic that needs more research information.
  • HealthVerity - Health Data Platform HealthVerity platform serves as the foundation for the rapid creation, exchange and management of healthcare and consumer data. Through best-in-class identity resolution and matching capabilities, increased...
  • Meta-Analysis Use quantitative statistical approaches to pool results across multiple studies to improve power or resolve uncertainty; may be used in conjunction with a systematic review.
  • Multi-Source Data Pools Multiple data sources aggregated into singular platforms for analysis. May or may not include real-time analytics capabilities.
  • Non-Comparative Study Assess an intervention using a single arm study design (without a control or comparator group).
  • Patient Reported Outcomes (PRO) Databases Database or collection of data related to health outcomes directly reported by the patient who experienced it, without interpretation of the patient's response by a clinician or anyone else.
  • Payer Outcomes-Based Contract Trial Study or analysis of data (claims, electronic HR/MR) to assess reimbursement or price to actual health outcomes.
  • Pragmatic Clinical Trial Randomized trial comparing two or more treatments in a real world setting. The trial possesses minimal exclusion criteria and closely follows the procedures of the clinical practice in order to mirror clinical care...
  • Predictive Analytics Variety of statistical techniques from data mining, predictive modeling, and machine learning, that analyze current and historical facts to make predictions about future or otherwise unknown events.
  • Pregnancy Registries Database containing, through utilizing observational research methods, standardized data about women taking medication or vaccines while pregnant. Data may also collected on the newborn.
  • Quantitative or Qualitative Research Either to understand concepts, thoughts, or experiences with qualitative research or to quantify the problem by generating numerical data or data that can be transformed into usable statistics with quantitative research.
  • Real World Evidence (RWE) Studies Studies (prospective or retrospective) utilizing data obtained from "real world settings" , and is outside the tight controls of a clinical trial design.
  • Real-World Data Acquire real-world data from patients' electronic medical records including clinical information generated during the course of healthcare.
  • Real-World Evidence Acquire clinical data from patients' medical records to analyze trends and the frequency of occurrence of different medical conditions.
  • Registries - Disease Database containing, through utilizing observational research methods, standardized data about patients who have the same disease.
  • Registries - Patient Database containing, through utilizing observational research methods, standardized data about patients who have the same condition, disease, or exposure and is used to evaluate an outcome
  • Registries - Product Includes specific information about a product of interest, route of administration, dose, duration of use, start and stop date.
  • Retrospective Exploratory Studies Retrospective exploratory studies
  • RWD - COVID-19 Data from COVID-19 patients, can include diagnosis, treatment, among others.
  • RWD - Diagnostics/Laboratory Includes information on laboratory procedures/results.
  • RWD - Electronic Medical Record (EMR) Digital version of a patient's medical or health chart containing demographic, clinical, medical, and other treatment information.
  • RWD - Genomics Genomic data collected from a patients with different diseases, can be derived from a range of sources.
  • RWD - Oncology Data from oncology patients, can include clinical treatment, diagnosis, among others.
  • RWD - Rare Diseases Data from patients with rare diseases, can include clinical treatment, diagnosis, among others.
  • RWD - Wearables Data gathered from sources including pedometers, mobile devices, smart watches, among others.
  • RWE/HEOR Data Analysis Analysis that helps you make sense of your RWE/HEOR data
  • RWE/HEOR/Market Access Safety Surveillance Monitor safety of treatment and determine methods to identify adverse events early
  • RWE/RWD Observational Research Research method for documenting clinical, economic, and or humanistic outcomes of actual medical practice absent the constraints of a more formal experimental design. See also Pragmatic Clinical Trials.
  • Secondary Real World Evidence Analyze clinical trial data.

Regulatory Affairs

  • Life Cycle Management Plan and strategy of the data collection and information throughout the different phases of product development (portfolio assessment, pre-clinical trials, clinical trials, pre-authorization, post-authorization, and RWE)
  • Medical Labeling Design and create medical labels that accurately reflect purpose, precautions and other information.
  • Patient Risk Management Identify, contain, and manage risks related to patient safety.
  • Period Benefit Risk Evaluation Report (PBRER) Preparation of safety reports to report adverse events that occurred during a specified time period. Evaluate if safety profile of treatment has changed since last report
  • Periodic Safety Update Report (PSUR) Preparation of safety reports to report adverse events that occurred during a specified time period. Evaluate if safety profile of treatment has changed since last report
  • Post Authorization Efficacy Study (PAES) Answer uncertainties in efficacy of treatment, and improve understanding of treatment and the benefit-risk profile. These studies are specifically asked for by European Medicines Agency (EMA) to continually grant...
Show all 12 in Regulatory Affairs 6 more
  • Post Authorization Safety Study (PASS) Evaluate the safety, benefit-risk profile, and risk management of a treatment. These studies are specifically asked for by European Medicines Agency (EMA) and they can be mandatory or voluntary.
  • Post-authorization Safety Studies Research efforts conducted after a drug has been approved for market to monitor its safety profile in the general population. These studies aim to identify, characterize, or quantify potential adverse effects...
  • Regulatory Submission Documents Request services related to the submission and writing of New Drug Applications (NDA), Investigational New Drugs (INDs), and Investigator Brochures (IB) to the FDA and other regulatory bodies.
  • Risk Benefit Assessment Determine ratio of treatment risk to the potential benefits.
  • Risk Evaluation & Mitigation Strategy (REMS) Evidence required by FDA to support the benefit of treatment outweighs the risks. Purpose of REMS is to prevent, monitor, and manage serious risk by informing, educating, and reinforcing actions to reduce frequency...
  • Safety Signals Early indication that a new or unknown adverse event occurred that may be caused by treatment and investigation is needed to determine a causal relationship. Can be investigated through spontaneous reports, studies...

Regulatory Consulting

  • Environmental Fate and Ecotoxicology Data Review Identify relevant endpoints for fate and behavior (metabolism and excretion, degradation and soil adsorption) and toxicity (soil organisms, aquatic organisms, and dung fauna) of animal health products.
  • Environmental Risk Assessment Conduct EU and US Environmental Assessment (ERA/EA) phases one and two according to VICH guidelines.
  • Toxicology Data Review Identify relevant toxicological endpoints for “No Observed (Adverse) Effect Level” (NO(A)EL) or “Lowest Observed (Adverse) Effect Level” (LO(A)EL).

Safety Pharmacology

  • Abuse and Dependence Liability Testing Determine the abuse or dependence potential of a therapeutic.
  • Abuse Liability Determine the dependence potential of a therapeutic.
  • CNS Behavioral Measure safety toxicology effects of CNS and behavioral drugs.
  • Conditioned Place Preference or Aversion Study - Mouse Conduct a study to establish the aversion or conditioned place preference and determine the motivational effect of your compound in mice.
  • Conditioned Place Preference or Aversion Study - Rat Conduct a study to establish the aversion or conditioned place preference and determine the motivational effect of your compound in rats.
  • Cytokine Release Syndrome In Vivo assessment of cytokine release syndrome liability in a humanized mouse
Show all 41 in Safety Pharmacology 35 more
  • Dependence Potential Study - Other Species Conduct a study to determine the dependence potential of your compound in other species.
  • Dependence Potential Study - Rat Conduct a study to determine the dependence potential of your compound in rats.
  • Developmental Neurotoxicty Study - Other Species A developmental neurotoxicity study will provide information on the effects of repeated exposure to a substance during in utero and early postnatal development.
  • Drug Discrimination Study - Other Species Conduct a study to investigate the length of psychoactive effects of your compound in other species and conduct dose range finding for further studies.
  • Drug Discrimination Study - Rat Conduct a study to investigate the length of psychoactive effects of your compound in rats and conduct dose range finding for further studies.
  • Endocrine Disruptor Screening Use biochemical, cell based or in vivo assays to identify and quantify endocrine-modulating agents.
  • Immunotoxicity Measure effects of drugs on immune function, allergic hypersensitization and autoimmune toxicity.
  • Implanted Telemetry Study - Dog / Canine Conduct a study that allows the continuous collection of cardiovascular data following dosing of your compound in dogs/canines.
  • Implanted Telemetry Study - Monkey / Non-human Primate Conduct a study that allows the continuous collection of cardiovascular data following dosing of your compound in monkeys/non-human primates.
  • Implanted Telemetry Study - Other Species Conduct a study that allows the continuous collection of cardiovascular data following dosing of your compound in other species.
  • Implanted Telemetry Study - Rat Conduct a study that allows the continuous collection of cardiovascular data following dosing of your compound in rats.
  • Jacketed External Telemetry (JET) Study - Dog / Canine Conduct a study that allows the continuous collection of cardiovascular data following dosing of your compound in dogs/canines.
  • Jacketed External Telemetry (JET) Study - Minipig Conduct a study that allows the continuous collection of cardiovascular data following dosing of your compound in minipigs.
  • Jacketed External Telemetry (JET) Study - Monkey / Non-human Primate Conduct a study that allows the continuous collection of cardiovascular data following dosing of your compound in monkeys/non-human primates.
  • Jacketed External Telemetry (JET) Study - Other Species Conduct a study that allows the continuous collection of cardiovascular data following dosing of your compound in other species.
  • Locomotor Activity Assessment Study - Rat Conduct a study to determine the psychostimulant or sedative activity or your compound in rats.
  • Microelectrode Array Neurotoxicity Assays Use microelectrode array to measure neurotoxicity-related activities.
  • Neurotoxicity Study Study of the adverse effects of a substance on the brain or peripheral nervous system.
  • Off Target Effects Assess toxicities by body weight, clinical chemistry, hematology, urinalysis and terminal necropsy and pathology.
  • Repeat Dose Neurotoxicity Study - Other Species Conduct a repeat dose study in other species to determine the neurotoxicity of your compound.
  • Repeat Dose Neurotoxicity Study - Rat Conduct a repeat dose study in rats to determine the neurotoxicity of your compound.
  • Respiratory Toxicology Assess difficulty breathing, altered respiration, blood gas changes and blood pH issues due to adverse reactions.
  • Safety Pharmacology Assess the impact of a therapeutic for human use on vital organ systems before first-in-man drug testing.
  • Safety Pharmacology Latin Square Study - Dog / Canine Conduct a safety pharmacology study with a Latin square design in dogs/canines.
  • Safety Pharmacology Latin Square Study - Monkey / Non-human Primate Conduct a safety pharmacology study with a Latin square design in monkeys/non-human primates.
  • Safety Pharmacology Latin Square Study - Other Species Conduct a safety pharmacology study with a Latin square design in other species.
  • Safety Pharmacology Study with Functional Observational Batteries (FOBs) - Other Species Conduct a safety pharmacology study with functional oberservational batteries in other species.
  • Safety Screen Panel Assays Safety Pharmacology safety screen panel assays enable early identification of significant off-target interactions with your compound(s)
  • Seizure Liability Study - Other Species Conduct a study to determine the seizure risk of your compound in other species.
  • Seizure Liability Study - Rat Conduct a study to determine the seizure risk of your compound in rats.
  • Self Administration Study - Other Species Conduct a study to investigate the potential addictive characteristics of your compound in other species.
  • Self Administration Study - Rat Conduct a study to investigate the potential addictive characteristics of your compound in rats.
  • Target Safety Assessment Understand the role of your drug target and assess risks in normal physiology.
  • Telemetry Use implantable or external devices to study physiological parameters in model organisms
  • Tissue Cross Reactivity Assess the toxic effects of humanized monoclonal antibodies in 33 normal types recommended by the FDA.

Scientific Data Services

  • Analysis of Variance Test several null hypotheses at the same time using ANOVA.
  • Automated Image Analysis Automated Image Analysis
  • Bayesian Statistics Extract information from data sets that are subject to error or noise to see unobserved possibilities.
  • Bioinformatics Bioinformatics is a powerful method of storing, retrieving and analyzing biological data.
  • Cancer Systems Biology Convert complex molecular data obtained from high-throughput technologies to deducible information.
  • Chemometrics Methods to analyze, interpret, and optimize chemical data, particularly in analytical chemistry and spectroscopy.
Show all 49 in Scientific Data Services 43 more
  • Clinical Genomics Use genome sequencing to inform patient diagnosis and care.
  • Cloud Computing Request on-demand computer resources specifically relating to large data storage and computing power.
  • Data and Text Mining Derive structured data from free text in order to become accessible for data-mining algorithms.
  • Data Curation Organize and integrate data collected from various sources to ease data discovery and retrieval.
  • Data Infrastructure Design and deploy an information management solution suited to users' specific needs.
  • Data Lineage & Quality Track the various processes through which data has been created, edited or exchanged.
  • Data Quality Framework Manage data quality issues to maintain good quality data outputs.
  • Database Integration Convert bioinformatics results from multiple data sources (DSs) into a single operational format.
  • Discovery Computational Systems Biology Model the interaction of biological system with drug candidates.
  • Epigenomics Data Analysis Quantify and analyze DNA methylation and/or DNA binding protein data sets.
  • Foundation Model A foundation model is a large-scale AI model trained on extensive datasets, designed to be adaptable for a variety of specific tasks.
  • Genome Data Analysis Analyze genomic DNA, RNA and protein sequence data.
  • High-Performance Computing Compute using higher performing parallel processing.
  • In Silico Genomics/Transcriptomics Data Analysis Interpret DNA sequencing and microarray data.
  • In Silico Metagenomics/Metatranscriptomics Data Analysis Use software to analyze genomic information from multiple environmental sources.
  • Large Language Models Use of Large Language models in target discovery, clinical trial design and development, analysis of clinical trial data and regulatory submissions. Services are tailored to the problem, specific context of biopharma.
  • LIM/eLab Notebook Services LIM/eLab Notebook Services
  • Machine Learning/ AI Predict and model an outcome (e.g. disease progression) based on input variables (i.e. features.)
  • Marker Analyses Identify associations between genetic markers and traits of interest to determine markers responsible for human diseases.
  • Metabolomics Data Analysis Use metabolites to identify any potential biomarkers or novel therapeutic targets that may play a role in the mechanisms responsible for the progression of a disease.
  • Metagenomics Data Analysis Deconvolute the genetic content of genomes contained in environmental samples by utilizing whole genome sequencing techniques to provide insight into microbial communities and host phenotypes.
  • Metasite A virtual site or a grouping of data from multiple websites.
  • Microbiome Data Analysis Determine the population composition of a microbial community and analyze its contribution to human or animal health.
  • Molecular Dynamics Software Run simulations that determine time-dependent behaviors of molecular systems.
  • Molecular Phylogenetics Analyze hereditary molecular differences in genomic sequences to compare genomes.
  • Multivariate Analysis (MVA) Analyze datasets with three or more variables simultaneously to discover hidden patterns, correlations, and underlying structure
  • Mutation Data Profiling Guide treatment decisions in cancer based on the identification of genomic mutations .
  • NGS: Next Generation Sequencing Data Analysis Use software to interpret data created by RNA-Seq, DNA-Seq, ChIP-Seq and DNA methylation experiments.
  • Omics Informatics Consulting Services for the analysis of large-scale molecular data sets.
  • Ontology Mapping Assign given ontologies to source data.&nbsp;
  • Pharmaco-genomics Genetic polymorphism contribution to inter-individual variability in drugs' responses and/or adverse events.
  • Scientific Data Visualization Exploration and reporting of data by means of graphs and plots.
  • Scientific Pipeline Implementation Design, develop and deploy data analyses workflows.
  • Semantic Tech & Triplestores Store and retrieve semantic facts.
  • Small RNA Gene Expression Quantify and analyze miRNA, piRNA, siRNA as well as other small nuclear RNAs from small-RNA-seq raw input data sets.
  • Software Tools Software tool for statistical analysis, data mining, genome annotation or NGS data analysis.
  • Strategic RFX Utilize the Scientist.com marketplace to run a strategic RFI/RFP to consolidate orders across different sites with preferred vendors, find new vendors, and leverage to negotiate better pricing.
  • System Development Plan, create and deploy an information system.
  • Systems Biomedicine Analyze complex interactions in biological systems with interdisciplinary scientific teams.
  • Systems Network Analysis Analyze and visualize molecular pathways including gene regulatory, protein-protein and drug-target networks.
  • Systems Pharmacology Understand how drugs interact with different molecular and cellular systems within biological models.
  • T Cell Epitope Mapping Use peptide libraries make it possible to rapidly identify the epitopes of T-Cells, T-Cell clones, T-Helper Cell Clones, T-cell lines, and unpurified T-cells.
  • WBA Technologies Request information or a price quote for WBA Technologies services. (global industry bodies driving the adoption of next-gen Wi-Fi, 5G, 6G, IoT, and OpenRoaming)

Specialty Dosing Routes

  • Chronic Inhalation Carcinogenicity Study - Other Species Conduct a repeat inhalation dose, chronic carcinogenicity study in other species to determine the tendency of your compound to produce tumors.
  • Chronic Inhalation Carcinogenicity Study - Rat Conduct a repeat inhalation dose, chronic carcinogenicity study in rats to determine the tendency of your compound to produce tumors.
  • Chronic Intranasal Carcinogenicity Study - Other Species Conduct a repeat dose intranasal, chronic carcinogenicity study in other species to determine the tendency of your compound to produce tumors.
  • Chronic Intranasal Carcinogenicity Study - Rats Conduct a repeat dose intranasal, chronic carcinogenicity study in rats to determine the tendency of your compound to produce tumors.
  • Chronic Intravenous Infusion Carcinogenicity Study - Other Species Conduct a repeat intravenous infusion dose, chronic carcinogenicity study in other species to determine the tendency of your compound to produce tumors.
  • Chronic Intravenous Infusion Carcinogenicity Study - Rat Conduct a repeat intravenous infusion dose, chronic carcinogenicity study in rats to determine the tendency of your compound to produce tumors.
Show all 59 in Specialty Dosing Routes 53 more
  • Dermal Toxicology Assess toxicity in rodent dermal testing models.
  • Inhalation Toxicology Measure toxicity by daily clinical observation, body weight, clinical chemistry, hematology, and terminal necropsy and pathology.
  • Intra-Articular Toxicology Conduct a study to determine the toxicity and toxicokinetic behavior of your compound when delivered directly to the joint.
  • Intra-Auricular Toxicology Conduct a study to determine the toxicity and toxicokinetic behavior of your compound when delivered via the ear.
  • Intracameral Implant Toxicity and/or Toxicokinetic Study - Dog / Canine Conduct an intracameral implant toxicity study in dogs/canines to determine the toxicity and toxicokinetic behavior of your compound.
  • Intracameral Implant Toxicity and/or Toxicokinetic Study - Monkey / Non-human Primate Conduct an intracameral implant toxicity study in monkeys/non-human primates to determine the toxicity and toxicokinetic behavior of your compound.
  • Intracameral Implant Toxicity and/or Toxicokinetic Study - Other Species Conduct an intracameral implant toxicity study in other species to determine the toxicity and toxicokinetic behavior of your compound.
  • Intracameral Implant Toxicity and/or Toxicokinetic Study - Rabbit, Non-pigmented (New Zealand White; NZW) Conduct an intracameral implant toxicity study in non-pigmented rabbits to determine the toxicity and toxicokinetic behavior of your compound.
  • Intracameral Implant Toxicity and/or Toxicokinetic Study - Rabbit, Pigmented (Dutch Belted, New Zealand Red) Conduct an intracameral implant toxicity study in pigmented rabbits to determine the toxicity and toxicokinetic behavior of your compound.
  • Intrathecal/Intraspinal Toxicology Conduct a study to determine the toxicity and toxicokinetic behavior of your compound when delivered via the intrathecal space.
  • Intravitreal Toxicity and/or Toxicokinetic Study - Dog / Canine Conduct an intravitreal ocular toxicity study in dogs/canines to determine the toxicity and toxicokinetic behavior of your compound.
  • Intravitreal Toxicity and/or Toxicokinetic Study - Minipig Conduct an intravitreal ocular toxicity study in minipigs to determine the toxicity and toxicokinetic behavior of your compound.
  • Intravitreal Toxicity and/or Toxicokinetic Study - Monkey / Non-human Primate Conduct an intravitreal ocular toxicity study in monkeys/non-human primates to determine the toxicity and toxicokinetic behavior of your compound.
  • Intravitreal Toxicity and/or Toxicokinetic Study - Other Species Conduct an intravitreal ocular toxicity study in other species to determine the toxicity and toxicokinetic behavior of your compound.
  • Intravitreal Toxicity and/or Toxicokinetic Study - Rabbit, Non-pigmented (New Zealand White; NZW) Conduct an intravitreal ocular toxicity study in non-pigmented rabbits to determine the toxicity and toxicokinetic behavior of your compound.
  • Intravitreal Toxicity and/or Toxicokinetic Study - Rabbit, Pigmented (Dutch Belted, New Zealand Red) Conduct an intravitreal ocular toxicity study in pigmented rabbits to determine the toxicity and toxicokinetic behavior of your compound.
  • Lethal Dose (LD), 50% Toxicity Test Measure acute toxicity by identifying the amount of pure toxin required to kill half of the experimental subjects.
  • Ophthalmologic Toxicology Measure toxicity by microscopy, vitrectomy, tonometry, electroretionography and corneal colorimetry.
  • Repeat Dose Inhalation Study - Other Species Conduct a repeat dose inhalation study in other species to determine the toxicity and toxicokinetic behavior of your compound.
  • Repeat Dose Inhalation Study - Rat Conduct a repeat dose inhalation study in rats to determine the toxicity and toxicokinetic behavior of your compound.
  • Repeat Dose Intranasal Study - Dog / Canine Conduct a repeat dose intranasal study in dogs/canines to determine the toxicity and toxicokinetic behavior of your compound.
  • Repeat Dose Intranasal Study - Monkey / Non-human Primate Conduct a repeat dose intranasal study in monkeys/non-human primates to determine the toxicity and toxicokinetic behavior of your compound.
  • Repeat Dose Intranasal Study - Mouse Conduct a repeat dose intranasal study in mice to determine the toxicity and toxicokinetic behavior of your compound.
  • Repeat Dose Intranasal Study - Other Species Conduct a repeat dose intranasal study in other species to determine the toxicity and toxicokinetic behavior of your compound.
  • Repeat Dose Intranasal Study - Rat Conduct a repeat dose intranasal study in rats to determine the toxicity and toxicokinetic behavior of your compound.
  • Repeat Dose Intravenous Infusion Study - Dog / Canine Conduct a repeat dose intravenous infusion study in dogs/canines to determine the toxicity and toxicokinetic behavior of your compound.
  • Repeat Dose Intravenous Infusion Study - Monkey / Non-human Primate Conduct a repeat dose intravenous infusion study in monkeys/non-human primates to determine the toxicity and toxicokinetic behavior of your compound.
  • Repeat Dose Intravenous Infusion Study - Other Species Conduct a repeat dose intravenous infusion study in other species to determine the toxicity and toxicokinetic behavior of your compound.
  • Repeat Dose Intravenous Infusion Study - Rats Conduct a repeat dose intravenous infusion study in rats to determine the toxicity and toxicokinetic behavior of your compound.
  • Single Dose Acute Inhalation Study - Other Species Conduct a single dose inhalation study in other species to determine the toxicokinetic behavior of your compound.
  • Single Dose Acute Inhalation Study - Rat Conduct a single dose inhalation study in rats to determine the toxicokinetic behavior of your compound.
  • Single Dose Acute Intranasal Study - Dog / Canine Conduct a single dose intranasal study in dogs/canines to determine the toxicokinetic behavior of your compound.
  • Single Dose Acute Intranasal Study - Mouse Conduct a single dose intranasal study in mice to determine the toxicokinetic behavior of your compound.
  • Single Dose Acute Intranasal Study - Other Species Conduct a single dose intranasal study in other species to determine the toxicokinetic behavior of your compound.
  • Single Dose Acute Intranasal Study - Rat Conduct a single dose intranasal study in rats to determine the toxicokinetic behavior of your compound.
  • Single Dose Acute Intravenous Infusion Study - Dog / Canine Conduct a single dose intravenous infusion study in dogs/canines to determine the toxicokinetic behavior of your compound.
  • Single Dose Acute Intravenous Infusion Study - Monkey / Non-human Primate Conduct a single dose intravenous infusion study in monkeys/non-human primates to determine the toxicokinetic behavior of your compound.
  • Single Dose Acute Intravenous Infusion Study - Other Species Conduct a single dose intravenous infusion study in other species to determine the toxicokinetic behavior of your compound.
  • Single Dose Acute Intravenous Infusion Study - Rats Conduct a single dose intravenous infusion study in rats to determine the toxicokinetic behavior of your compound.
  • Topical Dermal Toxicity and/or Toxicokinetic Study - Dog / Canine Conduct a dermal study to determine the toxicity and/or toxicokinetic behavior of your compound when applied topically to dogs/canines.
  • Topical Dermal Toxicity and/or Toxicokinetic Study - Minipig Conduct a dermal study to determine the toxicity and/or toxicokinetic behavior of your compound when applied topically to minipigs.
  • Topical Dermal Toxicity and/or Toxicokinetic Study - Monkeys/Non-human Primates Conduct a dermal study to determine the toxicity and/or toxicokinetic behavior of your compound when applied topically to monkeys/non-human primates.
  • Topical Dermal Toxicity and/or Toxicokinetic Study - Mouse Conduct a dermal study to determine the toxicity and/or toxicokinetic behavior of your compound when applied topically to mice.
  • Topical Dermal Toxicity and/or Toxicokinetic Study - Other Species Conduct a dermal study to determine the toxicity and/or toxicokinetic behavior of your compound when applied topically to other species.
  • Topical Dermal Toxicity and/or Toxicokinetic Study - Rabbit Conduct a dermal study to determine the toxicity and/or toxicokinetic behavior of your compound when applied topically to rabbits.
  • Topical Dermal Toxicity and/or Toxicokinetic Study - Rat Conduct a dermal study to determine the toxicity and/or toxicokinetic behavior of your compound when applied topically to rats.
  • Topical Ocular Toxicity and/or Toxicokinetic Study - Dog / Canine Conduct a topical ocular toxicity study in dogs/canines to determine the toxicity and toxicokinetic behavior of your compound.
  • Topical Ocular Toxicity and/or Toxicokinetic Study - Minipig Conduct a topical ocular toxicity study in minipigs to determine the toxicity and toxicokinetic behavior of your compound.
  • Topical Ocular Toxicity and/or Toxicokinetic Study - Monkey / Non-human Primate Conduct a topical ocular toxicity study in monkeys/non-human primates to determine the toxicity and toxicokinetic behavior of your compound.
  • Topical Ocular Toxicity and/or Toxicokinetic Study - Mouse Conduct a topical ocular toxicity study in mice to determine the toxicity and toxicokinetic behavior of your compound.
  • Topical Ocular Toxicity and/or Toxicokinetic Study - Rabbit, Non-pigmented (New Zealand White; NZW) Conduct a topical ocular toxicity study in non-pigmented rabbits to determine the toxicity and toxicokinetic behavior of your compound.
  • Topical Ocular Toxicity and/or Toxicokinetic Study - Rabbit, Pigmented (Dutch Belted, New Zealand Red) Conduct a topical ocular toxicity study in pigmented rabbits to determine the toxicity and toxicokinetic behavior of your compound.
  • Topical Ocular Toxicity and/or Toxicokinetic Study - Rat Conduct a topical ocular toxicity study in rats to determine the toxicity and toxicokinetic behavior of your compound.

Target Animal and Human Food Safety

  • Honey Bee Chronic Feeding Test Evaluate the toxic effects of an agrochemical after 10 days of feeding exposure in adult honey bees.
  • Target Animal Safety (TAS) Studies Evaluate potential harmful effects associated with the use of a new animal drug in a controlled setting.
  • Tolerance Studies Conduct tolerance studies on target animals of veterinary products.
  • Toxicity Test for Veterinary Drugs Use the drug at 10X the recommended dose for 3X the recommended duration to evaluate its safety.
  • Toxicokinetic Analysis Determine the drug concentration at which off-target or toxic effects occur.

Testing Services

  • Accelerated Stability Determine shelf life of drug formulations by comparing API breakdown at elevated temperature.
  • ASTM E1207: Antiperspirant Clinical Testing Determine antiperspirant efficacy for products (e.g. deodorant) that are intended to be applied to the underarm.
  • ASTM E2315: Time-Kill Procedure (Antimicrobial Testing Study) Assessment of Antimicrobial Activity Using a Time-Kill Procedure
  • Bacterial Identification Testing Use biochemical and molecular methods to identify unknown microorganisms.
  • Bacterial Reverse Mutation Assay Test whether a cosmetic product or ingredient causes DNA mutations in bacteria.
  • Characteristic Testing Characterization of physical and chemical properties of raw materials
Show all 61 in Testing Services 55 more
  • CLSI M26-A: Minimum Bactericidal Concentration (MBC) Determine the lowest concentration of an antimicrobial agent that is lethal to the target bacteria in vitro.
  • Collagen Production Test Test the regenerative ability of the skin under the influence of the test sample.
  • Consumer Care Testing and Substantiation Test personal care products using analytical, in vitro, and microbial test services
  • Cosmetic Preservative Efficacy Test Assess the efficacy of a product's preservative system.
  • Cosmetics Aerobic Plate Count Determine the level of aerobic bacteria present in a cosmetic or personal care product.
  • Cosmetics Anaerobic Plate Count Determine the level of anaerobic bacteria present in a cosmetic or personal care product.
  • Cosmetics Product Information File (PIF) audit Evaluate the cosmetics product information file which is a product dossier that contains all the most important information about the finished product.
  • Cosmetics safety assessments Conduct safety assessments such as Microbiological quality, Margin of Safety, and information about the packaging material of cosmetic products.
  • Cosmetics Yeast and Mold Count Determine the presence of fungi in a cosmetic or personal care product.
  • Elevated Temperature Stability Determine the stability of a product at elevated temperature.
  • Ex Vivo Eye Irritation Test (EVEIT) Use optical coherence tomography (OCT) to monitor full-thickness recovery of corneal tissue.
  • Freeze-Thaw Testing Use freeze-thaw cycling to measure the long-term durability of cosumer products.
  • Human Eye Instillation Test Assess the eye irritation potential of a product compared with a marketed control product.
  • Human Repeat Insult Patch Test (HRIPT) Examples of which include Topical Irritation, Allergenicity, Phototoxicity and Photoallergy testing.
  • In Vitro Claim Substantiation Evaluation using FDA Broad Spectrum and/ or ISO 24443
  • In Vitro Oral Care Product Testing Perform in vitro oral care product testing of dental products to evaluate safety and performance, including assessment for cleaning, brushing, whitening, stain removal, erosion, abrasivity and sensitivity.
  • In Vitro Skin Models Measure skin model penetration and invasion, photosensitivity and toxicity.
  • In Vitro Toxicology Testing Non-animal testing employing US and international methodologies for determining irritation and other undesirable potentials.
  • ISO 11930: Preservative Test Evaluate the antimicrobial stabilization of a cosmetic product as per ISO 11930.
  • ISO 16217: Water Resistant Testing Evaluation of sunscreen's water resistance (40 and 80 minute)
  • Membrane Permeability (PAMPA) Parallel Artificial Membrane Permeability Assay (PAMPA) - Measure passive diffusion of drugs by the parallel artificial membrane permeation assay.
  • Microbiological Sterility Testing Test the presence of viable microorganisms.
  • Non-Acnegenicity & Non-Comedogenicity Test Test whether a cosmetic product is likely to cause acne and comedones (pimples).
  • Ocular Corrosion Testing Use in vitro models to determine whether a product (or ingredient) can cause ocular corrosion.
  • Ocular Irritation Test Use human subjects to determine whether a cosmetic product or ingredient can cause ocular irritation.
  • OECD 428: In Vitro Skin Penetration Request OECD 428 services. This method is designed to provide information on absorption of a test substance, (ideally radiolabelled), applied to the surface of a skin sample separating the two chambers (a donor...
  • OECD 435: Skin Corrosion Test - Membrane Barrier Method Use in vitro models to determine whether a cosmetic product or ingredient can cause skin corrosion.
  • OECD 439: Skin Irritation Test (SIT) Reconstructed Human Epidermis Test (RhE) Method - An in vitro testing method designed to identify chemicals and/or mixtures capable of inducing moderate skin irritation.
  • OECD 442C: Direct Peptide Reactivity Assay (DPRA) Determine whether a test article satisfies the protein-binding criterion for skin sensitizers.
  • OECD 442D: ARE-Nrf2 Luciferase Test An in vitro test method (KeratinoSensTM and/or LuSens) that models the second key event in the Adverse Outcome Pathway for Dermal Sensitization.
  • OECD 442E: Human Cell Line Activation Test (h-CLAT) In vitro skin sensitization test to predict skin sensitization potency.
  • OECD 497: chemical sensitivity OECD TG 497 outlines the 2o3 approach to determine if a test chemical is potentially skin sensitivity .
  • OECD TG 492: Ocular Irritation Testing Use in vitro skin models to determine whether a product can cause dermal sensitization (e.g. EpiOcular Eye Irritation Test - EIT)
  • Package Compatibility Tests Ensure that the consumer product is not adversely affected by the package components and vice versa.
  • PAO Stability Trial Assess the stability of a consumer product under certain storage conditions.
  • Photoallergy Maximization Test Determine the photoallergenic potential of a topically applied product under maximization conditions.
  • Phototoxicity and Photosensitization Screening Screen a consumer healthcare product for irritancy and/or allergy potential following exposure to UV light.
  • Phototoxicology Phototoxicity testing identifies and evaluates the potential of chemical agents to induce toxicity upon subsequent exposure to light.
  • Raw Material Microbiological Testing Examples of which include Microbial Content using USP <61> and <62> and other standards, LAL Endotoxin, Ames Mutagenicity and Sterility.
  • Real-time Stability Test Assure stability and physical integrity of consumer products in real-time conditions.
  • Repeat Insult Patch Tests: Sensitisation Perform 100- and 200-subject patch tests to investigate sensitization (allergy) potential of a product following repeated exposure and challenge at a naïve skin site.
  • Safety In-Use Studies Safety-in-use studies assess the potential for a product to elicit adverse reactions under normal use conditions.
  • Sebum Production Testing to evaluate the oil production in the skin
  • Single Ocular Instillation Test Determine if a “tear-free” claim can be substantiated for a cosmetic product.
  • Skin Elasticity Testing Measure the skin's ability to resist pressure (firmness) and its ability to return to its original position pre- and post-treatment.
  • Skin Lightening Product Test Measure qualitative and quantitative changes in skin pigmentation under the influence of the test sample.
  • SPF Protection Efficacy Evaluation using FDA Final Rule (2011), Cosmetics Europe (COLIPA), ISO 24444
  • Stain Removal & Whitening Studies Assess the stain removal effectiveness of a tooth whitening product in healthy volunteers.
  • Tolerance Test Under Dermatologic Control Evaluate the acceptability and skin tolerance of a cosmetic product.
  • Trans-Epidermal Water Loss (TEWL) Use a sensing electrode encased in a chimney to measure the relative humidity percentage at the skin surface.
  • USP 51 Cosmetic Preservative Efficacy Test Evaluate the antimicrobial stabilization of a cosmetic product as per USP 51.
  • USP <61> Microbial Limits Test Determine whether a substance or preparation complies with an established specification for microbiological quality.
  • USP <62> Microbial Limits Test Determine the presence or absence of specific microorganisms.
  • UVA Protection Efficacy Evaluation of UVA protection using JCIA or ISO 24442
  • Viscoelasticity Evaluation when applying a sinusoidal force, calculating the resulting strain response and determining the elastic-spring-like storage modulus and the flow-like loss modulus.

Other services

  • 3D Force Microscopy of Cells Measure cell-generated forces in 3D biopolymer networks that mimic the physiological situation of living cells.
  • AgileData Transform raw data into meaningful and insightful information through through rapid interpretation.
  • AK-Polyfibers™ 3D Cell Culture Fabricate spheroids representative of native cellular environments and easy to handle.
  • BEACHMAX88 Next Generation Sequencing Service BEACHMAX88 Next Generation Sequencing (NGS) by Beachside Biotechnology is a cutting-edge and comprehensive sequencing service designed to meet the diverse needs of researchers, clinicians, and biotechnology...
  • Blanket Purchase Order Form Create a Blanket Purchase Order
  • Cell Painting Services An untargeted, unbiased, whole-cell assessment of compounds' effects on cellular phenotypes.
Show all 38 in Other services 32 more
  • Cureline Punchout Cureline Punchout Catalog
  • Custom Assay Services PhenoVista's Bespoke Assay Services gives you access to a team of scientists to custom develop an assay based on your specific biological questions.
  • Genewiz Human Tissue Sequencing Human Tissue Sequencing
  • IND Writing Receive assistance with materials for an IND application.
  • iONCscan Services Screen immunomodulators by targeting co-stimulatory and inhibitory checkpoint receptors to determine potency using cell-based assays.
  • Microgravity 3D Spheroids Mimic in vitro conditions using active microgravity spheroids in 3D tissue culture.
  • mRNA Synthesis with Dragon Pharmacology order mRNA transcripts via custom workflow with Dragon Pharmacology
  • nanoDSF Service Analyze the conformational and colloidal stability of proteins.
  • NDA Writing Receive assistance in the NDA application process.
  • New Request &nbsp;
  • New Supplier Request Please provide supplier contact details below. Note: to ensure efficient on-boarding and track progress, you will be added in our initial communication to the supplier.
  • Patient Derived Xenograft Model Study Demo Utilize PDX models for in vivo efficacy studies
  • Pfizer Market Access Pfizer Market Access
  • Plain Language Summaries Request services related to the creation of plain language summaries.
  • Qube - High Throughput Screening Screen large compound libraries for ion channel blockers and modulators.
  • Rare Diseases Recruitment of volunteers or study participants who have a rare disease, or specifically in the "U.S.when a chronic and enervating condition afflicts fewer than 200,000 people combined, and in the EU, when it affects...
  • Ready-2-Go AAV Gene Delivery Assay Service PhenoVista's R2G AAV Gene Delivery Assay Service uses a panel of diverse, iPSC-derived cells and several AAV serotypes to get you relevant results quickly!
  • Ready-2-Go Cell Health Assay Service PhenoVista's R2G Cell Health Assay Service uses a panel of cell lines and gets you relevant results quickly!
  • Ready-2-Go Liver Fibrosis Assay Service PhenoVista's R2G Liver Fibrosis Assay Service uses primary, human, hepatic stellate cells in an inducible model of fibrosis to get you relevant results quickly!
  • Ready-2-Go Lung Fibrosis Assay Service PhenoVista's R2G Lung Fibrosis Assay Service uses primary, human, lung fibroblasts in an inducible model of fibrosis to get you relevant results quickly!
  • Ready-2-Go Microglia Phagocytosis Assay Service PhenoVista's R2G Microglia Phagocytosis Assay Service uses human, iPSC-derived, microglia to get you time-resolved, relevant results quickly!
  • Ready-2-Go Mitochondrial Health Assay Service PhenoVista's R2G Mitochondrial Health Assay Service uses a panel of cell lines and gets you relevant results quickly!
  • Ready-2-Go Neurite Network Dynamics Assay Service PhenoVista's R2G Neurite Network Dynamics Assay Service uses human, iPSC-derived, glutamatergic neurons to get you reproducible, relevant results quickly!
  • Ready-2-Go Neurite Outgrowth Assay Service PhenoVista's R2G Neurite Outgrowth Assay Service uses human, iPSC-derived, glutamatergic neurons to get you reproducible, relevant results quickly!
  • Ready-2-Go Neuronal Mitochondrial Health Assay Service PhenoVista's R2G Neuronal Mitochondrial Health Assay Service uses human, iPSC-derived, glutamatergic neurons to get you relevant results quickly!
  • Ready-2-Go Neurotoxicity Assay Service PhenoVista's R2G Neurotoxicity Assay Service uses human, iPSC-derived, glutamatergic neurons to get you relevant results quickly!
  • Site Management Organizations Site Management Organization (SMO) is an organization that provides clinical trial related services to a contract research organization (CRO), a pharmaceutical company, a biotechnology company, a medical device...
  • Standing PO Request Request a Standing Purchase Order - a pre-approved PO that can be used across multiple individual Statements of Work (SOWs). They are ideal for ongoing or repeat work with the same vendor. You will be able to select...
  • Thermo Fisher Scientific Punchout Catalog US Thermo Fisher Scientific Punchout Catalog
  • Thermo Fisher Scientific Punchout EU Punchout for Thermo Fisher Scientific
  • Transcriptome In Vivo Analysis (TIVA) Use TIVA for photo-activated capture of mRNA from a single cell or sub-cellular region.
  • Trial Awareness Create awareness about a clinical trial.

Service areas:

Biology Chemistry

Source: Scientist.com supplier network

Where it operates

Sites by country, with the cities in each.

  • United States Newark 3 sites
  • United Kingdom Redcar, Cleveland 1 site

Source: Scientist.com supplier network (site locations)

About this supplier

In the supplier's own words, as listed in the Scientist.com network.

Vector Laboratories provides reagents, antibodies, assay kits, labeling kits, and enzyme substrate products.

Website
www.vectorlabs.com

Source: Scientist.com supplier network, written by the supplier

Get the Vector Laboratories report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Sources: Scientist.com supplier network.

Work with Vector Laboratories on Scientist.com

For prices, more details, or to contact Vector Laboratories, visit Scientist.com.

Sign in to Scientist.com to open this supplier in your organization's marketplace.